Value Set epSOSActiveIngredient 2013‑06‑03

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies an...

Description

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.

Value Set Name

Value Set Id

Version / effective date

Status

epSOSActiveIngredient

1.3.6.1.4.1.12559.11.10.1.3.1.42.24

January 2010 - 2013‑06‑03

Draft

Source Code System:

2.16.840.1.113883.6.73 WHO ATC

Level/ Type	Code	Display Name	Code System	Description
0-L	A	ALIMENTARY TRACT AND METABOLISM	WHO ATC
0-L	A01	STOMATOLOGICAL PREPARATIONS	WHO ATC
0-L	A01A	STOMATOLOGICAL PREPARATIONS	WHO ATC
0-L	A01AA	Caries prophylactic agents	WHO ATC
0-L	A01AA01	sodium fluoride	WHO ATC
0-L	A01AA02	sodium monofluorophosphate	WHO ATC
0-L	A01AA03	olaflur	WHO ATC
0-L	A01AA04	stannous fluoride	WHO ATC
0-L	A01AA30	combinations	WHO ATC
0-L	A01AA51	sodium fluoride, combinations	WHO ATC
0-L	A01AB	Antiinfectives and antiseptics for local oral treatment	WHO ATC
0-L	A01AB02	hydrogen peroxide	WHO ATC
0-L	A01AB03	chlorhexidine	WHO ATC
0-L	A01AB04	amphotericin B	WHO ATC
0-L	A01AB05	polynoxylin	WHO ATC
0-L	A01AB06	domiphen	WHO ATC
0-L	A01AB07	oxyquinoline	WHO ATC
0-L	A01AB08	neomycin	WHO ATC
0-L	A01AB09	miconazole	WHO ATC
0-L	A01AB10	natamycin	WHO ATC
0-L	A01AB11	various	WHO ATC
0-L	A01AB12	hexetidine	WHO ATC
0-L	A01AB13	tetracycline	WHO ATC
0-L	A01AB14	benzoxonium chloride	WHO ATC
0-L	A01AB15	tibezonium iodide	WHO ATC
0-L	A01AB16	mepartricin	WHO ATC
0-L	A01AB17	metronidazole	WHO ATC
0-L	A01AB18	clotrimazole	WHO ATC
0-L	A01AB19	sodium perborate	WHO ATC
0-L	A01AB21	chlortetracycline	WHO ATC
0-L	A01AB22	doxycycline	WHO ATC
0-L	A01AB23	minocycline	WHO ATC
0-L	A01AC	Corticosteroids for local oral treatment	WHO ATC
0-L	A01AC01	triamcinolone	WHO ATC
0-L	A01AC02	dexamethasone	WHO ATC
0-L	A01AC03	hydrocortisone	WHO ATC
0-L	A01AC54	prednisolone, combinations	WHO ATC
0-L	A01AD	Other agents for local oral treatment	WHO ATC
0-L	A01AD01	epinephrine	WHO ATC
0-L	A01AD02	benzydamine	WHO ATC
0-L	A01AD05	acetylsalicylic acid	WHO ATC
0-L	A01AD06	adrenalone	WHO ATC
0-L	A01AD07	amlexanox	WHO ATC
0-L	A01AD08	becaplermin	WHO ATC
0-L	A01AD11	various	WHO ATC
0-L	A02	DRUGS FOR ACID RELATED DISORDERS	WHO ATC
0-L	A02A	ANTACIDS	WHO ATC
0-L	A02AA	Magnesium compounds	WHO ATC
0-L	A02AA01	magnesium carbonate	WHO ATC
0-L	A02AA02	magnesium oxide	WHO ATC
0-L	A02AA03	magnesium peroxide	WHO ATC
0-L	A02AA04	magnesium hydroxide	WHO ATC
0-L	A02AA05	magnesium silicate	WHO ATC
0-L	A02AA10	combinations	WHO ATC
0-L	A02AB	Aluminium compounds	WHO ATC
0-L	A02AB01	aluminium hydroxide	WHO ATC
0-L	A02AB02	algeldrate	WHO ATC
0-L	A02AB03	aluminium phosphate	WHO ATC
0-L	A02AB04	dihydroxialumini sodium carbonate	WHO ATC
0-L	A02AB05	aluminium acetoacetate	WHO ATC
0-L	A02AB06	aloglutamol	WHO ATC
0-L	A02AB07	aluminium glycinate	WHO ATC
0-L	A02AB10	combinations	WHO ATC
0-L	A02AC	Calcium compounds	WHO ATC
0-L	A02AC01	calcium carbonate	WHO ATC
0-L	A02AC02	calcium silicate	WHO ATC
0-L	A02AC10	combinations	WHO ATC
0-L	A02AD	Combinations and complexes of aluminium, calcium and magnesium compounds	WHO ATC
0-L	A02AD01	ordinary salt combinations	WHO ATC
0-L	A02AD02	magaldrate	WHO ATC
0-L	A02AD03	almagate	WHO ATC
0-L	A02AD04	hydrotalcite	WHO ATC
0-L	A02AD05	almasilate	WHO ATC
0-L	A02AF	Antacids with antiflatulents	WHO ATC
0-L	A02AF01	magaldrate and antiflatulents	WHO ATC
0-L	A02AF02	ordinary salt combinations and antiflatulents	WHO ATC
0-L	A02AG	Antacids with antispasmodics	WHO ATC
0-L	A02AH	Antacids with sodium bicarbonate	WHO ATC
0-L	A02AX	Antacids, other combinations	WHO ATC
0-L	A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)	WHO ATC
0-L	A02BA	H2-receptor antagonists	WHO ATC
0-L	A02BA01	cimetidine	WHO ATC
0-L	A02BA02	ranitidine	WHO ATC
0-L	A02BA03	famotidine	WHO ATC
0-L	A02BA04	nizatidine	WHO ATC
0-L	A02BA05	niperotidine	WHO ATC
0-L	A02BA06	roxatidine	WHO ATC
0-L	A02BA07	ranitidine bismuth citrate	WHO ATC
0-L	A02BA08	lafutidine	WHO ATC
0-L	A02BA51	cimetidine, combinations	WHO ATC
0-L	A02BA53	famotidine, combinations	WHO ATC
0-L	A02BB	Prostaglandins	WHO ATC
0-L	A02BB01	misoprostol	WHO ATC
0-L	A02BB02	enprostil	WHO ATC
0-L	A02BC	Proton pump inhibitors	WHO ATC
0-L	A02BC01	omeprazole	WHO ATC
0-L	A02BC02	pantoprazole	WHO ATC
0-L	A02BC03	lansoprazole	WHO ATC
0-L	A02BC04	rabeprazole	WHO ATC
0-L	A02BC05	esomeprazole	WHO ATC
0-L	A02BD	Combinations for eradication of Helicobacter pylori	WHO ATC
0-L	A02BD01	omeprazole, amoxicillin and metronidazole	WHO ATC
0-L	A02BD02	lansoprazole, tetracycline and metronidazole	WHO ATC
0-L	A02BD03	lansoprazole, amoxicillin and metronidazole	WHO ATC
0-L	A02BD04	pantoprazole, amoxicillin and clarithromycin	WHO ATC
0-L	A02BD05	omeprazole, amoxicillin and clarithromycin	WHO ATC
0-L	A02BD06	esomeprazole, amoxicillin and clarithromycin	WHO ATC
0-L	A02BD07	lansoprazole, amoxicillin and clarithromycin	WHO ATC
0-L	A02BX	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	WHO ATC
0-L	A02BX01	carbenoxolone	WHO ATC
0-L	A02BX02	sucralfate	WHO ATC
0-L	A02BX03	pirenzepine	WHO ATC
0-L	A02BX04	methiosulfonium chloride	WHO ATC
0-L	A02BX05	bismuth subcitrate	WHO ATC
0-L	A02BX06	proglumide	WHO ATC
0-L	A02BX07	gefarnate	WHO ATC
0-L	A02BX08	sulglicotide	WHO ATC
0-L	A02BX09	acetoxolone	WHO ATC
0-L	A02BX10	zolimidine	WHO ATC
0-L	A02BX11	troxipide	WHO ATC
0-L	A02BX12	bismuth subnitrate	WHO ATC
0-L	A02BX13	alginic acid	WHO ATC
0-L	A02BX51	carbenoxolone, combinations excl. psycholeptics	WHO ATC
0-L	A02BX71	carbenoxolone, combinations with psycholeptics	WHO ATC
0-L	A02BX77	gefarnate, combinations with psycholeptics	WHO ATC
0-L	A02X	OTHER DRUGS FOR ACID RELATED DISORDERS	WHO ATC
0-L	A03	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS	WHO ATC
0-L	A03A	DRUGS FOR FUNCTIONAL BOWEL DISORDERS	WHO ATC
0-L	A03AA	Synthetic anticholinergics, esters with tertiary amino group	WHO ATC
0-L	A03AA01	oxyphencyclimine	WHO ATC
0-L	A03AA03	camylofin	WHO ATC
0-L	A03AA04	mebeverine	WHO ATC
0-L	A03AA05	trimebutine	WHO ATC
0-L	A03AA06	rociverine	WHO ATC
0-L	A03AA07	dicycloverine	WHO ATC
0-L	A03AA08	dihexyverine	WHO ATC
0-L	A03AA09	difemerine	WHO ATC
0-L	A03AA30	piperidolate	WHO ATC
0-L	A03AB	Synthetic anticholinergics, quaternary ammonium compounds	WHO ATC
0-L	A03AB01	benzilone	WHO ATC
0-L	A03AB02	glycopyrronium	WHO ATC
0-L	A03AB03	oxyphenonium	WHO ATC
0-L	A03AB04	penthienate	WHO ATC
0-L	A03AB05	propantheline	WHO ATC
0-L	A03AB06	otilonium bromide	WHO ATC
0-L	A03AB07	methantheline	WHO ATC
0-L	A03AB08	tridihexethyl	WHO ATC
0-L	A03AB09	isopropamide	WHO ATC
0-L	A03AB10	hexocyclium	WHO ATC
0-L	A03AB11	poldine	WHO ATC
0-L	A03AB12	mepenzolate	WHO ATC
0-L	A03AB13	bevonium	WHO ATC
0-L	A03AB14	pipenzolate	WHO ATC
0-L	A03AB15	diphemanil	WHO ATC
0-L	A03AB16	(2-benzhydryloxyethyl)diethyl-methylammonium iodide	WHO ATC
0-L	A03AB17	tiemonium iodide	WHO ATC
0-L	A03AB18	prifinium bromide	WHO ATC
0-L	A03AB19	timepidium bromide	WHO ATC
0-L	A03AB21	fenpiverinium	WHO ATC
0-L	A03AB53	oxyphenonium, combinations	WHO ATC
0-L	A03AC	Synthetic antispasmodics, amides with tertiary amines	WHO ATC
0-L	A03AC02	dimethylaminopropionylphenothiazine	WHO ATC
0-L	A03AC04	nicofetamide	WHO ATC
0-L	A03AC05	tiropramide	WHO ATC
0-L	A03AD	Papaverine and derivatives	WHO ATC
0-L	A03AD01	papaverine	WHO ATC
0-L	A03AD02	drotaverine	WHO ATC
0-L	A03AD30	moxaverine	WHO ATC
0-L	A03AE	Drugs acting on serotonin receptors	WHO ATC
0-L	A03AE01	alosetron	WHO ATC
0-L	A03AE02	tegaserod	WHO ATC
0-L	A03AE03	cilansetron	WHO ATC
0-L	A03AE04	prucalopride	WHO ATC
0-L	A03AX	Other drugs for functional bowel disorders	WHO ATC
0-L	A03AX01	fenpiprane	WHO ATC
0-L	A03AX02	diisopromine	WHO ATC
0-L	A03AX03	chlorbenzoxamine	WHO ATC
0-L	A03AX04	pinaverium	WHO ATC
0-L	A03AX05	fenoverine	WHO ATC
0-L	A03AX06	idanpramine	WHO ATC
0-L	A03AX07	proxazole	WHO ATC
0-L	A03AX08	alverine	WHO ATC
0-L	A03AX09	trepibutone	WHO ATC
0-L	A03AX10	isometheptene	WHO ATC
0-L	A03AX11	caroverine	WHO ATC
0-L	A03AX12	phloroglucinol	WHO ATC
0-L	A03AX13	silicones	WHO ATC
0-L	A03AX30	trimethyldiphenylpropylamine	WHO ATC
0-L	A03AX58	alverine, combinations	WHO ATC
0-L	A03B	BELLADONNA AND DERIVATIVES, PLAIN	WHO ATC
0-L	A03BA	Belladonna alkaloids, tertiary amines	WHO ATC
0-L	A03BA01	atropine	WHO ATC
0-L	A03BA03	hyoscyamine	WHO ATC
0-L	A03BA04	belladonna total alkaloids	WHO ATC
0-L	A03BB	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	WHO ATC
0-L	A03BB01	butylscopolamine	WHO ATC
0-L	A03BB02	methylatropine	WHO ATC
0-L	A03BB03	methylscopolamine	WHO ATC
0-L	A03BB04	fentonium	WHO ATC
0-L	A03BB05	cimetropium bromide	WHO ATC
0-L	A03C	ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS	WHO ATC
0-L	A03CA	Synthetic anticholinergic agents in combination with psycholeptics	WHO ATC
0-L	A03CA01	isopropamide and psycholeptics	WHO ATC
0-L	A03CA02	clidinium and psycholeptics	WHO ATC
0-L	A03CA03	oxyphencyclimine and psycholeptics	WHO ATC
0-L	A03CA04	otilonium bromide and psycholeptics	WHO ATC
0-L	A03CA05	glycopyrronium and psycholeptics	WHO ATC
0-L	A03CA06	bevonium and psycholeptics	WHO ATC
0-L	A03CA07	ambutonium and psycholeptics	WHO ATC
0-L	A03CA08	diphemanil and psycholeptics	WHO ATC
0-L	A03CA30	emepronium and psycholeptics	WHO ATC
0-L	A03CA34	propantheline and psycholeptics	WHO ATC
0-L	A03CB	Belladonna and derivatives in combination with psycholeptics	WHO ATC
0-L	A03CB01	methylscopolamine and psycholeptics	WHO ATC
0-L	A03CB02	belladonna total alkaloids and psycholeptics	WHO ATC
0-L	A03CB03	atropine and psycholeptics	WHO ATC
0-L	A03CB04	methylhomatropine and psycholeptics	WHO ATC
0-L	A03CB31	hyoscyamine and psycholeptics	WHO ATC
0-L	A03CC	Other antispasmodics in combination with psycholeptics	WHO ATC
0-L	A03D	ANTISPASMODICS IN COMBINATION WITH ANALGESICS	WHO ATC
0-L	A03DA	Synthetic anticholinergic agents in combination with analgesics	WHO ATC
0-L	A03DA01	tropenzilone and analgesics	WHO ATC
0-L	A03DA02	pitofenone and analgesics	WHO ATC
0-L	A03DA03	bevonium and analgesics	WHO ATC
0-L	A03DA04	ciclonium and analgesics	WHO ATC
0-L	A03DA05	camylofin and analgesics	WHO ATC
0-L	A03DA06	trospium and analgesics	WHO ATC
0-L	A03DA07	tiemonium iodide and analgesics	WHO ATC
0-L	A03DB	Belladonna and derivatives in combination with analgesics	WHO ATC
0-L	A03DB04	butylscopolamine and analgesics	WHO ATC
0-L	A03DC	Other antispasmodics in combination with analgesics	WHO ATC
0-L	A03E	ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS	WHO ATC
0-L	A03EA	Antispasmodics, psycholeptics and analgesics in combination	WHO ATC
0-L	A03ED	Antispasmodics in combination with other drugs	WHO ATC
0-L	A03F	PROPULSIVES	WHO ATC
0-L	A03FA	Propulsives	WHO ATC
0-L	A03FA01	metoclopramide	WHO ATC
0-L	A03FA02	cisapride	WHO ATC
0-L	A03FA03	domperidone	WHO ATC
0-L	A03FA04	bromopride	WHO ATC
0-L	A03FA05	alizapride	WHO ATC
0-L	A03FA06	clebopride	WHO ATC
0-L	A04	ANTIEMETICS AND ANTINAUSEANTS	WHO ATC
0-L	A04A	ANTIEMETICS AND ANTINAUSEANTS	WHO ATC
0-L	A04AA	Serotonin (5HT3) antagonists	WHO ATC
0-L	A04AA01	ondansetron	WHO ATC
0-L	A04AA02	granisetron	WHO ATC
0-L	A04AA03	tropisetron	WHO ATC
0-L	A04AA04	dolasetron	WHO ATC
0-L	A04AA05	palonosetron	WHO ATC
0-L	A04AD	Other antiemetics	WHO ATC
0-L	A04AD01	scopolamine	WHO ATC
0-L	A04AD02	cerium oxalate	WHO ATC
0-L	A04AD04	chlorobutanol	WHO ATC
0-L	A04AD05	metopimazine	WHO ATC
0-L	A04AD10	dronabinol	WHO ATC
0-L	A04AD11	nabilone	WHO ATC
0-L	A04AD12	aprepitant	WHO ATC
0-L	A04AD13	casopitant	WHO ATC
0-L	A04AD51	scopolamine, combinations	WHO ATC
0-L	A04AD54	chlorobutanol, combinations	WHO ATC
0-L	A05	BILE AND LIVER THERAPY	WHO ATC
0-L	A05A	BILE THERAPY	WHO ATC
0-L	A05AA	Bile acid preparations	WHO ATC
0-L	A05AA01	chenodeoxycholic acid	WHO ATC
0-L	A05AA02	ursodeoxycholic acid	WHO ATC
0-L	A05AA03	cholic acid	WHO ATC
0-L	A05AB	Preparations for biliary tract therapy	WHO ATC
0-L	A05AB01	nicotinyl methylamide	WHO ATC
0-L	A05AX	Other drugs for bile therapy	WHO ATC
0-L	A05AX01	piprozolin	WHO ATC
0-L	A05AX02	hymecromone	WHO ATC
0-L	A05AX03	cyclobutyrol	WHO ATC
0-L	A05B	LIVER THERAPY, LIPOTROPICS	WHO ATC
0-L	A05BA	Liver therapy	WHO ATC
0-L	A05BA01	arginine glutamate	WHO ATC
0-L	A05BA03	silymarin	WHO ATC
0-L	A05BA04	citiolone	WHO ATC
0-L	A05BA05	epomediol	WHO ATC
0-L	A05BA06	ornithine oxoglurate	WHO ATC
0-L	A05BA07	tidiacic arginine	WHO ATC
0-L	A05BA08	glycyrrhizic acid	WHO ATC
0-L	A05C	DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION	WHO ATC
0-L	A06	LAXATIVES	WHO ATC
0-L	A06A	LAXATIVES	WHO ATC
0-L	A06AA	Softeners, emollients	WHO ATC
0-L	A06AA01	liquid paraffin	WHO ATC
0-L	A06AA02	docusate sodium	WHO ATC
0-L	A06AA51	liquid paraffin, combinations	WHO ATC
0-L	A06AB	Contact laxatives	WHO ATC
0-L	A06AB01	oxyphenisatine	WHO ATC
0-L	A06AB02	bisacodyl	WHO ATC
0-L	A06AB03	dantron	WHO ATC
0-L	A06AB04	phenolphthalein	WHO ATC
0-L	A06AB05	castor oil	WHO ATC
0-L	A06AB06	senna glycosides	WHO ATC
0-L	A06AB07	cascara	WHO ATC
0-L	A06AB08	sodium picosulfate	WHO ATC
0-L	A06AB09	bisoxatin	WHO ATC
0-L	A06AB20	contact laxatives in combination	WHO ATC
0-L	A06AB30	contact laxatives in combination with belladonna alkaloids	WHO ATC
0-L	A06AB52	bisacodyl, combinations	WHO ATC
0-L	A06AB53	dantron, combinations	WHO ATC
0-L	A06AB56	senna glycosides, combinations	WHO ATC
0-L	A06AB57	cascara, combinations	WHO ATC
0-L	A06AB58	sodium picosulfate, combinations	WHO ATC
0-L	A06AC	Bulk producers	WHO ATC
0-L	A06AC01	ispaghula (psylla seeds)	WHO ATC
0-L	A06AC02	ethulose	WHO ATC
0-L	A06AC03	sterculia	WHO ATC
0-L	A06AC05	linseed	WHO ATC
0-L	A06AC06	methylcellulose	WHO ATC
0-L	A06AC07	triticum (wheat fibre)	WHO ATC
0-L	A06AC08	polycarbophil calcium	WHO ATC
0-L	A06AC51	ispaghula, combinations	WHO ATC
0-L	A06AC53	sterculia, combinations	WHO ATC
0-L	A06AC55	linseed, combinations	WHO ATC
0-L	A06AD	Osmotically acting laxatives	WHO ATC
0-L	A06AD01	magnesium carbonate	WHO ATC
0-L	A06AD02	magnesium oxide	WHO ATC
0-L	A06AD03	magnesium peroxide	WHO ATC
0-L	A06AD04	magnesium sulfate	WHO ATC
0-L	A06AD10	mineral salts in combination	WHO ATC
0-L	A06AD11	lactulose	WHO ATC
0-L	A06AD12	lactitol	WHO ATC
0-L	A06AD13	sodium sulfate	WHO ATC
0-L	A06AD14	pentaerithrityl	WHO ATC
0-L	A06AD15	macrogol	WHO ATC
0-L	A06AD16	mannitol	WHO ATC
0-L	A06AD17	sodium phosphate	WHO ATC
0-L	A06AD18	sorbitol	WHO ATC
0-L	A06AD19	magnesium citrate	WHO ATC
0-L	A06AD21	sodium tartrate	WHO ATC
0-L	A06AD61	lactulose, combinations	WHO ATC
0-L	A06AD65	macrogol, combinations	WHO ATC
0-L	A06AG	Enemas	WHO ATC
0-L	A06AG01	sodium phosphate	WHO ATC
0-L	A06AG02	bisacodyl	WHO ATC
0-L	A06AG03	dantron, incl. combinations	WHO ATC
0-L	A06AG04	glycerol	WHO ATC
0-L	A06AG06	oil	WHO ATC
0-L	A06AG07	sorbitol	WHO ATC
0-L	A06AG10	docusate sodium, incl. combinations	WHO ATC
0-L	A06AG11	laurilsulfate, incl. combinations	WHO ATC
0-L	A06AG20	combinations	WHO ATC
0-L	A06AH	Peripheral opioid receptor antagonists	WHO ATC
0-L	A06AH01	methylnaltrexone bromide	WHO ATC
0-L	A06AH02	alvimopan	WHO ATC
0-L	A06AX	Other laxatives	WHO ATC
0-L	A06AX01	glycerol	WHO ATC
0-L	A06AX02	carbon dioxide producing drugs	WHO ATC
0-L	A06AX03	lubiprostone	WHO ATC
0-L	A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS	WHO ATC
0-L	A07A	INTESTINAL ANTIINFECTIVES	WHO ATC
0-L	A07AA	Antibiotics	WHO ATC
0-L	A07AA01	neomycin	WHO ATC
0-L	A07AA02	nystatin	WHO ATC
0-L	A07AA03	natamycin	WHO ATC
0-L	A07AA04	streptomycin	WHO ATC
0-L	A07AA05	polymyxin B	WHO ATC
0-L	A07AA06	paromomycin	WHO ATC
0-L	A07AA07	amphotericin B	WHO ATC
0-L	A07AA08	kanamycin	WHO ATC
0-L	A07AA09	vancomycin	WHO ATC
0-L	A07AA10	colistin	WHO ATC
0-L	A07AA11	rifaximin	WHO ATC
0-L	A07AA51	neomycin, combinations	WHO ATC
0-L	A07AA54	streptomycin, combinations	WHO ATC
0-L	A07AB	Sulfonamides	WHO ATC
0-L	A07AB02	phthalylsulfathiazole	WHO ATC
0-L	A07AB03	sulfaguanidine	WHO ATC
0-L	A07AB04	succinylsulfathiazole	WHO ATC
0-L	A07AC	Imidazole derivatives	WHO ATC
0-L	A07AC01	miconazole	WHO ATC
0-L	A07AX	Other intestinal antiinfectives	WHO ATC
0-L	A07AX01	broxyquinoline	WHO ATC
0-L	A07AX02	acetarsol	WHO ATC
0-L	A07AX03	nifuroxazide	WHO ATC
0-L	A07AX04	nifurzide	WHO ATC
0-L	A07B	INTESTINAL ADSORBENTS	WHO ATC
0-L	A07BA	Charcoal preparations	WHO ATC
0-L	A07BA01	medicinal charcoal	WHO ATC
0-L	A07BA51	medicinal charcoal, combinations	WHO ATC
0-L	A07BB	Bismuth preparations	WHO ATC
0-L	A07BC	Other intestinal adsorbents	WHO ATC
0-L	A07BC01	pectin	WHO ATC
0-L	A07BC02	kaolin	WHO ATC
0-L	A07BC03	crospovidone	WHO ATC
0-L	A07BC04	attapulgite	WHO ATC
0-L	A07BC05	diosmectite	WHO ATC
0-L	A07BC30	combinations	WHO ATC
0-L	A07BC54	attapulgite, combinations	WHO ATC
0-L	A07C	ELECTROLYTES WITH CARBOHYDRATES	WHO ATC
0-L	A07CA	Oral rehydration salt formulations	WHO ATC
0-L	A07D	ANTIPROPULSIVES	WHO ATC
0-L	A07DA	Antipropulsives	WHO ATC
0-L	A07DA01	diphenoxylate	WHO ATC
0-L	A07DA02	opium	WHO ATC
0-L	A07DA03	loperamide	WHO ATC
0-L	A07DA04	difenoxin	WHO ATC
0-L	A07DA05	loperamide oxide	WHO ATC
0-L	A07DA52	morphine, combinations	WHO ATC
0-L	A07DA53	loperamide, combinations	WHO ATC
0-L	A07E	INTESTINAL ANTIINFLAMMATORY AGENTS	WHO ATC
0-L	A07EA	Corticosteroids acting locally	WHO ATC
0-L	A07EA01	prednisolone	WHO ATC
0-L	A07EA02	hydrocortisone	WHO ATC
0-L	A07EA03	prednisone	WHO ATC
0-L	A07EA04	betamethasone	WHO ATC
0-L	A07EA05	tixocortol	WHO ATC
0-L	A07EA06	budesonide	WHO ATC
0-L	A07EA07	beclometasone	WHO ATC
0-L	A07EB	Antiallergic agents, excl. corticosteroids	WHO ATC
0-L	A07EB01	cromoglicic acid	WHO ATC
0-L	A07EC	Aminosalicylic acid and similar agents	WHO ATC
0-L	A07EC01	sulfasalazine	WHO ATC
0-L	A07EC02	mesalazine	WHO ATC
0-L	A07EC03	olsalazine	WHO ATC
0-L	A07EC04	balsalazide	WHO ATC
0-L	A07F	ANTIDIARRHEAL MICROORGANISMS	WHO ATC
0-L	A07FA	Antidiarrheal microorganisms	WHO ATC
0-L	A07FA01	lactic acid producing organisms	WHO ATC
0-L	A07FA02	saccharomyces boulardii	WHO ATC
0-L	A07FA51	lactic acid producing organisms, combinations	WHO ATC
0-L	A07X	OTHER ANTIDIARRHEALS	WHO ATC
0-L	A07XA	Other antidiarrheals	WHO ATC
0-L	A07XA01	albumin tannate	WHO ATC
0-L	A07XA02	ceratonia	WHO ATC
0-L	A07XA03	calcium compounds	WHO ATC
0-L	A07XA04	racecadotril	WHO ATC
0-L	A07XA51	albumin tannate, combinations	WHO ATC
0-L	A08	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO ATC
0-L	A08A	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO ATC
0-L	A08AA	Centrally acting antiobesity products	WHO ATC
0-L	A08AA01	phentermine	WHO ATC
0-L	A08AA02	fenfluramine	WHO ATC
0-L	A08AA03	amfepramone	WHO ATC
0-L	A08AA04	dexfenfluramine	WHO ATC
0-L	A08AA05	mazindol	WHO ATC
0-L	A08AA06	etilamfetamine	WHO ATC
0-L	A08AA07	cathine	WHO ATC
0-L	A08AA08	clobenzorex	WHO ATC
0-L	A08AA09	mefenorex	WHO ATC
0-L	A08AA10	sibutramine	WHO ATC
0-L	A08AA56	ephedrine, combinations	WHO ATC
0-L	A08AB	Peripherally acting antiobesity products	WHO ATC
0-L	A08AB01	orlistat	WHO ATC
0-L	A08AX	Other antiobesity drugs	WHO ATC
0-L	A08AX01	rimonabant	WHO ATC
0-L	A09	DIGESTIVES, INCL. ENZYMES	WHO ATC
0-L	A09A	DIGESTIVES, INCL. ENZYMES	WHO ATC
0-L	A09AA	Enzyme preparations	WHO ATC
0-L	A09AA01	diastase	WHO ATC
0-L	A09AA02	multienzymes (lipase, protease etc.)	WHO ATC
0-L	A09AA03	pepsin	WHO ATC
0-L	A09AA04	tilactase	WHO ATC
0-L	A09AB	Acid preparations	WHO ATC
0-L	A09AB01	glutamic acid hydrochloride	WHO ATC
0-L	A09AB02	betaine hydrochloride	WHO ATC
0-L	A09AB03	hydrochloric acid	WHO ATC
0-L	A09AB04	citric acid	WHO ATC
0-L	A09AC	Enzyme and acid preparations, combinations	WHO ATC
0-L	A09AC01	pepsin and acid preparations	WHO ATC
0-L	A09AC02	multienzymes and acid preparations	WHO ATC
0-L	A10	DRUGS USED IN DIABETES	WHO ATC
0-L	A10A	INSULINS AND ANALOGUES	WHO ATC
0-L	A10AB	Insulins and analogues for injection, fast-acting	WHO ATC
0-L	A10AB01	insulin (human)	WHO ATC
0-L	A10AB02	insulin (beef)	WHO ATC
0-L	A10AB03	insulin (pork)	WHO ATC
0-L	A10AB04	insulin lispro	WHO ATC
0-L	A10AB05	insulin aspart	WHO ATC
0-L	A10AB06	insulin glulisine	WHO ATC
0-L	A10AB30	combinations	WHO ATC
0-L	A10AC	Insulins and analogues for injection, intermediate-acting	WHO ATC
0-L	A10AC01	insulin (human)	WHO ATC
0-L	A10AC02	insulin (beef)	WHO ATC
0-L	A10AC03	insulin (pork)	WHO ATC
0-L	A10AC04	insulin lispro	WHO ATC
0-L	A10AC30	combinations	WHO ATC
0-L	A10AD	Insulins and analogues for injection, intermediate-acting combined with fast-acting	WHO ATC
0-L	A10AD01	insulin (human)	WHO ATC
0-L	A10AD02	insulin (beef)	WHO ATC
0-L	A10AD03	insulin (pork)	WHO ATC
0-L	A10AD04	Insulin lispro	WHO ATC
0-L	A10AD05	insulin aspart	WHO ATC
0-L	A10AD30	combinations	WHO ATC
0-L	A10AE	Insulins and analogues for injection, long-acting	WHO ATC
0-L	A10AE01	insulin (human)	WHO ATC
0-L	A10AE02	insulin (beef)	WHO ATC
0-L	A10AE03	insulin (pork)	WHO ATC
0-L	A10AE04	insulin glargine	WHO ATC
0-L	A10AE05	insulin detemir	WHO ATC
0-L	A10AE30	combinations	WHO ATC
0-L	A10AF	Insulins and analogues for inhalation	WHO ATC
0-L	A10AF01	insulin (human)	WHO ATC
0-L	A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS	WHO ATC
0-L	A10BA	Biguanides	WHO ATC
0-L	A10BA01	phenformin	WHO ATC
0-L	A10BA02	metformin	WHO ATC
0-L	A10BA03	buformin	WHO ATC
0-L	A10BB	Sulfonamides, urea derivatives	WHO ATC
0-L	A10BB01	glibenclamide	WHO ATC
0-L	A10BB02	chlorpropamide	WHO ATC
0-L	A10BB03	tolbutamide	WHO ATC
0-L	A10BB04	glibornuride	WHO ATC
0-L	A10BB05	tolazamide	WHO ATC
0-L	A10BB06	carbutamide	WHO ATC
0-L	A10BB07	glipizide	WHO ATC
0-L	A10BB08	gliquidone	WHO ATC
0-L	A10BB09	gliclazide	WHO ATC
0-L	A10BB10	metahexamide	WHO ATC
0-L	A10BB11	glisoxepide	WHO ATC
0-L	A10BB12	glimepiride	WHO ATC
0-L	A10BB31	acetohexamide	WHO ATC
0-L	A10BC	Sulfonamides (heterocyclic)	WHO ATC
0-L	A10BC01	glymidine	WHO ATC
0-L	A10BD	Combinations of oral blood glucose lowering drugs	WHO ATC
0-L	A10BD01	phenformin and sulfonamides	WHO ATC
0-L	A10BD02	metformin and sulfonamides	WHO ATC
0-L	A10BD03	metformin and rosiglitazone	WHO ATC
0-L	A10BD04	glimepiride and rosiglitazone	WHO ATC
0-L	A10BD05	metformin and pioglitazone	WHO ATC
0-L	A10BD06	glimepiride and pioglitazone	WHO ATC
0-L	A10BD07	metformin and sitagliptin	WHO ATC
0-L	A10BD08	metformin and vildagliptin	WHO ATC
0-L	A10BD09	pioglitazone and alogliptin	WHO ATC
0-L	A10BF	Alpha glucosidase inhibitors	WHO ATC
0-L	A10BF01	acarbose	WHO ATC
0-L	A10BF02	miglitol	WHO ATC
0-L	A10BF03	voglibose	WHO ATC
0-L	A10BG	Thiazolidinediones	WHO ATC
0-L	A10BG01	troglitazone	WHO ATC
0-L	A10BG02	rosiglitazone	WHO ATC
0-L	A10BG03	pioglitazone	WHO ATC
0-L	A10BH	Dipeptidyl peptidase 4 (DPP-4) inhibitors	WHO ATC
0-L	A10BH01	sitagliptin	WHO ATC
0-L	A10BH02	vildagliptin	WHO ATC
0-L	A10BH03	saxagliptin	WHO ATC
0-L	A10BH04	alogliptin	WHO ATC
0-L	A10BX	Other blood glucose lowering drugs, excl. insulins	WHO ATC
0-L	A10BX01	guar gum	WHO ATC
0-L	A10BX02	repaglinide	WHO ATC
0-L	A10BX03	nateglinide	WHO ATC
0-L	A10BX04	exenatide	WHO ATC
0-L	A10BX05	pramlintide	WHO ATC
0-L	A10BX06	benfluorex	WHO ATC
0-L	A10BX07	liraglutide	WHO ATC
0-L	A10BX08	mitiglinide	WHO ATC
0-L	A10X	OTHER DRUGS USED IN DIABETES	WHO ATC
0-L	A10XA	Aldose reductase inhibitors	WHO ATC
0-L	A10XA01	tolrestat	WHO ATC
0-L	A11	VITAMINS	WHO ATC
0-L	A11A	MULTIVITAMINS, COMBINATIONS	WHO ATC
0-L	A11AA	Multivitamins with minerals	WHO ATC
0-L	A11AA01	multivitamins and iron	WHO ATC
0-L	A11AA02	multivitamins and calcium	WHO ATC
0-L	A11AA03	multivitamins and other minerals, incl. combinations	WHO ATC
0-L	A11AA04	multivitamins and trace elements	WHO ATC
0-L	A11AB	Multivitamins, other combinations	WHO ATC
0-L	A11B	MULTIVITAMINS, PLAIN	WHO ATC
0-L	A11BA	Multivitamins, plain	WHO ATC
0-L	A11C	VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO	WHO ATC
0-L	A11CA	Vitamin A, plain	WHO ATC
0-L	A11CA01	retinol (vit A)	WHO ATC
0-L	A11CA02	betacarotene	WHO ATC
0-L	A11CB	Vitamin A and D in combination	WHO ATC
0-L	A11CC	Vitamin D and analogues	WHO ATC
0-L	A11CC01	ergocalciferol	WHO ATC
0-L	A11CC02	dihydrotachysterol	WHO ATC
0-L	A11CC03	alfacalcidol	WHO ATC
0-L	A11CC04	calcitriol	WHO ATC
0-L	A11CC05	colecalciferol	WHO ATC
0-L	A11CC06	calcifediol	WHO ATC
0-L	A11CC20	combinations	WHO ATC
0-L	A11D	VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12	WHO ATC
0-L	A11DA	Vitamin B1, plain	WHO ATC
0-L	A11DA01	thiamine (vit B1)	WHO ATC
0-L	A11DA02	sulbutiamine	WHO ATC
0-L	A11DA03	benfotiamine	WHO ATC
0-L	A11DB	Vitamin B1 in combination with vitamin B6 and/or vitamin B12	WHO ATC
0-L	A11E	VITAMIN B-COMPLEX, INCL. COMBINATIONS	WHO ATC
0-L	A11EA	Vitamin B-complex, plain	WHO ATC
0-L	A11EB	Vitamin B-complex with vitamin C	WHO ATC
0-L	A11EC	Vitamin B-complex with minerals	WHO ATC
0-L	A11ED	Vitamin B-complex with anabolic steroids	WHO ATC
0-L	A11EX	Vitamin B-complex, other combinations	WHO ATC
0-L	A11G	ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS	WHO ATC
0-L	A11GA	Ascorbic acid (vitamin C), plain	WHO ATC
0-L	A11GA01	ascorbic acid (vit C)	WHO ATC
0-L	A11GB	Ascorbic acid (vitamin C), combinations	WHO ATC
0-L	A11GB01	ascorbic acid (vit C) and calcium	WHO ATC
0-L	A11H	OTHER PLAIN VITAMIN PREPARATIONS	WHO ATC
0-L	A11HA	Other plain vitamin preparations	WHO ATC
0-L	A11HA01	nicotinamide	WHO ATC
0-L	A11HA02	pyridoxine (vit B6)	WHO ATC
0-L	A11HA03	tocopherol (vit E)	WHO ATC
0-L	A11HA04	riboflavin (vit B2)	WHO ATC
0-L	A11HA05	biotin	WHO ATC
0-L	A11HA06	pyridoxal phosphate	WHO ATC
0-L	A11HA07	inositol	WHO ATC
0-L	A11HA08	tocofersolan	WHO ATC
0-L	A11HA30	dexpanthenol	WHO ATC
0-L	A11HA31	calcium pantothenate	WHO ATC
0-L	A11HA32	pantethine	WHO ATC
0-L	A11J	OTHER VITAMIN PRODUCTS, COMBINATIONS	WHO ATC
0-L	A11JA	Combinations of vitamins	WHO ATC
0-L	A11JB	Vitamins with minerals	WHO ATC
0-L	A11JC	Vitamins, other combinations	WHO ATC
0-L	A12	MINERAL SUPPLEMENTS	WHO ATC
0-L	A12A	CALCIUM	WHO ATC
0-L	A12AA	Calcium	WHO ATC
0-L	A12AA01	calcium phosphate	WHO ATC
0-L	A12AA02	calcium glubionate	WHO ATC
0-L	A12AA03	calcium gluconate	WHO ATC
0-L	A12AA04	calcium carbonate	WHO ATC
0-L	A12AA05	calcium lactate	WHO ATC
0-L	A12AA06	calcium lactate gluconate	WHO ATC
0-L	A12AA07	calcium chloride	WHO ATC
0-L	A12AA08	calcium glycerylphosphate	WHO ATC
0-L	A12AA09	calcium citrate lysine complex	WHO ATC
0-L	A12AA10	calcium glucoheptonate	WHO ATC
0-L	A12AA11	calcium pangamate	WHO ATC
0-L	A12AA12	calcium acetate anhydrous	WHO ATC
0-L	A12AA20	calcium (different salts in combination)	WHO ATC
0-L	A12AA30	calcium laevulate	WHO ATC
0-L	A12AX	Calcium, combinations with other drugs	WHO ATC
0-L	A12B	POTASSIUM	WHO ATC
0-L	A12BA	Potassium	WHO ATC
0-L	A12BA01	potassium chloride	WHO ATC
0-L	A12BA02	potassium citrate	WHO ATC
0-L	A12BA03	potassium hydrogentartrate	WHO ATC
0-L	A12BA04	potassium hydrogencarbonate	WHO ATC
0-L	A12BA05	potassium gluconate	WHO ATC
0-L	A12BA30	combinations	WHO ATC
0-L	A12BA51	potassium chloride, combinations	WHO ATC
0-L	A12C	OTHER MINERAL SUPPLEMENTS	WHO ATC
0-L	A12CA	Sodium	WHO ATC
0-L	A12CA01	sodium chloride	WHO ATC
0-L	A12CA02	sodium sulfate	WHO ATC
0-L	A12CB	Zinc	WHO ATC
0-L	A12CB01	zinc sulfate	WHO ATC
0-L	A12CB02	zinc gluconate	WHO ATC
0-L	A12CB03	zinc protein complex	WHO ATC
0-L	A12CC	Magnesium	WHO ATC
0-L	A12CC01	magnesium chloride	WHO ATC
0-L	A12CC02	magnesium sulfate	WHO ATC
0-L	A12CC03	magnesium gluconate	WHO ATC
0-L	A12CC04	magnesium citrate	WHO ATC
0-L	A12CC05	magnesium aspartate	WHO ATC
0-L	A12CC06	magnesium lactate	WHO ATC
0-L	A12CC07	magnesium levulinate	WHO ATC
0-L	A12CC08	magnesium pidolate	WHO ATC
0-L	A12CC09	magnesium orotate	WHO ATC
0-L	A12CC10	magnesium oxide	WHO ATC
0-L	A12CC30	magnesium (different salts in combination)	WHO ATC
0-L	A12CD	Fluoride	WHO ATC
0-L	A12CD01	sodium fluoride	WHO ATC
0-L	A12CD02	sodium monofluorophosphate	WHO ATC
0-L	A12CD51	fluoride, combinations	WHO ATC
0-L	A12CE	Selenium	WHO ATC
0-L	A12CE01	sodium selenate	WHO ATC
0-L	A12CE02	sodium selenite	WHO ATC
0-L	A12CX	Other mineral products	WHO ATC
0-L	A13	TONICS	WHO ATC
0-L	A13A	TONICS	WHO ATC
0-L	A14	ANABOLIC AGENTS FOR SYSTEMIC USE	WHO ATC
0-L	A14A	ANABOLIC STEROIDS	WHO ATC
0-L	A14AA	Androstan derivatives	WHO ATC
0-L	A14AA01	androstanolone	WHO ATC
0-L	A14AA02	stanozolol	WHO ATC
0-L	A14AA03	metandienone	WHO ATC
0-L	A14AA04	metenolone	WHO ATC
0-L	A14AA05	oxymetholone	WHO ATC
0-L	A14AA06	quinbolone	WHO ATC
0-L	A14AA07	prasterone	WHO ATC
0-L	A14AA08	oxandrolone	WHO ATC
0-L	A14AA09	norethandrolone	WHO ATC
0-L	A14AB	Estren derivatives	WHO ATC
0-L	A14AB01	nandrolone	WHO ATC
0-L	A14AB02	ethylestrenol	WHO ATC
0-L	A14AB03	oxabolone cipionate	WHO ATC
0-L	A14B	OTHER ANABOLIC AGENTS	WHO ATC
0-L	A15	APPETITE STIMULANTS	WHO ATC
0-L	A16	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS	WHO ATC
0-L	A16A	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS	WHO ATC
0-L	A16AA	Amino acids and derivatives	WHO ATC
0-L	A16AA01	levocarnitine	WHO ATC
0-L	A16AA02	ademetionine	WHO ATC
0-L	A16AA03	glutamine	WHO ATC
0-L	A16AA04	mercaptamine	WHO ATC
0-L	A16AA05	carglumic acid	WHO ATC
0-L	A16AA06	betaine	WHO ATC
0-L	A16AB	Enzymes	WHO ATC
0-L	A16AB01	alglucerase	WHO ATC
0-L	A16AB02	imiglucerase	WHO ATC
0-L	A16AB03	agalsidase alfa	WHO ATC
0-L	A16AB04	agalsidase beta	WHO ATC
0-L	A16AB05	laronidase	WHO ATC
0-L	A16AB06	sacrosidase	WHO ATC
0-L	A16AB07	alglucosidase alfa	WHO ATC
0-L	A16AB08	galsulfase	WHO ATC
0-L	A16AB09	idursulfase	WHO ATC
0-L	A16AX	Various alimentary tract and metabolism products	WHO ATC
0-L	A16AX01	tioctic acid	WHO ATC
0-L	A16AX02	anethole trithione	WHO ATC
0-L	A16AX03	sodium phenylbutyrate	WHO ATC
0-L	A16AX04	nitisinone	WHO ATC
0-L	A16AX05	zinc acetate	WHO ATC
0-L	A16AX06	miglustat	WHO ATC
0-L	A16AX07	sapropterin	WHO ATC
0-L	B	BLOOD AND BLOOD FORMING ORGANS	WHO ATC
0-L	B01	ANTITHROMBOTIC AGENTS	WHO ATC
0-L	B01A	ANTITHROMBOTIC AGENTS	WHO ATC
0-L	B01AA	Vitamin K antagonists	WHO ATC
0-L	B01AA01	dicoumarol	WHO ATC
0-L	B01AA02	phenindione	WHO ATC
0-L	B01AA03	warfarin	WHO ATC
0-L	B01AA04	phenprocoumon	WHO ATC
0-L	B01AA07	acenocoumarol	WHO ATC
0-L	B01AA08	ethyl biscoumacetate	WHO ATC
0-L	B01AA09	clorindione	WHO ATC
0-L	B01AA10	diphenadione	WHO ATC
0-L	B01AA11	tioclomarol	WHO ATC
0-L	B01AB	Heparin group	WHO ATC
0-L	B01AB01	heparin	WHO ATC
0-L	B01AB02	antithrombin III	WHO ATC
0-L	B01AB04	dalteparin	WHO ATC
0-L	B01AB05	enoxaparin	WHO ATC
0-L	B01AB06	nadroparin	WHO ATC
0-L	B01AB07	parnaparin	WHO ATC
0-L	B01AB08	reviparin	WHO ATC
0-L	B01AB09	danaparoid	WHO ATC
0-L	B01AB10	tinzaparin	WHO ATC
0-L	B01AB11	sulodexide	WHO ATC
0-L	B01AB12	bemiparin	WHO ATC
0-L	B01AB51	heparin, combinations	WHO ATC
0-L	B01AC	Platelet aggregation inhibitors excl. heparin	WHO ATC
0-L	B01AC01	ditazole	WHO ATC
0-L	B01AC02	cloricromen	WHO ATC
0-L	B01AC03	picotamide	WHO ATC
0-L	B01AC04	clopidogrel	WHO ATC
0-L	B01AC05	ticlopidine	WHO ATC
0-L	B01AC06	acetylsalicylic acid	WHO ATC
0-L	B01AC07	dipyridamole	WHO ATC
0-L	B01AC08	carbasalate calcium	WHO ATC
0-L	B01AC09	epoprostenol	WHO ATC
0-L	B01AC10	indobufen	WHO ATC
0-L	B01AC11	iloprost	WHO ATC
0-L	B01AC13	abciximab	WHO ATC
0-L	B01AC15	aloxiprin	WHO ATC
0-L	B01AC16	eptifibatide	WHO ATC
0-L	B01AC17	tirofiban	WHO ATC
0-L	B01AC18	triflusal	WHO ATC
0-L	B01AC19	beraprost	WHO ATC
0-L	B01AC21	treprostinil	WHO ATC
0-L	B01AC22	prasugrel	WHO ATC
0-L	B01AC30	combinations	WHO ATC
0-L	B01AD	Enzymes	WHO ATC
0-L	B01AD01	streptokinase	WHO ATC
0-L	B01AD02	alteplase	WHO ATC
0-L	B01AD03	anistreplase	WHO ATC
0-L	B01AD04	urokinase	WHO ATC
0-L	B01AD05	fibrinolysin	WHO ATC
0-L	B01AD06	brinase	WHO ATC
0-L	B01AD07	reteplase	WHO ATC
0-L	B01AD08	saruplase	WHO ATC
0-L	B01AD09	ancrod	WHO ATC
0-L	B01AD10	drotrecogin alfa (activated)	WHO ATC
0-L	B01AD11	tenecteplase	WHO ATC
0-L	B01AD12	protein C	WHO ATC
0-L	B01AE	Direct thrombin inhibitors	WHO ATC
0-L	B01AE01	desirudin	WHO ATC
0-L	B01AE02	lepirudin	WHO ATC
0-L	B01AE03	argatroban	WHO ATC
0-L	B01AE04	melagatran	WHO ATC
0-L	B01AE05	ximelagatran	WHO ATC
0-L	B01AE06	bivalirudin	WHO ATC
0-L	B01AE07	dabigatran etexilate	WHO ATC
0-L	B01AX	Other antithrombotic agents	WHO ATC
0-L	B01AX01	defibrotide	WHO ATC
0-L	B01AX04	dermatan sulfate	WHO ATC
0-L	B01AX05	fondaparinux	WHO ATC
0-L	B01AX06	rivaroxaban	WHO ATC
0-L	B02	ANTIHEMORRHAGICS	WHO ATC
0-L	B02A	ANTIFIBRINOLYTICS	WHO ATC
0-L	B02AA	Amino acids	WHO ATC
0-L	B02AA01	aminocaproic acid	WHO ATC
0-L	B02AA02	tranexamic acid	WHO ATC
0-L	B02AA03	aminomethylbenzoic acid	WHO ATC
0-L	B02AB	Proteinase inhibitors	WHO ATC
0-L	B02AB01	aprotinin	WHO ATC
0-L	B02AB02	alfa1 antitrypsin	WHO ATC
0-L	B02AB03	c1-inhibitor	WHO ATC
0-L	B02AB04	camostat	WHO ATC
0-L	B02B	VITAMIN K AND OTHER HEMOSTATICS	WHO ATC
0-L	B02BA	Vitamin K	WHO ATC
0-L	B02BA01	phytomenadione	WHO ATC
0-L	B02BA02	menadione	WHO ATC
0-L	B02BB	Fibrinogen	WHO ATC
0-L	B02BB01	human fibrinogen	WHO ATC
0-L	B02BC	Local hemostatics	WHO ATC
0-L	B02BC01	absorbable gelatin sponge	WHO ATC
0-L	B02BC02	oxidized cellulose	WHO ATC
0-L	B02BC03	tetragalacturonic acid hydroxymethylester	WHO ATC
0-L	B02BC05	adrenalone	WHO ATC
0-L	B02BC06	thrombin	WHO ATC
0-L	B02BC07	collagen	WHO ATC
0-L	B02BC08	calcium alginate	WHO ATC
0-L	B02BC09	epinephrine	WHO ATC
0-L	B02BC10	fibrinogen, human	WHO ATC
0-L	B02BC30	combinations	WHO ATC
0-L	B02BD	Blood coagulation factors	WHO ATC
0-L	B02BD01	coagulation factor IX, II, VII and X in combination	WHO ATC
0-L	B02BD02	coagulation factor VIII	WHO ATC
0-L	B02BD03	factor VIII inhibitor bypassing activity	WHO ATC
0-L	B02BD04	coagulation factor IX	WHO ATC
0-L	B02BD05	coagulation factor VII	WHO ATC
0-L	B02BD06	von Willebrand factor and coagulation factor VIII in combination	WHO ATC
0-L	B02BD07	coagulation factor XIII	WHO ATC
0-L	B02BD08	eptacog alfa (activated)	WHO ATC
0-L	B02BD09	nonacog alfa	WHO ATC
0-L	B02BD30	thrombin	WHO ATC
0-L	B02BX	Other systemic hemostatics	WHO ATC
0-L	B02BX01	etamsylate	WHO ATC
0-L	B02BX02	carbazochrome	WHO ATC
0-L	B02BX03	batroxobin	WHO ATC
0-L	B02BX04	romiplostim	WHO ATC
0-L	B02BX05	eltrombopag	WHO ATC
0-L	B03	ANTIANEMIC PREPARATIONS	WHO ATC
0-L	B03A	IRON PREPARATIONS	WHO ATC
0-L	B03AA	Iron bivalent, oral preparations	WHO ATC
0-L	B03AA01	ferrous glycine sulfate	WHO ATC
0-L	B03AA02	ferrous fumarate	WHO ATC
0-L	B03AA03	ferrous gluconate	WHO ATC
0-L	B03AA04	ferrous carbonate	WHO ATC
0-L	B03AA05	ferrous chloride	WHO ATC
0-L	B03AA06	ferrous succinate	WHO ATC
0-L	B03AA07	ferrous sulfate	WHO ATC
0-L	B03AA08	ferrous tartrate	WHO ATC
0-L	B03AA09	ferrous aspartate	WHO ATC
0-L	B03AA10	ferrous ascorbate	WHO ATC
0-L	B03AA11	ferrous iodine	WHO ATC
0-L	B03AB	Iron trivalent, oral preparations	WHO ATC
0-L	B03AB01	ferric sodium citrate	WHO ATC
0-L	B03AB02	saccharated iron oxide	WHO ATC
0-L	B03AB03	sodium feredetate	WHO ATC
0-L	B03AB04	ferric hydroxide	WHO ATC
0-L	B03AB05	dextriferron	WHO ATC
0-L	B03AB06	ferric citrate	WHO ATC
0-L	B03AB07	chondroitin sulfate-iron complex	WHO ATC
0-L	B03AB08	ferric acetyl transferrin	WHO ATC
0-L	B03AB09	ferric proteinsuccinylate	WHO ATC
0-L	B03AC	Iron trivalent, parenteral preparations	WHO ATC
0-L	B03AC01	dextriferron	WHO ATC
0-L	B03AC02	saccharated iron oxide	WHO ATC
0-L	B03AC03	iron-sorbitol-citric acid complex	WHO ATC
0-L	B03AC05	ferric sorbitol gluconic acid complex	WHO ATC
0-L	B03AC06	ferric oxide dextran complex	WHO ATC
0-L	B03AC07	ferric sodium gluconate complex	WHO ATC
0-L	B03AD	Iron in combination with folic acid	WHO ATC
0-L	B03AD01	ferrous amino acid complex	WHO ATC
0-L	B03AD02	ferrous fumarate	WHO ATC
0-L	B03AD03	ferrous sulfate	WHO ATC
0-L	B03AD04	dextriferron	WHO ATC
0-L	B03AE	Iron in other combinations	WHO ATC
0-L	B03AE01	iron, vitamin B12 and folic acid	WHO ATC
0-L	B03AE02	iron, multivitamins and folic acid	WHO ATC
0-L	B03AE03	iron and multivitamins	WHO ATC
0-L	B03AE04	iron, multivitamins and minerals	WHO ATC
0-L	B03AE10	various combinations	WHO ATC
0-L	B03B	VITAMIN B12 AND FOLIC ACID	WHO ATC
0-L	B03BA	Vitamin B12 (cyanocobalamin and analogues)	WHO ATC
0-L	B03BA01	cyanocobalamin	WHO ATC
0-L	B03BA02	cyanocobalamin tannin complex	WHO ATC
0-L	B03BA03	hydroxocobalamin	WHO ATC
0-L	B03BA04	cobamamide	WHO ATC
0-L	B03BA05	mecobalamin	WHO ATC
0-L	B03BA51	cyanocobalamin, combinations	WHO ATC
0-L	B03BA53	hydroxocobalamin, combinations	WHO ATC
0-L	B03BB	Folic acid and derivatives	WHO ATC
0-L	B03BB01	folic acid	WHO ATC
0-L	B03BB51	folic acid, combinations	WHO ATC
0-L	B03X	OTHER ANTIANEMIC PREPARATIONS	WHO ATC
0-L	B03XA	Other antianemic preparations	WHO ATC
0-L	B03XA01	erythropoietin	WHO ATC
0-L	B03XA02	darbepoetin alfa	WHO ATC
0-L	B03XA03	methoxy polyethylene glycol-epoetin beta	WHO ATC
0-L	B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS	WHO ATC
0-L	B05A	BLOOD AND RELATED PRODUCTS	WHO ATC
0-L	B05AA	Blood substitutes and plasma protein fractions	WHO ATC
0-L	B05AA01	albumin	WHO ATC
0-L	B05AA02	other plasma protein fractions	WHO ATC
0-L	B05AA03	fluorocarbon blood substitutes	WHO ATC
0-L	B05AA05	dextran	WHO ATC
0-L	B05AA06	gelatin agents	WHO ATC
0-L	B05AA07	hydroxyethylstarch	WHO ATC
0-L	B05AA08	hemoglobin crosfumaril	WHO ATC
0-L	B05AA09	hemoglobin raffimer	WHO ATC
0-L	B05AA10	hemoglobin glutamer (bovine)	WHO ATC
0-L	B05AX	Other blood products	WHO ATC
0-L	B05AX01	erythrocytes	WHO ATC
0-L	B05AX02	thrombocytes	WHO ATC
0-L	B05AX03	blood plasma	WHO ATC
0-L	B05AX04	stem cells from umbilical cord blood	WHO ATC
0-L	B05B	I.V. SOLUTIONS	WHO ATC
0-L	B05BA	Solutions for parenteral nutrition	WHO ATC
0-L	B05BA01	amino acids	WHO ATC
0-L	B05BA02	fat emulsions	WHO ATC
0-L	B05BA03	carbohydrates	WHO ATC
0-L	B05BA04	protein hydrolysates	WHO ATC
0-L	B05BA10	combinations	WHO ATC
0-L	B05BB	Solutions affecting the electrolyte balance	WHO ATC
0-L	B05BB01	electrolytes	WHO ATC
0-L	B05BB02	electrolytes with carbohydrates	WHO ATC
0-L	B05BB03	trometamol	WHO ATC
0-L	B05BC	Solutions producing osmotic diuresis	WHO ATC
0-L	B05BC01	mannitol	WHO ATC
0-L	B05BC02	carbamide	WHO ATC
0-L	B05C	IRRIGATING SOLUTIONS	WHO ATC
0-L	B05CA	Antiinfectives	WHO ATC
0-L	B05CA01	cetylpyridinium	WHO ATC
0-L	B05CA02	chlorhexidine	WHO ATC
0-L	B05CA03	nitrofural	WHO ATC
0-L	B05CA04	sulfamethizole	WHO ATC
0-L	B05CA05	taurolidine	WHO ATC
0-L	B05CA06	mandelic acid	WHO ATC
0-L	B05CA07	noxytiolin	WHO ATC
0-L	B05CA08	ethacridine lactate	WHO ATC
0-L	B05CA09	neomycin	WHO ATC
0-L	B05CA10	combinations	WHO ATC
0-L	B05CB	Salt solutions	WHO ATC
0-L	B05CB01	sodium chloride	WHO ATC
0-L	B05CB02	sodium citrate	WHO ATC
0-L	B05CB03	magnesium citrate	WHO ATC
0-L	B05CB04	sodium bicarbonate	WHO ATC
0-L	B05CB10	combinations	WHO ATC
0-L	B05CX	Other irrigating solutions	WHO ATC
0-L	B05CX01	glucose	WHO ATC
0-L	B05CX02	sorbitol	WHO ATC
0-L	B05CX03	glycine	WHO ATC
0-L	B05CX04	mannitol	WHO ATC
0-L	B05CX10	combinations	WHO ATC
0-L	B05D	PERITONEAL DIALYTICS	WHO ATC
0-L	B05DA	Isotonic solutions	WHO ATC
0-L	B05DB	Hypertonic solutions	WHO ATC
0-L	B05X	I.V. SOLUTION ADDITIVES	WHO ATC
0-L	B05XA	Electrolyte solutions	WHO ATC
0-L	B05XA01	potassium chloride	WHO ATC
0-L	B05XA02	sodium bicarbonate	WHO ATC
0-L	B05XA03	sodium chloride	WHO ATC
0-L	B05XA04	ammonium chloride	WHO ATC
0-L	B05XA05	magnesium sulfate	WHO ATC
0-L	B05XA06	potassium phosphate, incl. comb. with other potassium salts	WHO ATC
0-L	B05XA07	calcium chloride	WHO ATC
0-L	B05XA08	sodium acetate	WHO ATC
0-L	B05XA09	sodium phosphate	WHO ATC
0-L	B05XA10	magnesium phosphate	WHO ATC
0-L	B05XA11	magnesium chloride	WHO ATC
0-L	B05XA12	zinc chloride	WHO ATC
0-L	B05XA13	hydrochloric acid	WHO ATC
0-L	B05XA14	sodium glycerophosphate	WHO ATC
0-L	B05XA15	potassium lactate	WHO ATC
0-L	B05XA16	cardioplegia solutions	WHO ATC
0-L	B05XA17	potassium acetate	WHO ATC
0-L	B05XA30	combinations of electrolytes	WHO ATC
0-L	B05XA31	electrolytes in combination with other drugs	WHO ATC
0-L	B05XB	Amino acids	WHO ATC
0-L	B05XB01	arginine hydrochloride	WHO ATC
0-L	B05XB02	alanyl glutamine	WHO ATC
0-L	B05XB03	lysine	WHO ATC
0-L	B05XC	Vitamins	WHO ATC
0-L	B05XX	Other i.v. solution additives	WHO ATC
0-L	B05XX02	trometamol	WHO ATC
0-L	B05Z	HEMODIALYTICS AND HEMOFILTRATES	WHO ATC
0-L	B05ZA	Hemodialytics, concentrates	WHO ATC
0-L	B05ZB	Hemofiltrates	WHO ATC
0-L	B06	OTHER HEMATOLOGICAL AGENTS	WHO ATC
0-L	B06A	OTHER HEMATOLOGICAL AGENTS	WHO ATC
0-L	B06AA	Enzymes	WHO ATC
0-L	B06AA02	fibrinolysin and desoxyribonuclease	WHO ATC
0-L	B06AA03	hyaluronidase	WHO ATC
0-L	B06AA04	chymotrypsin	WHO ATC
0-L	B06AA07	trypsin	WHO ATC
0-L	B06AA10	desoxyribonuclease	WHO ATC
0-L	B06AA11	bromelains	WHO ATC
0-L	B06AA55	streptokinase, combinations	WHO ATC
0-L	B06AB	Other hem products	WHO ATC
0-L	B06AB01	hematin	WHO ATC
0-L	C	CARDIOVASCULAR SYSTEM	WHO ATC
0-L	C01	CARDIAC THERAPY	WHO ATC
0-L	C01A	CARDIAC GLYCOSIDES	WHO ATC
0-L	C01AA	Digitalis glycosides	WHO ATC
0-L	C01AA01	acetyldigitoxin	WHO ATC
0-L	C01AA02	acetyldigoxin	WHO ATC
0-L	C01AA03	digitalis leaves	WHO ATC
0-L	C01AA04	digitoxin	WHO ATC
0-L	C01AA05	digoxin	WHO ATC
0-L	C01AA06	lanatoside C	WHO ATC
0-L	C01AA07	deslanoside	WHO ATC
0-L	C01AA08	metildigoxin	WHO ATC
0-L	C01AA09	gitoformate	WHO ATC
0-L	C01AA52	acetyldigoxin, combinations	WHO ATC
0-L	C01AB	Scilla glycosides	WHO ATC
0-L	C01AB01	proscillaridin	WHO ATC
0-L	C01AB51	proscillaridin, combinations	WHO ATC
0-L	C01AC	Strophantus glycosides	WHO ATC
0-L	C01AC01	g-strophanthin	WHO ATC
0-L	C01AC03	cymarin	WHO ATC
0-L	C01AX	Other cardiac glycosides	WHO ATC
0-L	C01AX02	peruvoside	WHO ATC
0-L	C01B	ANTIARRHYTHMICS, CLASS I AND III	WHO ATC
0-L	C01BA	Antiarrhythmics, class Ia	WHO ATC
0-L	C01BA01	quinidine	WHO ATC
0-L	C01BA02	procainamide	WHO ATC
0-L	C01BA03	disopyramide	WHO ATC
0-L	C01BA04	sparteine	WHO ATC
0-L	C01BA05	ajmaline	WHO ATC
0-L	C01BA08	prajmaline	WHO ATC
0-L	C01BA12	lorajmine	WHO ATC
0-L	C01BA51	quinidine, combinations excl. psycholeptics	WHO ATC
0-L	C01BA71	quinidine, combinations with psycholeptics	WHO ATC
0-L	C01BB	Antiarrhythmics, class Ib	WHO ATC
0-L	C01BB01	lidocaine	WHO ATC
0-L	C01BB02	mexiletine	WHO ATC
0-L	C01BB03	tocainide	WHO ATC
0-L	C01BB04	aprindine	WHO ATC
0-L	C01BC	Antiarrhythmics, class Ic	WHO ATC
0-L	C01BC03	propafenone	WHO ATC
0-L	C01BC04	flecainide	WHO ATC
0-L	C01BC07	lorcainide	WHO ATC
0-L	C01BC08	encainide	WHO ATC
0-L	C01BD	Antiarrhythmics, class III	WHO ATC
0-L	C01BD01	amiodarone	WHO ATC
0-L	C01BD02	bretylium tosilate	WHO ATC
0-L	C01BD03	bunaftine	WHO ATC
0-L	C01BD04	dofetilide	WHO ATC
0-L	C01BD05	ibutilide	WHO ATC
0-L	C01BD06	tedisamil	WHO ATC
0-L	C01BG	Other class I antiarrhythmics	WHO ATC
0-L	C01BG01	moracizine	WHO ATC
0-L	C01BG07	cibenzoline	WHO ATC
0-L	C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES	WHO ATC
0-L	C01CA	Adrenergic and dopaminergic agents	WHO ATC
0-L	C01CA01	etilefrine	WHO ATC
0-L	C01CA02	isoprenaline	WHO ATC
0-L	C01CA03	norepinephrine	WHO ATC
0-L	C01CA04	dopamine	WHO ATC
0-L	C01CA05	norfenefrine	WHO ATC
0-L	C01CA06	phenylephrine	WHO ATC
0-L	C01CA07	dobutamine	WHO ATC
0-L	C01CA08	oxedrine	WHO ATC
0-L	C01CA09	metaraminol	WHO ATC
0-L	C01CA10	methoxamine	WHO ATC
0-L	C01CA11	mephentermine	WHO ATC
0-L	C01CA12	dimetofrine	WHO ATC
0-L	C01CA13	prenalterol	WHO ATC
0-L	C01CA14	dopexamine	WHO ATC
0-L	C01CA15	gepefrine	WHO ATC
0-L	C01CA16	ibopamine	WHO ATC
0-L	C01CA17	midodrine	WHO ATC
0-L	C01CA18	octopamine	WHO ATC
0-L	C01CA19	fenoldopam	WHO ATC
0-L	C01CA21	cafedrine	WHO ATC
0-L	C01CA22	arbutamine	WHO ATC
0-L	C01CA23	theodrenaline	WHO ATC
0-L	C01CA24	epinephrine	WHO ATC
0-L	C01CA30	combinations	WHO ATC
0-L	C01CA51	etilefrine, combinations	WHO ATC
0-L	C01CE	Phosphodiesterase inhibitors	WHO ATC
0-L	C01CE01	amrinone	WHO ATC
0-L	C01CE02	milrinone	WHO ATC
0-L	C01CE03	enoximone	WHO ATC
0-L	C01CE04	bucladesine	WHO ATC
0-L	C01CX	Other cardiac stimulants	WHO ATC
0-L	C01CX06	angiotensinamide	WHO ATC
0-L	C01CX07	xamoterol	WHO ATC
0-L	C01CX08	levosimendan	WHO ATC
0-L	C01D	VASODILATORS USED IN CARDIAC DISEASES	WHO ATC
0-L	C01DA	Organic nitrates	WHO ATC
0-L	C01DA02	glyceryl trinitrate	WHO ATC
0-L	C01DA04	methylpropylpropanediol dinitrate	WHO ATC
0-L	C01DA05	pentaerithrityl tetranitrate	WHO ATC
0-L	C01DA07	propatylnitrate	WHO ATC
0-L	C01DA08	isosorbide dinitrate	WHO ATC
0-L	C01DA09	trolnitrate	WHO ATC
0-L	C01DA13	eritrityl tetranitrate	WHO ATC
0-L	C01DA14	isosorbide mononitrate	WHO ATC
0-L	C01DA20	organic nitrates in combination	WHO ATC
0-L	C01DA38	tenitramine	WHO ATC
0-L	C01DA52	glyceryl trinitrate, combinations	WHO ATC
0-L	C01DA54	methylpropylpropanediol dinitrate, combinations	WHO ATC
0-L	C01DA55	pentaerithrityl tetranitrate, combinations	WHO ATC
0-L	C01DA57	propatylnitrate, combinations	WHO ATC
0-L	C01DA58	isosorbide dinitrate, combinations	WHO ATC
0-L	C01DA59	trolnitrate, combinations	WHO ATC
0-L	C01DA63	eritrityl tetranitrate, combinations	WHO ATC
0-L	C01DA70	organic nitrates in combination with psycholeptics	WHO ATC
0-L	C01DB	Quinolone vasodilators	WHO ATC
0-L	C01DB01	flosequinan	WHO ATC
0-L	C01DX	Other vasodilators used in cardiac diseases	WHO ATC
0-L	C01DX01	itramin tosilate	WHO ATC
0-L	C01DX02	prenylamine	WHO ATC
0-L	C01DX03	oxyfedrine	WHO ATC
0-L	C01DX04	benziodarone	WHO ATC
0-L	C01DX05	carbocromen	WHO ATC
0-L	C01DX06	hexobendine	WHO ATC
0-L	C01DX07	etafenone	WHO ATC
0-L	C01DX08	heptaminol	WHO ATC
0-L	C01DX09	imolamine	WHO ATC
0-L	C01DX10	dilazep	WHO ATC
0-L	C01DX11	trapidil	WHO ATC
0-L	C01DX12	molsidomine	WHO ATC
0-L	C01DX13	efloxate	WHO ATC
0-L	C01DX14	cinepazet	WHO ATC
0-L	C01DX15	cloridarol	WHO ATC
0-L	C01DX16	nicorandil	WHO ATC
0-L	C01DX18	linsidomine	WHO ATC
0-L	C01DX19	nesiritide	WHO ATC
0-L	C01DX51	itramin tosilate, combinations	WHO ATC
0-L	C01DX52	prenylamine, combinations	WHO ATC
0-L	C01DX53	oxyfedrine, combinations	WHO ATC
0-L	C01DX54	benziodarone, combinations	WHO ATC
0-L	C01E	OTHER CARDIAC PREPARATIONS	WHO ATC
0-L	C01EA	Prostaglandins	WHO ATC
0-L	C01EA01	alprostadil	WHO ATC
0-L	C01EB	Other cardiac preparations	WHO ATC
0-L	C01EB02	camphora	WHO ATC
0-L	C01EB03	indometacin	WHO ATC
0-L	C01EB04	crataegus glycosides	WHO ATC
0-L	C01EB05	creatinolfosfate	WHO ATC
0-L	C01EB06	fosfocreatine	WHO ATC
0-L	C01EB07	fructose 1,6-diphosphate	WHO ATC
0-L	C01EB09	ubidecarenone	WHO ATC
0-L	C01EB10	adenosine	WHO ATC
0-L	C01EB11	tiracizine	WHO ATC
0-L	C01EB13	acadesine	WHO ATC
0-L	C01EB15	trimetazidine	WHO ATC
0-L	C01EB16	ibuprofen	WHO ATC
0-L	C01EB17	ivabradine	WHO ATC
0-L	C01EB18	ranolazine	WHO ATC
0-L	C01EB19	icatibant	WHO ATC
0-L	C01EB21	regadenoson	WHO ATC
0-L	C01EX	Other cardiac combination products	WHO ATC
0-L	C02	ANTIHYPERTENSIVES	WHO ATC
0-L	C02A	ANTIADRENERGIC AGENTS, CENTRALLY ACTING	WHO ATC
0-L	C02AA	Rauwolfia alkaloids	WHO ATC
0-L	C02AA01	rescinnamine	WHO ATC
0-L	C02AA02	reserpine	WHO ATC
0-L	C02AA03	combinations of rauwolfia alkaloids	WHO ATC
0-L	C02AA04	rauwolfia alkaloids, whole root	WHO ATC
0-L	C02AA05	deserpidine	WHO ATC
0-L	C02AA06	methoserpidine	WHO ATC
0-L	C02AA07	bietaserpine	WHO ATC
0-L	C02AA52	reserpine, combinations	WHO ATC
0-L	C02AA53	combinations of rauwolfia alkoloids, combinations	WHO ATC
0-L	C02AA57	bietaserpine, combinations	WHO ATC
0-L	C02AB	Methyldopa	WHO ATC
0-L	C02AB01	methyldopa (levorotatory)	WHO ATC
0-L	C02AB02	methyldopa (racemic)	WHO ATC
0-L	C02AC	Imidazoline receptor agonists	WHO ATC
0-L	C02AC01	clonidine	WHO ATC
0-L	C02AC02	guanfacine	WHO ATC
0-L	C02AC04	tolonidine	WHO ATC
0-L	C02AC05	moxonidine	WHO ATC
0-L	C02AC06	rilmenidine	WHO ATC
0-L	C02B	ANTIADRENERGIC AGENTS, GANGLION-BLOCKING	WHO ATC
0-L	C02BA	Sulfonium derivatives	WHO ATC
0-L	C02BA01	trimetaphan	WHO ATC
0-L	C02BB	Secondary and tertiary amines	WHO ATC
0-L	C02BB01	mecamylamine	WHO ATC
0-L	C02BC	Bisquaternary ammonium compounds	WHO ATC
0-L	C02C	ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING	WHO ATC
0-L	C02CA	Alpha-adrenoreceptor antagonists	WHO ATC
0-L	C02CA01	prazosin	WHO ATC
0-L	C02CA02	indoramin	WHO ATC
0-L	C02CA03	trimazosin	WHO ATC
0-L	C02CA04	doxazosin	WHO ATC
0-L	C02CA06	urapidil	WHO ATC
0-L	C02CC	Guanidine derivatives	WHO ATC
0-L	C02CC01	betanidine	WHO ATC
0-L	C02CC02	guanethidine	WHO ATC
0-L	C02CC03	guanoxan	WHO ATC
0-L	C02CC04	debrisoquine	WHO ATC
0-L	C02CC05	guanoclor	WHO ATC
0-L	C02CC06	guanazodine	WHO ATC
0-L	C02CC07	guanoxabenz	WHO ATC
0-L	C02D	ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON	WHO ATC
0-L	C02DA	Thiazide derivatives	WHO ATC
0-L	C02DA01	diazoxide	WHO ATC
0-L	C02DB	Hydrazinophthalazine derivatives	WHO ATC
0-L	C02DB01	dihydralazine	WHO ATC
0-L	C02DB02	hydralazine	WHO ATC
0-L	C02DB03	endralazine	WHO ATC
0-L	C02DB04	cadralazine	WHO ATC
0-L	C02DC	Pyrimidine derivatives	WHO ATC
0-L	C02DC01	minoxidil	WHO ATC
0-L	C02DD	Nitroferricyanide derivatives	WHO ATC
0-L	C02DD01	nitroprusside	WHO ATC
0-L	C02DG	Guanidine derivatives	WHO ATC
0-L	C02DG01	pinacidil	WHO ATC
0-L	C02K	OTHER ANTIHYPERTENSIVES	WHO ATC
0-L	C02KA	Alkaloids, excl. rauwolfia	WHO ATC
0-L	C02KA01	veratrum	WHO ATC
0-L	C02KB	Tyrosine hydroxylase inhibitors	WHO ATC
0-L	C02KB01	metirosine	WHO ATC
0-L	C02KC	MAO inhibitors	WHO ATC
0-L	C02KC01	pargyline	WHO ATC
0-L	C02KD	Serotonin antagonists	WHO ATC
0-L	C02KD01	ketanserin	WHO ATC
0-L	C02KX	Other antihypertensives	WHO ATC
0-L	C02KX01	bosentan	WHO ATC
0-L	C02KX02	ambrisentan	WHO ATC
0-L	C02KX03	sitaxentan	WHO ATC
0-L	C02L	ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION	WHO ATC
0-L	C02LA	Rauwolfia alkaloids and diuretics in combination	WHO ATC
0-L	C02LA01	reserpine and diuretics	WHO ATC
0-L	C02LA02	rescinnamine and diuretics	WHO ATC
0-L	C02LA03	deserpidine and diuretics	WHO ATC
0-L	C02LA04	methoserpidine and diuretics	WHO ATC
0-L	C02LA07	bietaserpine and diuretics	WHO ATC
0-L	C02LA08	rauwolfia alkaloids, whole root and diuretics	WHO ATC
0-L	C02LA09	syrosingopine and diuretics	WHO ATC
0-L	C02LA50	comb. of rauwolfia alkaloids and diuretics incl. other combinations	WHO ATC
0-L	C02LA51	reserpine and diuretics, combinations with other drugs	WHO ATC
0-L	C02LA52	rescinnamine and diuretics, combinations with other drugs	WHO ATC
0-L	C02LA71	reserpine and diuretics, combinations with psycholeptics	WHO ATC
0-L	C02LB	Methyldopa and diuretics in combination	WHO ATC
0-L	C02LB01	methyldopa (levorotatory) and diuretics	WHO ATC
0-L	C02LC	Imidazoline receptor agonists in combination with diuretics	WHO ATC
0-L	C02LC01	clonidine and diuretics	WHO ATC
0-L	C02LC05	moxonidine and diuretics	WHO ATC
0-L	C02LC51	clonidine and diuretics, combinations with other drugs	WHO ATC
0-L	C02LE	Alpha-adrenoreceptor antagonists and diuretics	WHO ATC
0-L	C02LE01	prazosin and diuretics	WHO ATC
0-L	C02LF	Guanidine derivatives and diuretics	WHO ATC
0-L	C02LF01	guanethidine and diuretics	WHO ATC
0-L	C02LG	Hydrazinophthalazine derivatives and diuretics	WHO ATC
0-L	C02LG01	dihydralazine and diuretics	WHO ATC
0-L	C02LG02	hydralazine and diuretics	WHO ATC
0-L	C02LG03	picodralazine and diuretics	WHO ATC
0-L	C02LG51	dihydralazine and diuretics, combinations with other drugs	WHO ATC
0-L	C02LG73	picodralazine and diuretics, combinations with psycholeptics	WHO ATC
0-L	C02LK	Alkaloids, excl. rauwolfia, in combination with diuretics	WHO ATC
0-L	C02LK01	veratrum and diuretics	WHO ATC
0-L	C02LL	MAO inhibitors and diuretics	WHO ATC
0-L	C02LL01	pargyline and diuretics	WHO ATC
0-L	C02LN	Serotonin antagonists and diuretics	WHO ATC
0-L	C02LX	Other antihypertensives and diuretics	WHO ATC
0-L	C02LX01	pinacidil and diuretics	WHO ATC
0-L	C02N	COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02	WHO ATC
0-L	C03	DIURETICS	WHO ATC
0-L	C03A	LOW-CEILING DIURETICS, THIAZIDES	WHO ATC
0-L	C03AA	Thiazides, plain	WHO ATC
0-L	C03AA01	bendroflumethiazide	WHO ATC
0-L	C03AA02	hydroflumethiazide	WHO ATC
0-L	C03AA03	hydrochlorothiazide	WHO ATC
0-L	C03AA04	chlorothiazide	WHO ATC
0-L	C03AA05	polythiazide	WHO ATC
0-L	C03AA06	trichlormethiazide	WHO ATC
0-L	C03AA07	cyclopenthiazide	WHO ATC
0-L	C03AA08	methyclothiazide	WHO ATC
0-L	C03AA09	cyclothiazide	WHO ATC
0-L	C03AA13	mebutizide	WHO ATC
0-L	C03AB	Thiazides and potassium in combination	WHO ATC
0-L	C03AB01	bendroflumethiazide and potassium	WHO ATC
0-L	C03AB02	hydroflumethiazide and potassium	WHO ATC
0-L	C03AB03	hydrochlorothiazide and potassium	WHO ATC
0-L	C03AB04	chlorothiazide and potassium	WHO ATC
0-L	C03AB05	polythiazide and potassium	WHO ATC
0-L	C03AB06	trichlormethiazide and potassium	WHO ATC
0-L	C03AB07	cyclopenthiazide and potassium	WHO ATC
0-L	C03AB08	methyclothiazide and potassium	WHO ATC
0-L	C03AB09	cyclothiazide and potassium	WHO ATC
0-L	C03AH	Thiazides, combinations with psycholeptics and/or analgesics	WHO ATC
0-L	C03AH01	chlorothiazide, combinations	WHO ATC
0-L	C03AH02	hydroflumethiazide, combinations	WHO ATC
0-L	C03AX	Thiazides, combinations with other drugs	WHO ATC
0-L	C03AX01	hydrochlorothiazide, combinations	WHO ATC
0-L	C03B	LOW-CEILING DIURETICS, EXCL. THIAZIDES	WHO ATC
0-L	C03BA	Sulfonamides, plain	WHO ATC
0-L	C03BA02	quinethazone	WHO ATC
0-L	C03BA03	clopamide	WHO ATC
0-L	C03BA04	chlortalidone	WHO ATC
0-L	C03BA05	mefruside	WHO ATC
0-L	C03BA07	clofenamide	WHO ATC
0-L	C03BA08	metolazone	WHO ATC
0-L	C03BA09	meticrane	WHO ATC
0-L	C03BA10	xipamide	WHO ATC
0-L	C03BA11	indapamide	WHO ATC
0-L	C03BA12	clorexolone	WHO ATC
0-L	C03BA13	fenquizone	WHO ATC
0-L	C03BA82	clorexolone, comb. with psycholeptics	WHO ATC
0-L	C03BB	Sulfonamides and potassium in combination	WHO ATC
0-L	C03BB02	quinethazone and potassium	WHO ATC
0-L	C03BB03	clopamide and potassium	WHO ATC
0-L	C03BB04	chlortalidone and potassium	WHO ATC
0-L	C03BB05	mefruside and potassium	WHO ATC
0-L	C03BB07	clofenamide and potassium	WHO ATC
0-L	C03BC	Mercurial diuretics	WHO ATC
0-L	C03BC01	mersalyl	WHO ATC
0-L	C03BD	Xanthine derivatives	WHO ATC
0-L	C03BD01	theobromine	WHO ATC
0-L	C03BK	Sulfonamides, combinations with other drugs	WHO ATC
0-L	C03BX	Other low-ceiling diuretics	WHO ATC
0-L	C03BX03	cicletanine	WHO ATC
0-L	C03C	HIGH-CEILING DIURETICS	WHO ATC
0-L	C03CA	Sulfonamides, plain	WHO ATC
0-L	C03CA01	furosemide	WHO ATC
0-L	C03CA02	bumetanide	WHO ATC
0-L	C03CA03	piretanide	WHO ATC
0-L	C03CA04	torasemide	WHO ATC
0-L	C03CB	Sulfonamides and potassium in combination	WHO ATC
0-L	C03CB01	furosemide and potassium	WHO ATC
0-L	C03CB02	bumetanide and potassium	WHO ATC
0-L	C03CC	Aryloxyacetic acid derivatives	WHO ATC
0-L	C03CC01	etacrynic acid	WHO ATC
0-L	C03CC02	tienilic acid	WHO ATC
0-L	C03CD	Pyrazolone derivatives	WHO ATC
0-L	C03CD01	muzolimine	WHO ATC
0-L	C03CX	Other high-ceiling diuretics	WHO ATC
0-L	C03CX01	etozolin	WHO ATC
0-L	C03D	POTASSIUM-SPARING AGENTS	WHO ATC
0-L	C03DA	Aldosterone antagonists	WHO ATC
0-L	C03DA01	spironolactone	WHO ATC
0-L	C03DA02	potassium canrenoate	WHO ATC
0-L	C03DA03	canrenone	WHO ATC
0-L	C03DA04	eplerenone	WHO ATC
0-L	C03DB	Other potassium-sparing agents	WHO ATC
0-L	C03DB01	amiloride	WHO ATC
0-L	C03DB02	triamterene	WHO ATC
0-L	C03E	DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION	WHO ATC
0-L	C03EA	Low-ceiling diuretics and potassium-sparing agents	WHO ATC
0-L	C03EA01	hydrochlorothiazide and potassium-sparing agents	WHO ATC
0-L	C03EA02	trichlormethiazide and potassium-sparing agents	WHO ATC
0-L	C03EA03	epitizide and potassium-sparing agents	WHO ATC
0-L	C03EA04	altizide and potassium-sparing agents	WHO ATC
0-L	C03EA05	mebutizide and potassium-sparing agents	WHO ATC
0-L	C03EA06	chlortalidone and potassium-sparing agents	WHO ATC
0-L	C03EA07	cyclopenthiazide and potassium-sparing agents	WHO ATC
0-L	C03EA12	metolazone and potassium-sparing agents	WHO ATC
0-L	C03EA13	bendroflumethiazide and potassium-sparing agents	WHO ATC
0-L	C03EA14	butizide and potassium-sparing agents	WHO ATC
0-L	C03EB	High-ceiling diuretics and potassium-sparing agents	WHO ATC
0-L	C03EB01	furosemide and potassium-sparing agents	WHO ATC
0-L	C03EB02	bumetanide and potassium-sparing agents	WHO ATC
0-L	C03X	OTHER DIURETICS	WHO ATC
0-L	C03XA	Vasopressin antagonists	WHO ATC
0-L	C03XA01	tolvaptan	WHO ATC
0-L	C03XA02	conivaptan	WHO ATC
0-L	C04	PERIPHERAL VASODILATORS	WHO ATC
0-L	C04A	PERIPHERAL VASODILATORS	WHO ATC
0-L	C04AA	2-amino-1-phenylethanol derivatives	WHO ATC
0-L	C04AA01	isoxsuprine	WHO ATC
0-L	C04AA02	buphenine	WHO ATC
0-L	C04AA31	bamethan	WHO ATC
0-L	C04AB	Imidazoline derivatives	WHO ATC
0-L	C04AB01	phentolamine	WHO ATC
0-L	C04AB02	tolazoline	WHO ATC
0-L	C04AC	Nicotinic acid and derivatives	WHO ATC
0-L	C04AC01	nicotinic acid	WHO ATC
0-L	C04AC02	nicotinyl alcohol (pyridylcarbinol)	WHO ATC
0-L	C04AC03	inositol nicotinate	WHO ATC
0-L	C04AC07	ciclonicate	WHO ATC
0-L	C04AD	Purine derivatives	WHO ATC
0-L	C04AD01	pentifylline	WHO ATC
0-L	C04AD02	xantinol nicotinate	WHO ATC
0-L	C04AD03	pentoxifylline	WHO ATC
0-L	C04AD04	etofylline nicotinate	WHO ATC
0-L	C04AE	Ergot alkaloids	WHO ATC
0-L	C04AE01	ergoloid mesylates	WHO ATC
0-L	C04AE02	nicergoline	WHO ATC
0-L	C04AE04	dihydroergocristine	WHO ATC
0-L	C04AE51	ergoloid mesylates, combinations	WHO ATC
0-L	C04AE54	dihydroergocristine, combinations	WHO ATC
0-L	C04AF	Enzymes	WHO ATC
0-L	C04AF01	kallidinogenase	WHO ATC
0-L	C04AX	Other peripheral vasodilators	WHO ATC
0-L	C04AX01	cyclandelate	WHO ATC
0-L	C04AX02	phenoxybenzamine	WHO ATC
0-L	C04AX07	vincamine	WHO ATC
0-L	C04AX10	moxisylyte	WHO ATC
0-L	C04AX11	bencyclane	WHO ATC
0-L	C04AX17	vinburnine	WHO ATC
0-L	C04AX19	suloctidil	WHO ATC
0-L	C04AX20	buflomedil	WHO ATC
0-L	C04AX21	naftidrofuryl	WHO ATC
0-L	C04AX23	butalamine	WHO ATC
0-L	C04AX24	visnadine	WHO ATC
0-L	C04AX26	cetiedil	WHO ATC
0-L	C04AX27	cinepazide	WHO ATC
0-L	C04AX28	ifenprodil	WHO ATC
0-L	C04AX30	azapetine	WHO ATC
0-L	C04AX32	fasudil	WHO ATC
0-L	C05	VASOPROTECTIVES	WHO ATC
0-L	C05A	AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANALFISSURES FOR TOPICAL USE	WHO ATC
0-L	C05AA	Corticosteroids	WHO ATC
0-L	C05AA01	hydrocortisone	WHO ATC
0-L	C05AA04	prednisolone	WHO ATC
0-L	C05AA05	betamethasone	WHO ATC
0-L	C05AA06	fluorometholone	WHO ATC
0-L	C05AA08	fluocortolone	WHO ATC
0-L	C05AA09	dexamethasone	WHO ATC
0-L	C05AA10	fluocinolone acetonide	WHO ATC
0-L	C05AA11	fluocinonide	WHO ATC
0-L	C05AB	Antibiotics	WHO ATC
0-L	C05AD	Local anesthetics	WHO ATC
0-L	C05AD01	lidocaine	WHO ATC
0-L	C05AD02	tetracaine	WHO ATC
0-L	C05AD03	benzocaine	WHO ATC
0-L	C05AD04	cinchocaine	WHO ATC
0-L	C05AD05	procaine	WHO ATC
0-L	C05AD06	oxetacaine	WHO ATC
0-L	C05AD07	pramocaine	WHO ATC
0-L	C05AE	Muscle relaxants	WHO ATC
0-L	C05AE01	glyceryl trinitrate	WHO ATC
0-L	C05AE02	isosorbide dinitrate	WHO ATC
0-L	C05AX	Other agents for treatment of hemorrhoids and anal fissures for topical use	WHO ATC
0-L	C05AX01	aluminium preparations	WHO ATC
0-L	C05AX02	bismuth preparations, combinations	WHO ATC
0-L	C05AX03	other preparations, combinations	WHO ATC
0-L	C05AX04	zinc preparations	WHO ATC
0-L	C05AX05	tribenoside	WHO ATC
0-L	C05B	ANTIVARICOSE THERAPY	WHO ATC
0-L	C05BA	Heparins or heparinoids for topical use	WHO ATC
0-L	C05BA01	organo-heparinoid	WHO ATC
0-L	C05BA02	sodium apolate	WHO ATC
0-L	C05BA03	heparin	WHO ATC
0-L	C05BA04	pentosan polysulfate sodium	WHO ATC
0-L	C05BA51	heparinoid, combinations	WHO ATC
0-L	C05BA53	heparin, combinations	WHO ATC
0-L	C05BB	Sclerosing agents for local injection	WHO ATC
0-L	C05BB01	monoethanolamine oleate	WHO ATC
0-L	C05BB02	polidocanol	WHO ATC
0-L	C05BB03	invert sugar	WHO ATC
0-L	C05BB04	sodium tetradecyl sulfate	WHO ATC
0-L	C05BB05	phenol	WHO ATC
0-L	C05BB56	glucose, combinations	WHO ATC
0-L	C05BX	Other sclerosing agents	WHO ATC
0-L	C05BX01	calcium dobesilate	WHO ATC
0-L	C05BX51	calcium dobesilate, combinations	WHO ATC
0-L	C05C	CAPILLARY STABILIZING AGENTS	WHO ATC
0-L	C05CA	Bioflavonoids	WHO ATC
0-L	C05CA01	rutoside	WHO ATC
0-L	C05CA02	monoxerutin	WHO ATC
0-L	C05CA03	diosmin	WHO ATC
0-L	C05CA04	troxerutin	WHO ATC
0-L	C05CA05	hidrosmin	WHO ATC
0-L	C05CA51	rutoside, combinations	WHO ATC
0-L	C05CA53	diosmin, combinations	WHO ATC
0-L	C05CA54	troxerutin, combinations	WHO ATC
0-L	C05CX	Other capillary stabilizing agents	WHO ATC
0-L	C05CX01	tribenoside	WHO ATC
0-L	C07	BETA BLOCKING AGENTS	WHO ATC
0-L	C07A	BETA BLOCKING AGENTS	WHO ATC
0-L	C07AA	Beta blocking agents, non-selective	WHO ATC
0-L	C07AA01	alprenolol	WHO ATC
0-L	C07AA02	oxprenolol	WHO ATC
0-L	C07AA03	pindolol	WHO ATC
0-L	C07AA05	propranolol	WHO ATC
0-L	C07AA06	timolol	WHO ATC
0-L	C07AA07	sotalol	WHO ATC
0-L	C07AA12	nadolol	WHO ATC
0-L	C07AA14	mepindolol	WHO ATC
0-L	C07AA15	carteolol	WHO ATC
0-L	C07AA16	tertatolol	WHO ATC
0-L	C07AA17	bopindolol	WHO ATC
0-L	C07AA19	bupranolol	WHO ATC
0-L	C07AA23	penbutolol	WHO ATC
0-L	C07AA27	cloranolol	WHO ATC
0-L	C07AA57	sotalol, combinations	WHO ATC
0-L	C07AB	Beta blocking agents, selective	WHO ATC
0-L	C07AB01	practolol	WHO ATC
0-L	C07AB02	metoprolol	WHO ATC
0-L	C07AB03	atenolol	WHO ATC
0-L	C07AB04	acebutolol	WHO ATC
0-L	C07AB05	betaxolol	WHO ATC
0-L	C07AB06	bevantolol	WHO ATC
0-L	C07AB07	bisoprolol	WHO ATC
0-L	C07AB08	celiprolol	WHO ATC
0-L	C07AB09	esmolol	WHO ATC
0-L	C07AB10	epanolol	WHO ATC
0-L	C07AB11	s-atenolol	WHO ATC
0-L	C07AB12	nebivolol	WHO ATC
0-L	C07AB13	talinolol	WHO ATC
0-L	C07AB52	metoprolol, combinations	WHO ATC
0-L	C07AB57	bisoprolol, combinations	WHO ATC
0-L	C07AG	Alpha and beta blocking agents	WHO ATC
0-L	C07AG01	labetalol	WHO ATC
0-L	C07AG02	carvedilol	WHO ATC
0-L	C07B	BETA BLOCKING AGENTS AND THIAZIDES	WHO ATC
0-L	C07BA	Beta blocking agents, non-selective, and thiazides	WHO ATC
0-L	C07BA02	oxprenolol and thiazides	WHO ATC
0-L	C07BA05	propranolol and thiazides	WHO ATC
0-L	C07BA06	timolol and thiazides	WHO ATC
0-L	C07BA07	sotalol and thiazides	WHO ATC
0-L	C07BA12	nadolol and thiazides	WHO ATC
0-L	C07BA68	metipranolol and thiazides, combinations	WHO ATC
0-L	C07BB	Beta blocking agents, selective, and thiazides	WHO ATC
0-L	C07BB02	metoprolol and thiazides	WHO ATC
0-L	C07BB03	atenolol and thiazides	WHO ATC
0-L	C07BB04	acebutolol and thiazides	WHO ATC
0-L	C07BB06	bevantolol and thiazides	WHO ATC
0-L	C07BB07	bisoprolol and thiazides	WHO ATC
0-L	C07BB52	metoprolol and thiazides, combinations	WHO ATC
0-L	C07BG	Alpha and beta blocking agents and thiazides	WHO ATC
0-L	C07BG01	labetalol and thiazides	WHO ATC
0-L	C07C	BETA BLOCKING AGENTS AND OTHER DIURETICS	WHO ATC
0-L	C07CA	Beta blocking agents, non-selective, and other diuretics	WHO ATC
0-L	C07CA02	oxprenolol and other diuretics	WHO ATC
0-L	C07CA03	pindolol and other diuretics	WHO ATC
0-L	C07CA17	bopindolol and other diuretics	WHO ATC
0-L	C07CA23	penbutolol and other diuretics	WHO ATC
0-L	C07CB	Beta blocking agents, selective, and other diuretics	WHO ATC
0-L	C07CB02	metoprolol and other diuretics	WHO ATC
0-L	C07CB03	atenolol and other diuretics	WHO ATC
0-L	C07CB53	atenolol and other diuretics, combinations	WHO ATC
0-L	C07CG	Alpha and beta blocking agents and other diuretics	WHO ATC
0-L	C07CG01	labetalol and other diuretics	WHO ATC
0-L	C07D	BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS	WHO ATC
0-L	C07DA	Beta blocking agents, non-selective, thiazides and other diuretics	WHO ATC
0-L	C07DA06	timolol, thiazides and other diuretics	WHO ATC
0-L	C07DB	Beta blocking agents, selective, thiazides and other diuretics	WHO ATC
0-L	C07DB01	atenolol, thiazides and other diuretics	WHO ATC
0-L	C07E	BETA BLOCKING AGENTS AND VASODILATORS	WHO ATC
0-L	C07EA	Beta blocking agents, non-selective, and vasodilators	WHO ATC
0-L	C07EB	Beta blocking agents, selective, and vasodilators	WHO ATC
0-L	C07F	BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES	WHO ATC
0-L	C07FA	Beta blocking agents, non-selective, and other antihypertensives	WHO ATC
0-L	C07FA05	propranolol and other antihypertensives	WHO ATC
0-L	C07FB	Beta blocking agents, selective, and other antihypertensives	WHO ATC
0-L	C07FB02	metoprolol and other antihypertensives	WHO ATC
0-L	C07FB03	atenolol and other antihypertensives	WHO ATC
0-L	C08	CALCIUM CHANNEL BLOCKERS	WHO ATC
0-L	C08C	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS	WHO ATC
0-L	C08CA	Dihydropyridine derivatives	WHO ATC
0-L	C08CA01	amlodipine	WHO ATC
0-L	C08CA02	felodipine	WHO ATC
0-L	C08CA03	isradipine	WHO ATC
0-L	C08CA04	nicardipine	WHO ATC
0-L	C08CA05	nifedipine	WHO ATC
0-L	C08CA06	nimodipine	WHO ATC
0-L	C08CA07	nisoldipine	WHO ATC
0-L	C08CA08	nitrendipine	WHO ATC
0-L	C08CA09	lacidipine	WHO ATC
0-L	C08CA10	nilvadipine	WHO ATC
0-L	C08CA11	manidipine	WHO ATC
0-L	C08CA12	barnidipine	WHO ATC
0-L	C08CA13	lercanidipine	WHO ATC
0-L	C08CA14	cilnidipine	WHO ATC
0-L	C08CA15	benidipine	WHO ATC
0-L	C08CA55	nifedipine, combinations	WHO ATC
0-L	C08CX	Other selective calcium channel blockers with mainly vascular effects	WHO ATC
0-L	C08CX01	mibefradil	WHO ATC
0-L	C08D	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS	WHO ATC
0-L	C08DA	Phenylalkylamine derivatives	WHO ATC
0-L	C08DA01	verapamil	WHO ATC
0-L	C08DA02	gallopamil	WHO ATC
0-L	C08DA51	verapamil, combinations	WHO ATC
0-L	C08DB	Benzothiazepine derivatives	WHO ATC
0-L	C08DB01	diltiazem	WHO ATC
0-L	C08E	NON-SELECTIVE CALCIUM CHANNEL BLOCKERS	WHO ATC
0-L	C08EA	Phenylalkylamine derivatives	WHO ATC
0-L	C08EA01	fendiline	WHO ATC
0-L	C08EA02	bepridil	WHO ATC
0-L	C08EX	Other non-selective calcium channel blockers	WHO ATC
0-L	C08EX01	lidoflazine	WHO ATC
0-L	C08EX02	perhexiline	WHO ATC
0-L	C08G	CALCIUM CHANNEL BLOCKERS AND DIURETICS	WHO ATC
0-L	C08GA	Calcium channel blockers and diuretics	WHO ATC
0-L	C08GA01	nifedipine and diuretics	WHO ATC
0-L	C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM	WHO ATC
0-L	C09A	ACE INHIBITORS, PLAIN	WHO ATC
0-L	C09AA	ACE inhibitors, plain	WHO ATC
0-L	C09AA01	captopril	WHO ATC
0-L	C09AA02	enalapril	WHO ATC
0-L	C09AA03	lisinopril	WHO ATC
0-L	C09AA04	perindopril	WHO ATC
0-L	C09AA05	ramipril	WHO ATC
0-L	C09AA06	quinapril	WHO ATC
0-L	C09AA07	benazepril	WHO ATC
0-L	C09AA08	cilazapril	WHO ATC
0-L	C09AA09	fosinopril	WHO ATC
0-L	C09AA10	trandolapril	WHO ATC
0-L	C09AA11	spirapril	WHO ATC
0-L	C09AA12	delapril	WHO ATC
0-L	C09AA13	moexipril	WHO ATC
0-L	C09AA14	temocapril	WHO ATC
0-L	C09AA15	zofenopril	WHO ATC
0-L	C09AA16	imidapril	WHO ATC
0-L	C09B	ACE INHIBITORS, COMBINATIONS	WHO ATC
0-L	C09BA	ACE inhibitors and diuretics	WHO ATC
0-L	C09BA01	captopril and diuretics	WHO ATC
0-L	C09BA02	enalapril and diuretics	WHO ATC
0-L	C09BA03	lisinopril and diuretics	WHO ATC
0-L	C09BA04	perindopril and diuretics	WHO ATC
0-L	C09BA05	ramipril and diuretics	WHO ATC
0-L	C09BA06	quinapril and diuretics	WHO ATC
0-L	C09BA07	benazepril and diuretics	WHO ATC
0-L	C09BA08	cilazapril and diuretics	WHO ATC
0-L	C09BA09	fosinopril and diuretics	WHO ATC
0-L	C09BA12	delapril and diuretics	WHO ATC
0-L	C09BA13	moexipril and diuretics	WHO ATC
0-L	C09BA15	zofenopril and diuretics	WHO ATC
0-L	C09BB	ACE inhibitors and calcium channel blockers	WHO ATC
0-L	C09BB02	enalapril and lercanidipine	WHO ATC
0-L	C09BB03	lisinopril and amlodipine	WHO ATC
0-L	C09BB04	perindopril and amlodipine	WHO ATC
0-L	C09BB05	ramipril and felodipine	WHO ATC
0-L	C09BB10	trandolapril and verapamil	WHO ATC
0-L	C09BB12	delapril and manidipine	WHO ATC
0-L	C09C	ANGIOTENSIN II ANTAGONISTS, PLAIN	WHO ATC
0-L	C09CA	Angiotensin II antagonists, plain	WHO ATC
0-L	C09CA01	losartan	WHO ATC
0-L	C09CA02	eprosartan	WHO ATC
0-L	C09CA03	valsartan	WHO ATC
0-L	C09CA04	irbesartan	WHO ATC
0-L	C09CA05	tasosartan	WHO ATC
0-L	C09CA06	candesartan	WHO ATC
0-L	C09CA07	telmisartan	WHO ATC
0-L	C09CA08	olmesartan medoxomil	WHO ATC
0-L	C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS	WHO ATC
0-L	C09DA	Angiotensin II antagonists and diuretics	WHO ATC
0-L	C09DA01	losartan and diuretics	WHO ATC
0-L	C09DA02	eprosartan and diuretics	WHO ATC
0-L	C09DA03	valsartan and diuretics	WHO ATC
0-L	C09DA04	irbesartan and diuretics	WHO ATC
0-L	C09DA06	candesartan and diuretics	WHO ATC
0-L	C09DA07	telmisartan and diuretics	WHO ATC
0-L	C09DA08	olmesartan medoxomil and diuretics	WHO ATC
0-L	C09DB	Angiotensin II antagonists and calcium channel blockers	WHO ATC
0-L	C09DB01	valsartan and amlodipine	WHO ATC
0-L	C09DB02	olmesartan medoxomil and amlodipine	WHO ATC
0-L	C09DB04	telmisartan and amlodipine	WHO ATC
0-L	C09DX	Angiotensin II antagonists, other combinations	WHO ATC
0-L	C09DX01	valsartan, amlodipine and hydrochlorothiazide	WHO ATC
0-L	C09DX02	valsartan and aliskiren	WHO ATC
0-L	C09X	OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM	WHO ATC
0-L	C09XA	Renin-inhibitors	WHO ATC
0-L	C09XA01	remikiren	WHO ATC
0-L	C09XA02	aliskiren	WHO ATC
0-L	C09XA52	aliskiren and hydrochlorothiazide	WHO ATC
0-L	C10	LIPID MODIFYING AGENTS	WHO ATC
0-L	C10A	LIPID MODIFYING AGENTS, PLAIN	WHO ATC
0-L	C10AA	HMG CoA reductase inhibitors	WHO ATC
0-L	C10AA01	simvastatin	WHO ATC
0-L	C10AA02	lovastatin	WHO ATC
0-L	C10AA03	pravastatin	WHO ATC
0-L	C10AA04	fluvastatin	WHO ATC
0-L	C10AA05	atorvastatin	WHO ATC
0-L	C10AA06	cerivastatin	WHO ATC
0-L	C10AA07	rosuvastatin	WHO ATC
0-L	C10AA08	pitavastatin	WHO ATC
0-L	C10AB	Fibrates	WHO ATC
0-L	C10AB01	clofibrate	WHO ATC
0-L	C10AB02	bezafibrate	WHO ATC
0-L	C10AB03	aluminium clofibrate	WHO ATC
0-L	C10AB04	gemfibrozil	WHO ATC
0-L	C10AB05	fenofibrate	WHO ATC
0-L	C10AB06	simfibrate	WHO ATC
0-L	C10AB07	ronifibrate	WHO ATC
0-L	C10AB08	ciprofibrate	WHO ATC
0-L	C10AB09	etofibrate	WHO ATC
0-L	C10AB10	clofibride	WHO ATC
0-L	C10AC	Bile acid sequestrants	WHO ATC
0-L	C10AC01	colestyramine	WHO ATC
0-L	C10AC02	colestipol	WHO ATC
0-L	C10AC03	colextran	WHO ATC
0-L	C10AC04	colesevelam	WHO ATC
0-L	C10AD	Nicotinic acid and derivatives	WHO ATC
0-L	C10AD01	niceritrol	WHO ATC
0-L	C10AD02	nicotinic acid	WHO ATC
0-L	C10AD03	nicofuranose	WHO ATC
0-L	C10AD04	aluminium nicotinate	WHO ATC
0-L	C10AD05	nicotinyl alcohol (pyridylcarbinol)	WHO ATC
0-L	C10AD06	acipimox	WHO ATC
0-L	C10AD52	nicotinic acid, combinations	WHO ATC
0-L	C10AX	Other lipid modifying agents	WHO ATC
0-L	C10AX01	dextrothyroxine	WHO ATC
0-L	C10AX02	probucol	WHO ATC
0-L	C10AX03	tiadenol	WHO ATC
0-L	C10AX05	meglutol	WHO ATC
0-L	C10AX06	omega-3-triglycerides incl. other esters and acids	WHO ATC
0-L	C10AX07	magnesium pyridoxal 5-phosphate glutamate	WHO ATC
0-L	C10AX08	policosanol	WHO ATC
0-L	C10AX09	ezetimibe	WHO ATC
0-L	C10AX10	alipogene tiparvovec	WHO ATC
0-L	C10B	LIPID MODIFYING AGENTS, COMBINATIONS	WHO ATC
0-L	C10BA	HMG CoA reductase inhibitors in combination with other lipid modifying agents	WHO ATC
0-L	C10BA01	lovastatin and nicotinic acid	WHO ATC
0-L	C10BA02	simvastatin and ezetimibe	WHO ATC
0-L	C10BA03	pravastatin and fenofibrate	WHO ATC
0-L	C10BX	HMG CoA reductase inhibitors, other combinations	WHO ATC
0-L	C10BX01	simvastatin and acetylsalicylic acid	WHO ATC
0-L	C10BX02	pravastatin and acetylsalicylic acid	WHO ATC
0-L	C10BX03	atorvastatin and amlodipine	WHO ATC
0-L	D	DERMATOLOGICALS	WHO ATC
0-L	D01	ANTIFUNGALS FOR DERMATOLOGICAL USE	WHO ATC
0-L	D01A	ANTIFUNGALS FOR TOPICAL USE	WHO ATC
0-L	D01AA	Antibiotics	WHO ATC
0-L	D01AA01	nystatin	WHO ATC
0-L	D01AA02	natamycin	WHO ATC
0-L	D01AA03	hachimycin	WHO ATC
0-L	D01AA04	pecilocin	WHO ATC
0-L	D01AA06	mepartricin	WHO ATC
0-L	D01AA07	pyrrolnitrin	WHO ATC
0-L	D01AA08	griseofulvin	WHO ATC
0-L	D01AA20	combinations	WHO ATC
0-L	D01AC	Imidazole and triazole derivatives	WHO ATC
0-L	D01AC01	clotrimazole	WHO ATC
0-L	D01AC02	miconazole	WHO ATC
0-L	D01AC03	econazole	WHO ATC
0-L	D01AC04	chlormidazole	WHO ATC
0-L	D01AC05	isoconazole	WHO ATC
0-L	D01AC06	tiabendazole	WHO ATC
0-L	D01AC07	tioconazole	WHO ATC
0-L	D01AC08	ketoconazole	WHO ATC
0-L	D01AC09	sulconazole	WHO ATC
0-L	D01AC10	bifonazole	WHO ATC
0-L	D01AC11	oxiconazole	WHO ATC
0-L	D01AC12	fenticonazole	WHO ATC
0-L	D01AC13	omoconazole	WHO ATC
0-L	D01AC14	sertaconazole	WHO ATC
0-L	D01AC15	fluconazole	WHO ATC
0-L	D01AC16	flutrimazole	WHO ATC
0-L	D01AC20	combinations	WHO ATC
0-L	D01AC52	miconazole, combinations	WHO ATC
0-L	D01AC60	bifonazole, combinations	WHO ATC
0-L	D01AE	Other antifungals for topical use	WHO ATC
0-L	D01AE01	bromochlorosalicylanilide	WHO ATC
0-L	D01AE02	methylrosaniline	WHO ATC
0-L	D01AE03	tribromometacresol	WHO ATC
0-L	D01AE04	undecylenic acid	WHO ATC
0-L	D01AE05	polynoxylin	WHO ATC
0-L	D01AE06	2-(4-chlorphenoxy)-ethanol	WHO ATC
0-L	D01AE07	chlorphenesin	WHO ATC
0-L	D01AE08	ticlatone	WHO ATC
0-L	D01AE09	sulbentine	WHO ATC
0-L	D01AE10	ethyl hydroxybenzoate	WHO ATC
0-L	D01AE11	haloprogin	WHO ATC
0-L	D01AE12	salicylic acid	WHO ATC
0-L	D01AE13	selenium sulfide	WHO ATC
0-L	D01AE14	ciclopirox	WHO ATC
0-L	D01AE15	terbinafine	WHO ATC
0-L	D01AE16	amorolfine	WHO ATC
0-L	D01AE17	dimazole	WHO ATC
0-L	D01AE18	tolnaftate	WHO ATC
0-L	D01AE19	tolciclate	WHO ATC
0-L	D01AE20	combinations	WHO ATC
0-L	D01AE21	flucytosine	WHO ATC
0-L	D01AE22	naftifine	WHO ATC
0-L	D01AE23	butenafine	WHO ATC
0-L	D01AE54	undecylenic acid, combinations	WHO ATC
0-L	D01B	ANTIFUNGALS FOR SYSTEMIC USE	WHO ATC
0-L	D01BA	Antifungals for systemic use	WHO ATC
0-L	D01BA01	griseofulvin	WHO ATC
0-L	D01BA02	terbinafine	WHO ATC
0-L	D02	EMOLLIENTS AND PROTECTIVES	WHO ATC
0-L	D02A	EMOLLIENTS AND PROTECTIVES	WHO ATC
0-L	D02AA	Silicone products	WHO ATC
0-L	D02AB	Zinc products	WHO ATC
0-L	D02AC	Soft paraffin and fat products	WHO ATC
0-L	D02AD	Liquid plasters	WHO ATC
0-L	D02AE	Carbamide products	WHO ATC
0-L	D02AE01	carbamide	WHO ATC
0-L	D02AE51	carbamide, combinations	WHO ATC
0-L	D02AF	Salicylic acid preparations	WHO ATC
0-L	D02AX	Other emollients and protectives	WHO ATC
0-L	D02B	PROTECTIVES AGAINST UV-RADIATION	WHO ATC
0-L	D02BA	Protectives against UV-radiation for topical use	WHO ATC
0-L	D02BA01	aminobenzoic acid	WHO ATC
0-L	D02BA02	octinoxate	WHO ATC
0-L	D02BB	Protectives against UV-radiation for systemic use	WHO ATC
0-L	D02BB01	betacarotene	WHO ATC
0-L	D03	PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS	WHO ATC
0-L	D03A	CICATRIZANTS	WHO ATC
0-L	D03AA	Cod-liver oil ointments	WHO ATC
0-L	D03AX	Other cicatrizants	WHO ATC
0-L	D03AX01	cadexomer iodine	WHO ATC
0-L	D03AX02	dextranomer	WHO ATC
0-L	D03AX03	dexpanthenol	WHO ATC
0-L	D03AX04	calcium pantothenate	WHO ATC
0-L	D03AX05	hyaluronic acid	WHO ATC
0-L	D03AX06	becaplermin	WHO ATC
0-L	D03AX09	crilanomer	WHO ATC
0-L	D03AX10	enoxolone	WHO ATC
0-L	D03B	ENZYMES	WHO ATC
0-L	D03BA	Proteolytic enzymes	WHO ATC
0-L	D03BA01	trypsin	WHO ATC
0-L	D03BA02	collagenase	WHO ATC
0-L	D03BA52	collagenase, combinations	WHO ATC
0-L	D04	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.	WHO ATC
0-L	D04A	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.	WHO ATC
0-L	D04AA	Antihistamines for topical use	WHO ATC
0-L	D04AA01	thonzylamine	WHO ATC
0-L	D04AA02	mepyramine	WHO ATC
0-L	D04AA03	thenalidine	WHO ATC
0-L	D04AA04	tripelennamine	WHO ATC
0-L	D04AA09	chloropyramine	WHO ATC
0-L	D04AA10	promethazine	WHO ATC
0-L	D04AA12	tolpropamine	WHO ATC
0-L	D04AA13	dimetindene	WHO ATC
0-L	D04AA14	clemastine	WHO ATC
0-L	D04AA15	bamipine	WHO ATC
0-L	D04AA22	isothipendyl	WHO ATC
0-L	D04AA32	diphenhydramine	WHO ATC
0-L	D04AA33	diphenhydramine methylbromide	WHO ATC
0-L	D04AA34	chlorphenoxamine	WHO ATC
0-L	D04AB	Anesthetics for topical use	WHO ATC
0-L	D04AB01	lidocaine	WHO ATC
0-L	D04AB02	cinchocaine	WHO ATC
0-L	D04AB03	oxybuprocaine	WHO ATC
0-L	D04AB04	benzocaine	WHO ATC
0-L	D04AB05	quinisocaine	WHO ATC
0-L	D04AB06	tetracaine	WHO ATC
0-L	D04AB07	pramocaine	WHO ATC
0-L	D04AX	Other antipruritics	WHO ATC
0-L	D05	ANTIPSORIATICS	WHO ATC
0-L	D05A	ANTIPSORIATICS FOR TOPICAL USE	WHO ATC
0-L	D05AA	Tars	WHO ATC
0-L	D05AC	Antracen derivatives	WHO ATC
0-L	D05AC01	dithranol	WHO ATC
0-L	D05AC51	dithranol, combinations	WHO ATC
0-L	D05AD	Psoralens for topical use	WHO ATC
0-L	D05AD01	trioxysalen	WHO ATC
0-L	D05AD02	methoxsalen	WHO ATC
0-L	D05AX	Other antipsoriatics for topical use	WHO ATC
0-L	D05AX01	fumaric acid	WHO ATC
0-L	D05AX02	calcipotriol	WHO ATC
0-L	D05AX03	calcitriol	WHO ATC
0-L	D05AX04	tacalcitol	WHO ATC
0-L	D05AX05	tazarotene	WHO ATC
0-L	D05AX52	calcipotriol, combinations	WHO ATC
0-L	D05B	ANTIPSORIATICS FOR SYSTEMIC USE	WHO ATC
0-L	D05BA	Psoralens for systemic use	WHO ATC
0-L	D05BA01	trioxysalen	WHO ATC
0-L	D05BA02	methoxsalen	WHO ATC
0-L	D05BA03	bergapten	WHO ATC
0-L	D05BB	Retinoids for treatment of psoriasis	WHO ATC
0-L	D05BB01	etretinate	WHO ATC
0-L	D05BB02	acitretin	WHO ATC
0-L	D05BX	Other antipsoriatics for systemic use	WHO ATC
0-L	D05BX51	fumaric acid derivatives, combinations	WHO ATC
0-L	D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE	WHO ATC
0-L	D06A	ANTIBIOTICS FOR TOPICAL USE	WHO ATC
0-L	D06AA	Tetracycline and derivatives	WHO ATC
0-L	D06AA01	demeclocycline	WHO ATC
0-L	D06AA02	chlortetracycline	WHO ATC
0-L	D06AA03	oxytetracycline	WHO ATC
0-L	D06AA04	tetracycline	WHO ATC
0-L	D06AX	Other antibiotics for topical use	WHO ATC
0-L	D06AX01	fusidic acid	WHO ATC
0-L	D06AX02	chloramphenicol	WHO ATC
0-L	D06AX04	neomycin	WHO ATC
0-L	D06AX05	bacitracin	WHO ATC
0-L	D06AX07	gentamicin	WHO ATC
0-L	D06AX08	tyrothricin	WHO ATC
0-L	D06AX09	mupirocin	WHO ATC
0-L	D06AX10	virginiamycin	WHO ATC
0-L	D06AX11	rifaximin	WHO ATC
0-L	D06AX12	amikacin	WHO ATC
0-L	D06AX13	retapamulin	WHO ATC
0-L	D06B	CHEMOTHERAPEUTICS FOR TOPICAL USE	WHO ATC
0-L	D06BA	Sulfonamides	WHO ATC
0-L	D06BA01	silver sulfadiazine	WHO ATC
0-L	D06BA02	sulfathiazole	WHO ATC
0-L	D06BA03	mafenide	WHO ATC
0-L	D06BA04	sulfamethizole	WHO ATC
0-L	D06BA05	sulfanilamide	WHO ATC
0-L	D06BA06	sulfamerazine	WHO ATC
0-L	D06BA51	silver sulfadiazine, combinations	WHO ATC
0-L	D06BB	Antivirals	WHO ATC
0-L	D06BB01	idoxuridine	WHO ATC
0-L	D06BB02	tromantadine	WHO ATC
0-L	D06BB03	aciclovir	WHO ATC
0-L	D06BB04	podophyllotoxin	WHO ATC
0-L	D06BB05	inosine	WHO ATC
0-L	D06BB06	penciclovir	WHO ATC
0-L	D06BB07	lysozyme	WHO ATC
0-L	D06BB08	ibacitabine	WHO ATC
0-L	D06BB09	edoxudine	WHO ATC
0-L	D06BB10	imiquimod	WHO ATC
0-L	D06BB11	docosanol	WHO ATC
0-L	D06BB53	aciclovir, combinations	WHO ATC
0-L	D06BX	Other chemotherapeutics	WHO ATC
0-L	D06BX01	metronidazole	WHO ATC
0-L	D06C	ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS	WHO ATC
0-L	D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS	WHO ATC
0-L	D07A	CORTICOSTEROIDS, PLAIN	WHO ATC
0-L	D07AA	Corticosteroids, weak (group I)	WHO ATC
0-L	D07AA01	methylprednisolone	WHO ATC
0-L	D07AA02	hydrocortisone	WHO ATC
0-L	D07AA03	prednisolone	WHO ATC
0-L	D07AB	Corticosteroids, moderately potent (group II)	WHO ATC
0-L	D07AB01	clobetasone	WHO ATC
0-L	D07AB02	hydrocortisone butyrate	WHO ATC
0-L	D07AB03	flumetasone	WHO ATC
0-L	D07AB04	fluocortin	WHO ATC
0-L	D07AB05	fluperolone	WHO ATC
0-L	D07AB06	fluorometholone	WHO ATC
0-L	D07AB07	fluprednidene	WHO ATC
0-L	D07AB08	desonide	WHO ATC
0-L	D07AB09	triamcinolone	WHO ATC
0-L	D07AB10	alclometasone	WHO ATC
0-L	D07AB11	hydrocortisone buteprate	WHO ATC
0-L	D07AB19	dexamethasone	WHO ATC
0-L	D07AB21	clocortolone	WHO ATC
0-L	D07AB30	combinations of corticosteroids	WHO ATC
0-L	D07AC	Corticosteroids, potent (group III)	WHO ATC
0-L	D07AC01	betamethasone	WHO ATC
0-L	D07AC02	fluclorolone	WHO ATC
0-L	D07AC03	desoximetasone	WHO ATC
0-L	D07AC04	fluocinolone acetonide	WHO ATC
0-L	D07AC05	fluocortolone	WHO ATC
0-L	D07AC06	diflucortolone	WHO ATC
0-L	D07AC07	fludroxycortide	WHO ATC
0-L	D07AC08	fluocinonide	WHO ATC
0-L	D07AC09	budesonide	WHO ATC
0-L	D07AC10	diflorasone	WHO ATC
0-L	D07AC11	amcinonide	WHO ATC
0-L	D07AC12	halometasone	WHO ATC
0-L	D07AC13	mometasone	WHO ATC
0-L	D07AC14	methylprednisolone aceponate	WHO ATC
0-L	D07AC15	beclometasone	WHO ATC
0-L	D07AC16	hydrocortisone aceponate	WHO ATC
0-L	D07AC17	fluticasone	WHO ATC
0-L	D07AC18	prednicarbate	WHO ATC
0-L	D07AC19	difluprednate	WHO ATC
0-L	D07AC21	ulobetasol	WHO ATC
0-L	D07AD	Corticosteroids, very potent (group IV)	WHO ATC
0-L	D07AD01	clobetasol	WHO ATC
0-L	D07AD02	halcinonide	WHO ATC
0-L	D07B	CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS	WHO ATC
0-L	D07BA	Corticosteroids, weak, combinations with antiseptics	WHO ATC
0-L	D07BA01	prednisolone and antiseptics	WHO ATC
0-L	D07BA04	hydrocortisone and antiseptics	WHO ATC
0-L	D07BB	Corticosteroids, moderately potent, combinations with antiseptics	WHO ATC
0-L	D07BB01	flumetasone and antiseptics	WHO ATC
0-L	D07BB02	desonide and antiseptics	WHO ATC
0-L	D07BB03	triamcinolone and antiseptics	WHO ATC
0-L	D07BB04	hydrocortisone butyrate and antiseptics	WHO ATC
0-L	D07BC	Corticosteroids, potent, combinations with antiseptics	WHO ATC
0-L	D07BC01	betamethasone and antiseptics	WHO ATC
0-L	D07BC02	fluocinolone acetonide and antiseptics	WHO ATC
0-L	D07BC03	fluocortolone and antiseptics	WHO ATC
0-L	D07BC04	diflucortolone and antiseptics	WHO ATC
0-L	D07BD	Corticosteroids, very potent, combinations with antiseptics	WHO ATC
0-L	D07C	CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS	WHO ATC
0-L	D07CA	Corticosteroids, weak, combinations with antibiotics	WHO ATC
0-L	D07CA01	hydrocortisone and antibiotics	WHO ATC
0-L	D07CA02	methylprednisolone and antibiotics	WHO ATC
0-L	D07CA03	prednisolone and antibiotics	WHO ATC
0-L	D07CB	Corticosteroids, moderately potent, combinations with antibiotics	WHO ATC
0-L	D07CB01	triamcinolone and antibiotics	WHO ATC
0-L	D07CB02	fluprednidene and antibiotics	WHO ATC
0-L	D07CB03	fluorometholone and antibiotics	WHO ATC
0-L	D07CB04	dexamethasone and antibiotics	WHO ATC
0-L	D07CB05	flumetasone and antibiotics	WHO ATC
0-L	D07CC	Corticosteroids, potent, combinations with antibiotics	WHO ATC
0-L	D07CC01	betamethasone and antibiotics	WHO ATC
0-L	D07CC02	fluocinolone acetonide and antibiotics	WHO ATC
0-L	D07CC03	fludroxycortide and antibiotics	WHO ATC
0-L	D07CC04	beclometasone and antibiotics	WHO ATC
0-L	D07CC05	fluocinonide and antibiotics	WHO ATC
0-L	D07CC06	fluocortolone and antibiotics	WHO ATC
0-L	D07CD	Corticosteroids, very potent, combinations with antibiotics	WHO ATC
0-L	D07CD01	clobetasol and antibiotics	WHO ATC
0-L	D07X	CORTICOSTEROIDS, OTHER COMBINATIONS	WHO ATC
0-L	D07XA	Corticosteroids, weak, other combinations	WHO ATC
0-L	D07XA01	hydrocortisone	WHO ATC
0-L	D07XA02	prednisolone	WHO ATC
0-L	D07XB	Corticosteroids, moderately potent, other combinations	WHO ATC
0-L	D07XB01	flumetasone	WHO ATC
0-L	D07XB02	triamcinolone	WHO ATC
0-L	D07XB03	fluprednidene	WHO ATC
0-L	D07XB04	fluorometholone	WHO ATC
0-L	D07XB05	dexamethasone	WHO ATC
0-L	D07XB30	combinations of corticosteroids	WHO ATC
0-L	D07XC	Corticosteroids, potent, other combinations	WHO ATC
0-L	D07XC01	betamethasone	WHO ATC
0-L	D07XC02	desoximetasone	WHO ATC
0-L	D07XC03	mometasone	WHO ATC
0-L	D07XC04	diflucortolone	WHO ATC
0-L	D07XD	Corticosteroids, very potent, other combinations	WHO ATC
0-L	D08	ANTISEPTICS AND DISINFECTANTS	WHO ATC
0-L	D08A	ANTISEPTICS AND DISINFECTANTS	WHO ATC
0-L	D08AA	Acridine derivatives	WHO ATC
0-L	D08AA01	ethacridine lactate	WHO ATC
0-L	D08AA02	aminoacridine	WHO ATC
0-L	D08AA03	euflavine	WHO ATC
0-L	D08AB	Aluminium agents	WHO ATC
0-L	D08AC	Biguanides and amidines	WHO ATC
0-L	D08AC01	dibrompropamidine	WHO ATC
0-L	D08AC02	chlorhexidine	WHO ATC
0-L	D08AC03	propamidine	WHO ATC
0-L	D08AC04	hexamidine	WHO ATC
0-L	D08AC05	polihexanide	WHO ATC
0-L	D08AC52	chlorhexidine, combinations	WHO ATC
0-L	D08AD	Boric acid products	WHO ATC
0-L	D08AE	Phenol and derivatives	WHO ATC
0-L	D08AE01	hexachlorophene	WHO ATC
0-L	D08AE02	policresulen	WHO ATC
0-L	D08AE03	phenol	WHO ATC
0-L	D08AE04	triclosan	WHO ATC
0-L	D08AE05	chloroxylenol	WHO ATC
0-L	D08AE06	biphenylol	WHO ATC
0-L	D08AF	Nitrofuran derivatives	WHO ATC
0-L	D08AF01	nitrofural	WHO ATC
0-L	D08AG	Iodine products	WHO ATC
0-L	D08AG01	iodine/octylphenoxypolyglycolether	WHO ATC
0-L	D08AG02	povidone-iodine	WHO ATC
0-L	D08AG03	iodine	WHO ATC
0-L	D08AG04	diiodohydroxypropane	WHO ATC
0-L	D08AH	Quinoline derivatives	WHO ATC
0-L	D08AH01	dequalinium	WHO ATC
0-L	D08AH02	chlorquinaldol	WHO ATC
0-L	D08AH03	oxyquinoline	WHO ATC
0-L	D08AH30	clioquinol	WHO ATC
0-L	D08AJ	Quaternary ammonium compounds	WHO ATC
0-L	D08AJ01	benzalkonium	WHO ATC
0-L	D08AJ02	cetrimonium	WHO ATC
0-L	D08AJ03	cetylpyridinium	WHO ATC
0-L	D08AJ04	cetrimide	WHO ATC
0-L	D08AJ05	benzoxonium chloride	WHO ATC
0-L	D08AJ06	didecyldimethylammonium chloride	WHO ATC
0-L	D08AJ08	benzethonium chloride	WHO ATC
0-L	D08AJ57	octenidine, combinations	WHO ATC
0-L	D08AJ58	benzethonium chloride, combinations	WHO ATC
0-L	D08AJ59	dodeclonium bromide, combinations	WHO ATC
0-L	D08AK	Mercurial products	WHO ATC
0-L	D08AK01	mercuric amidochloride	WHO ATC
0-L	D08AK02	phenylmercuric borate	WHO ATC
0-L	D08AK03	mercuric chloride	WHO ATC
0-L	D08AK04	mercurochrome	WHO ATC
0-L	D08AK05	mercury, metallic	WHO ATC
0-L	D08AK06	thiomersal	WHO ATC
0-L	D08AK30	mercuric iodide	WHO ATC
0-L	D08AL	Silver compounds	WHO ATC
0-L	D08AL01	silver nitrate	WHO ATC
0-L	D08AL30	silver	WHO ATC
0-L	D08AX	Other antiseptics and disinfectants	WHO ATC
0-L	D08AX01	hydrogen peroxide	WHO ATC
0-L	D08AX02	eosin	WHO ATC
0-L	D08AX03	propanol	WHO ATC
0-L	D08AX04	tosylchloramide sodium	WHO ATC
0-L	D08AX05	isopropanol	WHO ATC
0-L	D08AX06	potassium permanganate	WHO ATC
0-L	D08AX07	sodium hypochlorite	WHO ATC
0-L	D08AX08	ethanol	WHO ATC
0-L	D08AX53	propanol, combinations	WHO ATC
0-L	D09	MEDICATED DRESSINGS	WHO ATC
0-L	D09A	MEDICATED DRESSINGS	WHO ATC
0-L	D09AA	Medicated dressings with antiinfectives	WHO ATC
0-L	D09AA01	framycetin	WHO ATC
0-L	D09AA02	fusidic acid	WHO ATC
0-L	D09AA03	nitrofural	WHO ATC
0-L	D09AA04	phenylmercuric nitrate	WHO ATC
0-L	D09AA05	benzododecinium	WHO ATC
0-L	D09AA06	triclosan	WHO ATC
0-L	D09AA07	cetylpyridinium	WHO ATC
0-L	D09AA08	aluminium chlorohydrate	WHO ATC
0-L	D09AA09	povidone-iodine	WHO ATC
0-L	D09AA10	clioquinol	WHO ATC
0-L	D09AA11	benzalkonium	WHO ATC
0-L	D09AA12	chlorhexidine	WHO ATC
0-L	D09AA13	iodoform	WHO ATC
0-L	D09AB	Zinc bandages	WHO ATC
0-L	D09AB01	zinc bandage without supplements	WHO ATC
0-L	D09AB02	zinc bandage with supplements	WHO ATC
0-L	D09AX	Soft paraffin dressings	WHO ATC
0-L	D10	ANTI-ACNE PREPARATIONS	WHO ATC
0-L	D10A	ANTI-ACNE PREPARATIONS FOR TOPICAL USE	WHO ATC
0-L	D10AA	Corticosteroids, combinations for treatment of acne	WHO ATC
0-L	D10AA01	fluorometholone	WHO ATC
0-L	D10AA02	methylprednisolone	WHO ATC
0-L	D10AA03	dexamethasone	WHO ATC
0-L	D10AB	Preparations containing sulfur	WHO ATC
0-L	D10AB01	bithionol	WHO ATC
0-L	D10AB02	sulfur	WHO ATC
0-L	D10AB03	tioxolone	WHO ATC
0-L	D10AB05	mesulfen	WHO ATC
0-L	D10AD	Retinoids for topical use in acne	WHO ATC
0-L	D10AD01	tretinoin	WHO ATC
0-L	D10AD02	retinol	WHO ATC
0-L	D10AD03	adapalene	WHO ATC
0-L	D10AD04	isotretinoin	WHO ATC
0-L	D10AD05	motretinide	WHO ATC
0-L	D10AD51	tretinoin, combinations	WHO ATC
0-L	D10AD53	adapalene, combinations	WHO ATC
0-L	D10AD54	isotretinoin, combinations	WHO ATC
0-L	D10AE	Peroxides	WHO ATC
0-L	D10AE01	benzoyl peroxide	WHO ATC
0-L	D10AE51	benzoyl peroxide, combinations	WHO ATC
0-L	D10AF	Antiinfectives for treatment of acne	WHO ATC
0-L	D10AF01	clindamycin	WHO ATC
0-L	D10AF02	erythromycin	WHO ATC
0-L	D10AF03	chloramphenicol	WHO ATC
0-L	D10AF04	meclocycline	WHO ATC
0-L	D10AF51	clindamycin, combinations	WHO ATC
0-L	D10AF52	erythromycin, combinations	WHO ATC
0-L	D10AX	Other anti-acne preparations for topical use	WHO ATC
0-L	D10AX01	aluminium chloride	WHO ATC
0-L	D10AX02	resorcinol	WHO ATC
0-L	D10AX03	azelaic acid	WHO ATC
0-L	D10AX04	aluminium oxide	WHO ATC
0-L	D10AX05	dapsone	WHO ATC
0-L	D10AX30	various combinations	WHO ATC
0-L	D10B	ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE	WHO ATC
0-L	D10BA	Retinoids for treatment of acne	WHO ATC
0-L	D10BA01	isotretinoin	WHO ATC
0-L	D10BX	Other anti-acne preparations for systemic use	WHO ATC
0-L	D10BX01	ichtasol	WHO ATC
0-L	D11	OTHER DERMATOLOGICAL PREPARATIONS	WHO ATC
0-L	D11A	OTHER DERMATOLOGICAL PREPARATIONS	WHO ATC
0-L	D11AA	Antihidrotics	WHO ATC
0-L	D11AC	Medicated shampoos	WHO ATC
0-L	D11AC01	cetrimide	WHO ATC
0-L	D11AC02	cadmium compounds	WHO ATC
0-L	D11AC03	selenium compounds	WHO ATC
0-L	D11AC06	povidone-iodine	WHO ATC
0-L	D11AC08	sulfur compounds	WHO ATC
0-L	D11AC09	xenysalate	WHO ATC
0-L	D11AC30	others	WHO ATC
0-L	D11AE	Androgens for topical use	WHO ATC
0-L	D11AE01	metandienone	WHO ATC
0-L	D11AF	Wart and anti-corn preparations	WHO ATC
0-L	D11AH	Agents for atopic dermatitis, excluding corticosteroids	WHO ATC
0-L	D11AH01	tacrolimus	WHO ATC
0-L	D11AH02	pimecrolimus	WHO ATC
0-L	D11AH03	cromoglicic acid	WHO ATC
0-L	D11AX	Other dermatologicals	WHO ATC
0-L	D11AX01	minoxidil	WHO ATC
0-L	D11AX02	gamolenic acid	WHO ATC
0-L	D11AX03	calcium gluconate	WHO ATC
0-L	D11AX04	lithium succinate	WHO ATC
0-L	D11AX05	magnesium sulfate	WHO ATC
0-L	D11AX06	mequinol	WHO ATC
0-L	D11AX08	tiratricol	WHO ATC
0-L	D11AX09	oxaceprol	WHO ATC
0-L	D11AX10	finasteride	WHO ATC
0-L	D11AX11	hydroquinone	WHO ATC
0-L	D11AX12	pyrithione zinc	WHO ATC
0-L	D11AX13	monobenzone	WHO ATC
0-L	D11AX16	eflornithine	WHO ATC
0-L	D11AX18	diclofenac	WHO ATC
0-L	D11AX19	alitretinoin	WHO ATC
0-L	D11AX52	gamolenic acid, combinations	WHO ATC
0-L	D11AX57	collagen, combinations	WHO ATC
0-L	G	GENITO URINARY SYSTEM AND SEX HORMONES	WHO ATC
0-L	G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS	WHO ATC
0-L	G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONSWITH CORTICOSTEROIDS	WHO ATC
0-L	G01AA	Antibiotics	WHO ATC
0-L	G01AA01	nystatin	WHO ATC
0-L	G01AA02	natamycin	WHO ATC
0-L	G01AA03	amphotericin B	WHO ATC
0-L	G01AA04	candicidin	WHO ATC
0-L	G01AA05	chloramphenicol	WHO ATC
0-L	G01AA06	hachimycin	WHO ATC
0-L	G01AA07	oxytetracycline	WHO ATC
0-L	G01AA08	carfecillin	WHO ATC
0-L	G01AA09	mepartricin	WHO ATC
0-L	G01AA10	clindamycin	WHO ATC
0-L	G01AA11	pentamycin	WHO ATC
0-L	G01AA51	nystatin, combinations	WHO ATC
0-L	G01AB	Arsenic compounds	WHO ATC
0-L	G01AB01	acetarsol	WHO ATC
0-L	G01AC	Quinoline derivatives	WHO ATC
0-L	G01AC01	diiodohydroxyquinoline	WHO ATC
0-L	G01AC02	clioquinol	WHO ATC
0-L	G01AC03	chlorquinaldol	WHO ATC
0-L	G01AC05	dequalinium	WHO ATC
0-L	G01AC06	broxyquinoline	WHO ATC
0-L	G01AC30	oxyquinoline	WHO ATC
0-L	G01AD	Organic acids	WHO ATC
0-L	G01AD01	lactic acid	WHO ATC
0-L	G01AD02	acetic acid	WHO ATC
0-L	G01AD03	ascorbic acid	WHO ATC
0-L	G01AE	Sulfonamides	WHO ATC
0-L	G01AE01	sulfatolamide	WHO ATC
0-L	G01AE10	combinations of sulfonamides	WHO ATC
0-L	G01AF	Imidazole derivatives	WHO ATC
0-L	G01AF01	metronidazole	WHO ATC
0-L	G01AF02	clotrimazole	WHO ATC
0-L	G01AF04	miconazole	WHO ATC
0-L	G01AF05	econazole	WHO ATC
0-L	G01AF06	ornidazole	WHO ATC
0-L	G01AF07	isoconazole	WHO ATC
0-L	G01AF08	tioconazole	WHO ATC
0-L	G01AF11	ketoconazole	WHO ATC
0-L	G01AF12	fenticonazole	WHO ATC
0-L	G01AF13	azanidazole	WHO ATC
0-L	G01AF14	propenidazole	WHO ATC
0-L	G01AF15	butoconazole	WHO ATC
0-L	G01AF16	omoconazole	WHO ATC
0-L	G01AF17	oxiconazole	WHO ATC
0-L	G01AF18	flutrimazole	WHO ATC
0-L	G01AF20	combinations of imidazole derivatives	WHO ATC
0-L	G01AG	Triazole derivatives	WHO ATC
0-L	G01AG02	terconazole	WHO ATC
0-L	G01AX	Other antiinfectives and antiseptics	WHO ATC
0-L	G01AX01	clodantoin	WHO ATC
0-L	G01AX02	inosine	WHO ATC
0-L	G01AX03	policresulen	WHO ATC
0-L	G01AX05	nifuratel	WHO ATC
0-L	G01AX06	furazolidone	WHO ATC
0-L	G01AX09	methylrosaniline	WHO ATC
0-L	G01AX11	povidone-iodine	WHO ATC
0-L	G01AX12	ciclopirox	WHO ATC
0-L	G01AX13	protiofate	WHO ATC
0-L	G01AX14	lactobacillus fermentum	WHO ATC
0-L	G01AX15	copper usnate	WHO ATC
0-L	G01AX66	octenidine, combinations	WHO ATC
0-L	G01B	ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS	WHO ATC
0-L	G01BA	Antibiotics and corticosteroids	WHO ATC
0-L	G01BC	Quinoline derivatives and corticosteroids	WHO ATC
0-L	G01BD	Antiseptics and corticosteroids	WHO ATC
0-L	G01BE	Sulfonamides and corticosteroids	WHO ATC
0-L	G01BF	Imidazole derivatives and corticosteroids	WHO ATC
0-L	G02	OTHER GYNECOLOGICALS	WHO ATC
0-L	G02A	OXYTOCICS	WHO ATC
0-L	G02AB	Ergot alkaloids	WHO ATC
0-L	G02AB01	methylergometrine	WHO ATC
0-L	G02AB02	ergot alkaloids	WHO ATC
0-L	G02AB03	ergometrine	WHO ATC
0-L	G02AC	Ergot alkaloids and oxytocin incl. analogues, in combination	WHO ATC
0-L	G02AC01	methylergometrine and oxytocin	WHO ATC
0-L	G02AD	Prostaglandins	WHO ATC
0-L	G02AD01	dinoprost	WHO ATC
0-L	G02AD02	dinoprostone	WHO ATC
0-L	G02AD03	gemeprost	WHO ATC
0-L	G02AD04	carboprost	WHO ATC
0-L	G02AD05	sulprostone	WHO ATC
0-L	G02AD06	misoprostol	WHO ATC
0-L	G02AX	Other oxytocics	WHO ATC
0-L	G02B	CONTRACEPTIVES FOR TOPICAL USE	WHO ATC
0-L	G02BA	Intrauterine contraceptives	WHO ATC
0-L	G02BA01	plastic IUD	WHO ATC
0-L	G02BA02	plastic IUD with copper	WHO ATC
0-L	G02BA03	plastic IUD with progestogen	WHO ATC
0-L	G02BB	Intravaginal contraceptives	WHO ATC
0-L	G02BB01	vaginal ring with progestogen and estrogen	WHO ATC
0-L	G02C	OTHER GYNECOLOGICALS	WHO ATC
0-L	G02CA	Sympathomimetics, labour repressants	WHO ATC
0-L	G02CA01	ritodrine	WHO ATC
0-L	G02CA02	buphenine	WHO ATC
0-L	G02CA03	fenoterol	WHO ATC
0-L	G02CB	Prolactine inhibitors	WHO ATC
0-L	G02CB01	bromocriptine	WHO ATC
0-L	G02CB02	lisuride	WHO ATC
0-L	G02CB03	cabergoline	WHO ATC
0-L	G02CB04	quinagolide	WHO ATC
0-L	G02CB05	metergoline	WHO ATC
0-L	G02CB06	terguride	WHO ATC
0-L	G02CC	Antiinflammatory products for vaginal administration	WHO ATC
0-L	G02CC01	ibuprofen	WHO ATC
0-L	G02CC02	naproxen	WHO ATC
0-L	G02CC03	benzydamine	WHO ATC
0-L	G02CC04	flunoxaprofen	WHO ATC
0-L	G02CX	Other gynecologicals	WHO ATC
0-L	G02CX01	atosiban	WHO ATC
0-L	G03	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM	WHO ATC
0-L	G03A	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE	WHO ATC
0-L	G03AA	Progestogens and estrogens, fixed combinations	WHO ATC
0-L	G03AA01	etynodiol and estrogen	WHO ATC
0-L	G03AA02	quingestanol and estrogen	WHO ATC
0-L	G03AA03	lynestrenol and estrogen	WHO ATC
0-L	G03AA04	megestrol and estrogen	WHO ATC
0-L	G03AA05	norethisterone and estrogen	WHO ATC
0-L	G03AA06	norgestrel and estrogen	WHO ATC
0-L	G03AA07	levonorgestrel and estrogen	WHO ATC
0-L	G03AA08	medroxyprogesterone and estrogen	WHO ATC
0-L	G03AA09	desogestrel and estrogen	WHO ATC
0-L	G03AA10	gestodene and estrogen	WHO ATC
0-L	G03AA11	norgestimate and estrogen	WHO ATC
0-L	G03AA12	drospirenone and estrogen	WHO ATC
0-L	G03AA13	norelgestromin and estrogen	WHO ATC
0-L	G03AA14	nomegestrol and estrogen	WHO ATC
0-L	G03AB	Progestogens and estrogens, sequential preparations	WHO ATC
0-L	G03AB01	megestrol and estrogen	WHO ATC
0-L	G03AB02	lynestrenol and estrogen	WHO ATC
0-L	G03AB03	levonorgestrel and estrogen	WHO ATC
0-L	G03AB04	norethisterone and estrogen	WHO ATC
0-L	G03AB05	desogestrel and estrogen	WHO ATC
0-L	G03AB06	gestodene and estrogen	WHO ATC
0-L	G03AB07	chlormadinone and estrogen	WHO ATC
0-L	G03AC	Progestogens	WHO ATC
0-L	G03AC01	norethisterone	WHO ATC
0-L	G03AC02	lynestrenol	WHO ATC
0-L	G03AC03	levonorgestrel	WHO ATC
0-L	G03AC04	quingestanol	WHO ATC
0-L	G03AC05	megestrol	WHO ATC
0-L	G03AC06	medroxyprogesterone	WHO ATC
0-L	G03AC07	norgestrienone	WHO ATC
0-L	G03AC08	etonogestrel	WHO ATC
0-L	G03AC09	desogestrel	WHO ATC
0-L	G03B	ANDROGENS	WHO ATC
0-L	G03BA	3-oxoandrosten (4) derivatives	WHO ATC
0-L	G03BA01	fluoxymesterone	WHO ATC
0-L	G03BA02	methyltestosterone	WHO ATC
0-L	G03BA03	testosterone	WHO ATC
0-L	G03BB	5-androstanon (3) derivatives	WHO ATC
0-L	G03BB01	mesterolone	WHO ATC
0-L	G03BB02	androstanolone	WHO ATC
0-L	G03C	ESTROGENS	WHO ATC
0-L	G03CA	Natural and semisynthetic estrogens, plain	WHO ATC
0-L	G03CA01	ethinylestradiol	WHO ATC
0-L	G03CA03	estradiol	WHO ATC
0-L	G03CA04	estriol	WHO ATC
0-L	G03CA06	chlorotrianisene	WHO ATC
0-L	G03CA07	estrone	WHO ATC
0-L	G03CA09	promestriene	WHO ATC
0-L	G03CA53	estradiol, combinations	WHO ATC
0-L	G03CA57	conjugated estrogens	WHO ATC
0-L	G03CB	Synthetic estrogens, plain	WHO ATC
0-L	G03CB01	dienestrol	WHO ATC
0-L	G03CB02	diethylstilbestrol	WHO ATC
0-L	G03CB03	methallenestril	WHO ATC
0-L	G03CB04	moxestrol	WHO ATC
0-L	G03CC	Estrogens, combinations with other drugs	WHO ATC
0-L	G03CC02	dienestrol	WHO ATC
0-L	G03CC03	methallenestril	WHO ATC
0-L	G03CC04	estrone	WHO ATC
0-L	G03CC05	diethylstilbestrol	WHO ATC
0-L	G03CC06	estriol	WHO ATC
0-L	G03CX	Other estrogens	WHO ATC
0-L	G03CX01	tibolone	WHO ATC
0-L	G03D	PROGESTOGENS	WHO ATC
0-L	G03DA	Pregnen (4) derivatives	WHO ATC
0-L	G03DA01	gestonorone	WHO ATC
0-L	G03DA02	medroxyprogesterone	WHO ATC
0-L	G03DA03	hydroxyprogesterone	WHO ATC
0-L	G03DA04	progesterone	WHO ATC
0-L	G03DB	Pregnadien derivatives	WHO ATC
0-L	G03DB01	dydrogesterone	WHO ATC
0-L	G03DB02	megestrol	WHO ATC
0-L	G03DB03	medrogestone	WHO ATC
0-L	G03DB04	nomegestrol	WHO ATC
0-L	G03DB05	demegestone	WHO ATC
0-L	G03DB06	chlormadinone	WHO ATC
0-L	G03DB07	promegestone	WHO ATC
0-L	G03DC	Estren derivatives	WHO ATC
0-L	G03DC01	allylestrenol	WHO ATC
0-L	G03DC02	norethisterone	WHO ATC
0-L	G03DC03	lynestrenol	WHO ATC
0-L	G03DC04	ethisterone	WHO ATC
0-L	G03DC06	etynodiol	WHO ATC
0-L	G03DC31	methylestrenolone	WHO ATC
0-L	G03E	ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION	WHO ATC
0-L	G03EA	Androgens and estrogens	WHO ATC
0-L	G03EA01	methyltestosterone and estrogen	WHO ATC
0-L	G03EA02	testosterone and estrogen	WHO ATC
0-L	G03EA03	prasterone and estrogen	WHO ATC
0-L	G03EB	Androgen, progestogen and estrogen in combination	WHO ATC
0-L	G03EK	Androgens and female sex hormones in combination with other drugs	WHO ATC
0-L	G03EK01	methyltestosterone	WHO ATC
0-L	G03F	PROGESTOGENS AND ESTROGENS IN COMBINATION	WHO ATC
0-L	G03FA	Progestogens and estrogens, fixed combinations	WHO ATC
0-L	G03FA01	norethisterone and estrogen	WHO ATC
0-L	G03FA02	hydroxyprogesterone and estrogen	WHO ATC
0-L	G03FA03	ethisterone and estrogen	WHO ATC
0-L	G03FA04	progesterone and estrogen	WHO ATC
0-L	G03FA05	methylnortestosterone and estrogen	WHO ATC
0-L	G03FA06	etynodiol and estrogen	WHO ATC
0-L	G03FA07	lynestrenol and estrogen	WHO ATC
0-L	G03FA08	megestrol and estrogen	WHO ATC
0-L	G03FA09	noretynodrel and estrogen	WHO ATC
0-L	G03FA10	norgestrel and estrogen	WHO ATC
0-L	G03FA11	levonorgestrel and estrogen	WHO ATC
0-L	G03FA12	medroxyprogesterone and estrogen	WHO ATC
0-L	G03FA13	norgestimate and estrogen	WHO ATC
0-L	G03FA14	dydrogesterone and estrogen	WHO ATC
0-L	G03FA15	dienogest and estrogen	WHO ATC
0-L	G03FA16	trimegestone and estrogen	WHO ATC
0-L	G03FA17	drospirenone and estrogen	WHO ATC
0-L	G03FB	Progestogens and estrogens, sequential preparations	WHO ATC
0-L	G03FB01	norgestrel and estrogen	WHO ATC
0-L	G03FB02	lynestrenol and estrogen	WHO ATC
0-L	G03FB03	chlormadinone and estrogen	WHO ATC
0-L	G03FB04	megestrol and estrogen	WHO ATC
0-L	G03FB05	norethisterone and estrogen	WHO ATC
0-L	G03FB06	medroxyprogesterone and estrogen	WHO ATC
0-L	G03FB07	medrogestone and estrogen	WHO ATC
0-L	G03FB08	dydrogesterone and estrogen	WHO ATC
0-L	G03FB09	levonorgestrel and estrogen	WHO ATC
0-L	G03FB10	desogestrel and estrogen	WHO ATC
0-L	G03FB11	trimegestone and estrogen	WHO ATC
0-L	G03G	GONADOTROPINS AND OTHER OVULATION STIMULANTS	WHO ATC
0-L	G03GA	Gonadotropins	WHO ATC
0-L	G03GA01	chorionic gonadotrophin	WHO ATC
0-L	G03GA02	human menopausal gonadotrophin	WHO ATC
0-L	G03GA03	serum gonadotrophin	WHO ATC
0-L	G03GA04	urofollitropin	WHO ATC
0-L	G03GA05	follitropin alfa	WHO ATC
0-L	G03GA06	follitropin beta	WHO ATC
0-L	G03GA07	lutropin alfa	WHO ATC
0-L	G03GA08	choriogonadotropin alfa	WHO ATC
0-L	G03GA09	corifollitropin alfa	WHO ATC
0-L	G03GA30	combinations	WHO ATC
0-L	G03GB	Ovulation stimulants, synthetic	WHO ATC
0-L	G03GB01	cyclofenil	WHO ATC
0-L	G03GB02	clomifene	WHO ATC
0-L	G03GB03	epimestrol	WHO ATC
0-L	G03H	ANTIANDROGENS	WHO ATC
0-L	G03HA	Antiandrogens, plain	WHO ATC
0-L	G03HA01	cyproterone	WHO ATC
0-L	G03HB	Antiandrogens and estrogens	WHO ATC
0-L	G03HB01	cyproterone and estrogen	WHO ATC
0-L	G03X	OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM	WHO ATC
0-L	G03XA	Antigonadotropins and similar agents	WHO ATC
0-L	G03XA01	danazol	WHO ATC
0-L	G03XA02	gestrinone	WHO ATC
0-L	G03XB	Antiprogestogens	WHO ATC
0-L	G03XB01	mifepristone	WHO ATC
0-L	G03XC	Selective estrogen receptor modulators	WHO ATC
0-L	G03XC01	raloxifene	WHO ATC
0-L	G03XC02	bazedoxifene	WHO ATC
0-L	G04	UROLOGICALS	WHO ATC
0-L	G04B	OTHER UROLOGICALS, INCL. ANTISPASMODICS	WHO ATC
0-L	G04BA	Acidifiers	WHO ATC
0-L	G04BA01	ammonium chloride	WHO ATC
0-L	G04BA03	calcium chloride	WHO ATC
0-L	G04BC	Urinary concrement solvents	WHO ATC
0-L	G04BD	Urinary antispasmodics	WHO ATC
0-L	G04BD01	emepronium	WHO ATC
0-L	G04BD02	flavoxate	WHO ATC
0-L	G04BD03	meladrazine	WHO ATC
0-L	G04BD04	oxybutynin	WHO ATC
0-L	G04BD05	terodiline	WHO ATC
0-L	G04BD06	propiverine	WHO ATC
0-L	G04BD07	tolterodine	WHO ATC
0-L	G04BD08	solifenacin	WHO ATC
0-L	G04BD09	trospium	WHO ATC
0-L	G04BD10	darifenacin	WHO ATC
0-L	G04BD11	fesoterodine	WHO ATC
0-L	G04BE	Drugs used in erectile dysfunction	WHO ATC
0-L	G04BE01	alprostadil	WHO ATC
0-L	G04BE02	papaverine	WHO ATC
0-L	G04BE03	sildenafil	WHO ATC
0-L	G04BE04	yohimbine	WHO ATC
0-L	G04BE05	phentolamine	WHO ATC
0-L	G04BE06	moxisylyte	WHO ATC
0-L	G04BE07	apomorphine	WHO ATC
0-L	G04BE08	tadalafil	WHO ATC
0-L	G04BE09	vardenafil	WHO ATC
0-L	G04BE30	combinations	WHO ATC
0-L	G04BE52	papaverine, combinations	WHO ATC
0-L	G04BX	Other urologicals	WHO ATC
0-L	G04BX01	magnesium hydroxide	WHO ATC
0-L	G04BX03	acetohydroxamic acid	WHO ATC
0-L	G04BX06	phenazopyridine	WHO ATC
0-L	G04BX10	succinimide	WHO ATC
0-L	G04BX11	collagen	WHO ATC
0-L	G04BX12	phenyl salicylate	WHO ATC
0-L	G04BX13	dimethyl sulfoxide	WHO ATC
0-L	G04BX14	dapoxetine	WHO ATC
0-L	G04C	DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY	WHO ATC
0-L	G04CA	Alpha-adrenoreceptor antagonists	WHO ATC
0-L	G04CA01	alfuzosin	WHO ATC
0-L	G04CA02	tamsulosin	WHO ATC
0-L	G04CA03	terazosin	WHO ATC
0-L	G04CA04	silodosin	WHO ATC
0-L	G04CA51	alfuzosin and finasteride	WHO ATC
0-L	G04CA52	tamsulosin and dutasteride	WHO ATC
0-L	G04CB	Testosterone-5-alpha reductase inhibitors	WHO ATC
0-L	G04CB01	finasteride	WHO ATC
0-L	G04CB02	dutasteride	WHO ATC
0-L	G04CX	Other drugs used in benign prostatic hypertrophy	WHO ATC
0-L	G04CX01	pygeum africanum	WHO ATC
0-L	G04CX02	serenoa repens	WHO ATC
0-L	G04CX03	mepartricin	WHO ATC
0-L	H	SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS	WHO ATC
0-L	H01	PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES	WHO ATC
0-L	H01A	ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES	WHO ATC
0-L	H01AA	ACTH	WHO ATC
0-L	H01AA01	corticotropin	WHO ATC
0-L	H01AA02	tetracosactide	WHO ATC
0-L	H01AB	Thyrotropin	WHO ATC
0-L	H01AB01	thyrotropin	WHO ATC
0-L	H01AC	Somatropin and somatropin agonists	WHO ATC
0-L	H01AC01	somatropin	WHO ATC
0-L	H01AC02	somatrem	WHO ATC
0-L	H01AC03	mecasermin	WHO ATC
0-L	H01AC04	sermorelin	WHO ATC
0-L	H01AC05	mecasermin rinfabate	WHO ATC
0-L	H01AX	Other anterior pituitary lobe hormones and analogues	WHO ATC
0-L	H01AX01	pegvisomant	WHO ATC
0-L	H01B	POSTERIOR PITUITARY LOBE HORMONES	WHO ATC
0-L	H01BA	Vasopressin and analogues	WHO ATC
0-L	H01BA01	vasopressin	WHO ATC
0-L	H01BA02	desmopressin	WHO ATC
0-L	H01BA03	lypressin	WHO ATC
0-L	H01BA04	terlipressin	WHO ATC
0-L	H01BA05	ornipressin	WHO ATC
0-L	H01BA06	argipressin	WHO ATC
0-L	H01BB	Oxytocin and analogues	WHO ATC
0-L	H01BB01	demoxytocin	WHO ATC
0-L	H01BB02	oxytocin	WHO ATC
0-L	H01BB03	carbetocin	WHO ATC
0-L	H01C	HYPOTHALAMIC HORMONES	WHO ATC
0-L	H01CA	Gonadotropin-releasing hormones	WHO ATC
0-L	H01CA01	gonadorelin	WHO ATC
0-L	H01CA02	nafarelin	WHO ATC
0-L	H01CA03	histrelin	WHO ATC
0-L	H01CB	Antigrowth hormones	WHO ATC
0-L	H01CB01	somatostatin	WHO ATC
0-L	H01CB02	octreotide	WHO ATC
0-L	H01CB03	lanreotide	WHO ATC
0-L	H01CB04	vapreotide	WHO ATC
0-L	H01CC	Anti-gonadotropin-releasing hormones	WHO ATC
0-L	H01CC01	ganirelix	WHO ATC
0-L	H01CC02	cetrorelix	WHO ATC
0-L	H02	CORTICOSTEROIDS FOR SYSTEMIC USE	WHO ATC
0-L	H02A	CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN	WHO ATC
0-L	H02AA	Mineralocorticoids	WHO ATC
0-L	H02AA01	aldosterone	WHO ATC
0-L	H02AA02	fludrocortisone	WHO ATC
0-L	H02AA03	desoxycortone	WHO ATC
0-L	H02AB	Glucocorticoids	WHO ATC
0-L	H02AB01	betamethasone	WHO ATC
0-L	H02AB02	dexamethasone	WHO ATC
0-L	H02AB03	fluocortolone	WHO ATC
0-L	H02AB04	methylprednisolone	WHO ATC
0-L	H02AB05	paramethasone	WHO ATC
0-L	H02AB06	prednisolone	WHO ATC
0-L	H02AB07	prednisone	WHO ATC
0-L	H02AB08	triamcinolone	WHO ATC
0-L	H02AB09	hydrocortisone	WHO ATC
0-L	H02AB10	cortisone	WHO ATC
0-L	H02AB11	prednylidene	WHO ATC
0-L	H02AB12	rimexolone	WHO ATC
0-L	H02AB13	deflazacort	WHO ATC
0-L	H02AB14	cloprednol	WHO ATC
0-L	H02AB15	meprednisone	WHO ATC
0-L	H02AB17	cortivazol	WHO ATC
0-L	H02B	CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS	WHO ATC
0-L	H02BX	Corticosteroids for systemic use, combinations	WHO ATC
0-L	H02BX01	methylprednisolone, combinations	WHO ATC
0-L	H02C	ANTIADRENAL PREPARATIONS	WHO ATC
0-L	H02CA	Anticorticosteroids	WHO ATC
0-L	H02CA01	trilostane	WHO ATC
0-L	H03	THYROID THERAPY	WHO ATC
0-L	H03A	THYROID PREPARATIONS	WHO ATC
0-L	H03AA	Thyroid hormones	WHO ATC
0-L	H03AA01	levothyroxine sodium	WHO ATC
0-L	H03AA02	liothyronine sodium	WHO ATC
0-L	H03AA03	combinations of levothyroxine and liothyronine	WHO ATC
0-L	H03AA04	tiratricol	WHO ATC
0-L	H03AA05	thyroid gland preparations	WHO ATC
0-L	H03B	ANTITHYROID PREPARATIONS	WHO ATC
0-L	H03BA	Thiouracils	WHO ATC
0-L	H03BA01	methylthiouracil	WHO ATC
0-L	H03BA02	propylthiouracil	WHO ATC
0-L	H03BA03	benzylthiouracil	WHO ATC
0-L	H03BB	Sulfur-containing imidazole derivatives	WHO ATC
0-L	H03BB01	carbimazole	WHO ATC
0-L	H03BB02	thiamazole	WHO ATC
0-L	H03BB52	thiamazole, combinations	WHO ATC
0-L	H03BC	Perchlorates	WHO ATC
0-L	H03BC01	potassium perchlorate	WHO ATC
0-L	H03BX	Other antithyroid preparations	WHO ATC
0-L	H03BX01	diiodotyrosine	WHO ATC
0-L	H03BX02	dibromotyrosine	WHO ATC
0-L	H03C	IODINE THERAPY	WHO ATC
0-L	H03CA	Iodine therapy	WHO ATC
0-L	H04	PANCREATIC HORMONES	WHO ATC
0-L	H04A	GLYCOGENOLYTIC HORMONES	WHO ATC
0-L	H04AA	Glycogenolytic hormones	WHO ATC
0-L	H04AA01	glucagon	WHO ATC
0-L	H05	CALCIUM HOMEOSTASIS	WHO ATC
0-L	H05A	PARATHYROID HORMONES AND ANALOGUES	WHO ATC
0-L	H05AA	Parathyroid hormones and analogues	WHO ATC
0-L	H05AA01	parathyroid gland extract	WHO ATC
0-L	H05AA02	teriparatide	WHO ATC
0-L	H05AA03	parathyroid hormone	WHO ATC
0-L	H05B	ANTI-PARATHYROID AGENTS	WHO ATC
0-L	H05BA	Calcitonin preparations	WHO ATC
0-L	H05BA01	calcitonin (salmon synthetic)	WHO ATC
0-L	H05BA02	calcitonin (pork natural)	WHO ATC
0-L	H05BA03	calcitonin (human synthetic)	WHO ATC
0-L	H05BA04	elcatonin	WHO ATC
0-L	H05BX	Other anti-parathyroid agents	WHO ATC
0-L	H05BX01	cinacalcet	WHO ATC
0-L	H05BX02	paricalcitol	WHO ATC
0-L	H05BX03	doxercalciferol	WHO ATC
0-L	J	ANTIINFECTIVES FOR SYSTEMIC USE	WHO ATC
0-L	J01	ANTIBACTERIALS FOR SYSTEMIC USE	WHO ATC
0-L	J01A	TETRACYCLINES	WHO ATC
0-L	J01AA	Tetracyclines	WHO ATC
0-L	J01AA01	demeclocycline	WHO ATC
0-L	J01AA02	doxycycline	WHO ATC
0-L	J01AA03	chlortetracycline	WHO ATC
0-L	J01AA04	lymecycline	WHO ATC
0-L	J01AA05	metacycline	WHO ATC
0-L	J01AA06	oxytetracycline	WHO ATC
0-L	J01AA07	tetracycline	WHO ATC
0-L	J01AA08	minocycline	WHO ATC
0-L	J01AA09	rolitetracycline	WHO ATC
0-L	J01AA10	penimepicycline	WHO ATC
0-L	J01AA11	clomocycline	WHO ATC
0-L	J01AA12	tigecycline	WHO ATC
0-L	J01AA20	combinations of tetracyclines	WHO ATC
0-L	J01AA56	oxytetracycline, combinations	WHO ATC
0-L	J01B	AMPHENICOLS	WHO ATC
0-L	J01BA	Amphenicols	WHO ATC
0-L	J01BA01	chloramphenicol	WHO ATC
0-L	J01BA02	thiamphenicol	WHO ATC
0-L	J01BA52	thiamphenicol, combinations	WHO ATC
0-L	J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS	WHO ATC
0-L	J01CA	Penicillins with extended spectrum	WHO ATC
0-L	J01CA01	ampicillin	WHO ATC
0-L	J01CA02	pivampicillin	WHO ATC
0-L	J01CA03	carbenicillin	WHO ATC
0-L	J01CA04	amoxicillin	WHO ATC
0-L	J01CA05	carindacillin	WHO ATC
0-L	J01CA06	bacampicillin	WHO ATC
0-L	J01CA07	epicillin	WHO ATC
0-L	J01CA08	pivmecillinam	WHO ATC
0-L	J01CA09	azlocillin	WHO ATC
0-L	J01CA10	mezlocillin	WHO ATC
0-L	J01CA11	mecillinam	WHO ATC
0-L	J01CA12	piperacillin	WHO ATC
0-L	J01CA13	ticarcillin	WHO ATC
0-L	J01CA14	metampicillin	WHO ATC
0-L	J01CA15	talampicillin	WHO ATC
0-L	J01CA16	sulbenicillin	WHO ATC
0-L	J01CA17	temocillin	WHO ATC
0-L	J01CA18	hetacillin	WHO ATC
0-L	J01CA20	combinations	WHO ATC
0-L	J01CA51	ampicillin, combinations	WHO ATC
0-L	J01CE	Beta-lactamase sensitive penicillins	WHO ATC
0-L	J01CE01	benzylpenicillin	WHO ATC
0-L	J01CE02	phenoxymethylpenicillin	WHO ATC
0-L	J01CE03	propicillin	WHO ATC
0-L	J01CE04	azidocillin	WHO ATC
0-L	J01CE05	pheneticillin	WHO ATC
0-L	J01CE06	penamecillin	WHO ATC
0-L	J01CE07	clometocillin	WHO ATC
0-L	J01CE08	benzathine benzylpenicillin	WHO ATC
0-L	J01CE09	procaine benzylpenicillin	WHO ATC
0-L	J01CE10	benzathine phenoxymethylpenicillin	WHO ATC
0-L	J01CE30	combinations	WHO ATC
0-L	J01CF	Beta-lactamase resistant penicillins	WHO ATC
0-L	J01CF01	dicloxacillin	WHO ATC
0-L	J01CF02	cloxacillin	WHO ATC
0-L	J01CF03	meticillin	WHO ATC
0-L	J01CF04	oxacillin	WHO ATC
0-L	J01CF05	flucloxacillin	WHO ATC
0-L	J01CG	Beta-lactamase inhibitors	WHO ATC
0-L	J01CG01	sulbactam	WHO ATC
0-L	J01CG02	tazobactam	WHO ATC
0-L	J01CR	Combinations of penicillins, incl. beta-lactamase inhibitors	WHO ATC
0-L	J01CR01	ampicillin and enzyme inhibitor	WHO ATC
0-L	J01CR02	amoxicillin and enzyme inhibitor	WHO ATC
0-L	J01CR03	ticarcillin and enzyme inhibitor	WHO ATC
0-L	J01CR04	sultamicillin	WHO ATC
0-L	J01CR05	piperacillin and enzyme inhibitor	WHO ATC
0-L	J01CR50	combinations of penicillins	WHO ATC
0-L	J01D	OTHER BETA-LACTAM ANTIBACTERIALS	WHO ATC
0-L	J01DB	First-generation cephalosporins	WHO ATC
0-L	J01DB01	cefalexin	WHO ATC
0-L	J01DB02	cefaloridine	WHO ATC
0-L	J01DB03	cefalotin	WHO ATC
0-L	J01DB04	cefazolin	WHO ATC
0-L	J01DB05	cefadroxil	WHO ATC
0-L	J01DB06	cefazedone	WHO ATC
0-L	J01DB07	cefatrizine	WHO ATC
0-L	J01DB08	cefapirin	WHO ATC
0-L	J01DB09	cefradine	WHO ATC
0-L	J01DB10	cefacetrile	WHO ATC
0-L	J01DB11	cefroxadine	WHO ATC
0-L	J01DB12	ceftezole	WHO ATC
0-L	J01DC	Second-generation cephalosporins	WHO ATC
0-L	J01DC01	cefoxitin	WHO ATC
0-L	J01DC02	cefuroxime	WHO ATC
0-L	J01DC03	cefamandole	WHO ATC
0-L	J01DC04	cefaclor	WHO ATC
0-L	J01DC05	cefotetan	WHO ATC
0-L	J01DC06	cefonicid	WHO ATC
0-L	J01DC07	cefotiam	WHO ATC
0-L	J01DC08	loracarbef	WHO ATC
0-L	J01DC09	cefmetazole	WHO ATC
0-L	J01DC10	cefprozil	WHO ATC
0-L	J01DC11	ceforanide	WHO ATC
0-L	J01DD	Third-generation cephalosporins	WHO ATC
0-L	J01DD01	cefotaxime	WHO ATC
0-L	J01DD02	ceftazidime	WHO ATC
0-L	J01DD03	cefsulodin	WHO ATC
0-L	J01DD04	ceftriaxone	WHO ATC
0-L	J01DD05	cefmenoxime	WHO ATC
0-L	J01DD06	latamoxef	WHO ATC
0-L	J01DD07	ceftizoxime	WHO ATC
0-L	J01DD08	cefixime	WHO ATC
0-L	J01DD09	cefodizime	WHO ATC
0-L	J01DD10	cefetamet	WHO ATC
0-L	J01DD11	cefpiramide	WHO ATC
0-L	J01DD12	cefoperazone	WHO ATC
0-L	J01DD13	cefpodoxime	WHO ATC
0-L	J01DD14	ceftibuten	WHO ATC
0-L	J01DD15	cefdinir	WHO ATC
0-L	J01DD16	cefditoren	WHO ATC
0-L	J01DD17	cefcapene	WHO ATC
0-L	J01DD54	ceftriaxone, combinations	WHO ATC
0-L	J01DD62	cefoperazone, combinations	WHO ATC
0-L	J01DE	Fourth-generation cephalosporins	WHO ATC
0-L	J01DE01	cefepime	WHO ATC
0-L	J01DE02	cefpirome	WHO ATC
0-L	J01DE03	cefozopran	WHO ATC
0-L	J01DF	Monobactams	WHO ATC
0-L	J01DF01	aztreonam	WHO ATC
0-L	J01DH	Carbapenems	WHO ATC
0-L	J01DH02	meropenem	WHO ATC
0-L	J01DH03	ertapenem	WHO ATC
0-L	J01DH04	doripenem	WHO ATC
0-L	J01DH05	biapenem	WHO ATC
0-L	J01DH51	imipenem and enzyme inhibitor	WHO ATC
0-L	J01DH55	panipenem and betamipron	WHO ATC
0-L	J01DI	Other cephalosporins	WHO ATC
0-L	J01DI01	ceftobiprole medocaril	WHO ATC
0-L	J01E	SULFONAMIDES AND TRIMETHOPRIM	WHO ATC
0-L	J01EA	Trimethoprim and derivatives	WHO ATC
0-L	J01EA01	trimethoprim	WHO ATC
0-L	J01EA02	brodimoprim	WHO ATC
0-L	J01EA03	iclaprim	WHO ATC
0-L	J01EB	Short-acting sulfonamides	WHO ATC
0-L	J01EB01	sulfaisodimidine	WHO ATC
0-L	J01EB02	sulfamethizole	WHO ATC
0-L	J01EB03	sulfadimidine	WHO ATC
0-L	J01EB04	sulfapyridine	WHO ATC
0-L	J01EB05	sulfafurazole	WHO ATC
0-L	J01EB06	sulfanilamide	WHO ATC
0-L	J01EB07	sulfathiazole	WHO ATC
0-L	J01EB08	sulfathiourea	WHO ATC
0-L	J01EB20	combinations	WHO ATC
0-L	J01EC	Intermediate-acting sulfonamides	WHO ATC
0-L	J01EC01	sulfamethoxazole	WHO ATC
0-L	J01EC02	sulfadiazine	WHO ATC
0-L	J01EC03	sulfamoxole	WHO ATC
0-L	J01EC20	combinations	WHO ATC
0-L	J01ED	Long-acting sulfonamides	WHO ATC
0-L	J01ED01	sulfadimethoxine	WHO ATC
0-L	J01ED02	sulfalene	WHO ATC
0-L	J01ED03	sulfametomidine	WHO ATC
0-L	J01ED04	sulfametoxydiazine	WHO ATC
0-L	J01ED05	sulfamethoxypyridazine	WHO ATC
0-L	J01ED06	sulfaperin	WHO ATC
0-L	J01ED07	sulfamerazine	WHO ATC
0-L	J01ED08	sulfaphenazole	WHO ATC
0-L	J01ED09	sulfamazone	WHO ATC
0-L	J01ED20	combinations	WHO ATC
0-L	J01EE	Combinations of sulfonamides and trimethoprim, incl. derivatives	WHO ATC
0-L	J01EE01	sulfamethoxazole and trimethoprim	WHO ATC
0-L	J01EE02	sulfadiazine and trimethoprim	WHO ATC
0-L	J01EE03	sulfametrole and trimethoprim	WHO ATC
0-L	J01EE04	sulfamoxole and trimethoprim	WHO ATC
0-L	J01EE05	sulfadimidine and trimethoprim	WHO ATC
0-L	J01EE06	sulfadiazine and tetroxoprim	WHO ATC
0-L	J01EE07	sulfamerazine and trimethoprim	WHO ATC
0-L	J01F	MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS	WHO ATC
0-L	J01FA	Macrolides	WHO ATC
0-L	J01FA01	erythromycin	WHO ATC
0-L	J01FA02	spiramycin	WHO ATC
0-L	J01FA03	midecamycin	WHO ATC
0-L	J01FA05	oleandomycin	WHO ATC
0-L	J01FA06	roxithromycin	WHO ATC
0-L	J01FA07	josamycin	WHO ATC
0-L	J01FA08	troleandomycin	WHO ATC
0-L	J01FA09	clarithromycin	WHO ATC
0-L	J01FA10	azithromycin	WHO ATC
0-L	J01FA11	miocamycin	WHO ATC
0-L	J01FA12	rokitamycin	WHO ATC
0-L	J01FA13	dirithromycin	WHO ATC
0-L	J01FA14	flurithromycin	WHO ATC
0-L	J01FA15	telithromycin	WHO ATC
0-L	J01FF	Lincosamides	WHO ATC
0-L	J01FF01	clindamycin	WHO ATC
0-L	J01FF02	lincomycin	WHO ATC
0-L	J01FG	Streptogramins	WHO ATC
0-L	J01FG01	pristinamycin	WHO ATC
0-L	J01FG02	quinupristin/dalfopristin	WHO ATC
0-L	J01G	AMINOGLYCOSIDE ANTIBACTERIALS	WHO ATC
0-L	J01GA	Streptomycins	WHO ATC
0-L	J01GA01	streptomycin	WHO ATC
0-L	J01GA02	streptoduocin	WHO ATC
0-L	J01GB	Other aminoglycosides	WHO ATC
0-L	J01GB01	tobramycin	WHO ATC
0-L	J01GB03	gentamicin	WHO ATC
0-L	J01GB04	kanamycin	WHO ATC
0-L	J01GB05	neomycin	WHO ATC
0-L	J01GB06	amikacin	WHO ATC
0-L	J01GB07	netilmicin	WHO ATC
0-L	J01GB08	sisomicin	WHO ATC
0-L	J01GB09	dibekacin	WHO ATC
0-L	J01GB10	ribostamycin	WHO ATC
0-L	J01GB11	isepamicin	WHO ATC
0-L	J01GB12	arbekacin	WHO ATC
0-L	J01M	QUINOLONE ANTIBACTERIALS	WHO ATC
0-L	J01MA	Fluoroquinolones	WHO ATC
0-L	J01MA01	ofloxacin	WHO ATC
0-L	J01MA02	ciprofloxacin	WHO ATC
0-L	J01MA03	pefloxacin	WHO ATC
0-L	J01MA04	enoxacin	WHO ATC
0-L	J01MA05	temafloxacin	WHO ATC
0-L	J01MA06	norfloxacin	WHO ATC
0-L	J01MA07	lomefloxacin	WHO ATC
0-L	J01MA08	fleroxacin	WHO ATC
0-L	J01MA09	sparfloxacin	WHO ATC
0-L	J01MA10	rufloxacin	WHO ATC
0-L	J01MA11	grepafloxacin	WHO ATC
0-L	J01MA12	levofloxacin	WHO ATC
0-L	J01MA13	trovafloxacin	WHO ATC
0-L	J01MA14	moxifloxacin	WHO ATC
0-L	J01MA15	gemifloxacin	WHO ATC
0-L	J01MA16	gatifloxacin	WHO ATC
0-L	J01MA17	prulifloxacin	WHO ATC
0-L	J01MA18	pazufloxacin	WHO ATC
0-L	J01MA19	garenoxacin	WHO ATC
0-L	J01MB	Other quinolones	WHO ATC
0-L	J01MB01	rosoxacin	WHO ATC
0-L	J01MB02	nalidixic acid	WHO ATC
0-L	J01MB03	piromidic acid	WHO ATC
0-L	J01MB04	pipemidic acid	WHO ATC
0-L	J01MB05	oxolinic acid	WHO ATC
0-L	J01MB06	cinoxacin	WHO ATC
0-L	J01MB07	flumequine	WHO ATC
0-L	J01R	COMBINATIONS OF ANTIBACTERIALS	WHO ATC
0-L	J01RA	Combinations of antibacterials	WHO ATC
0-L	J01RA01	penicillins, combinations with other antibacterials	WHO ATC
0-L	J01RA02	sulfonamides, combinations with other antibacterials (excl. trimethoprim)	WHO ATC
0-L	J01RA03	cefuroxime, combinations with other antibacterials	WHO ATC
0-L	J01RA04	spiramycin, combinations with other antibacterials	WHO ATC
0-L	J01X	OTHER ANTIBACTERIALS	WHO ATC
0-L	J01XA	Glycopeptide antibacterials	WHO ATC
0-L	J01XA01	vancomycin	WHO ATC
0-L	J01XA02	teicoplanin	WHO ATC
0-L	J01XA03	telavancin	WHO ATC
0-L	J01XA04	dalbavancin	WHO ATC
0-L	J01XA05	oritavancin	WHO ATC
0-L	J01XB	Polymyxins	WHO ATC
0-L	J01XB01	colistin	WHO ATC
0-L	J01XB02	polymyxin B	WHO ATC
0-L	J01XC	Steroid antibacterials	WHO ATC
0-L	J01XC01	fusidic acid	WHO ATC
0-L	J01XD	Imidazole derivatives	WHO ATC
0-L	J01XD01	metronidazole	WHO ATC
0-L	J01XD02	tinidazole	WHO ATC
0-L	J01XD03	ornidazole	WHO ATC
0-L	J01XE	Nitrofuran derivatives	WHO ATC
0-L	J01XE01	nitrofurantoin	WHO ATC
0-L	J01XE02	nifurtoinol	WHO ATC
0-L	J01XX	Other antibacterials	WHO ATC
0-L	J01XX01	fosfomycin	WHO ATC
0-L	J01XX02	xibornol	WHO ATC
0-L	J01XX03	clofoctol	WHO ATC
0-L	J01XX04	spectinomycin	WHO ATC
0-L	J01XX05	methenamine	WHO ATC
0-L	J01XX06	mandelic acid	WHO ATC
0-L	J01XX07	nitroxoline	WHO ATC
0-L	J01XX08	linezolid	WHO ATC
0-L	J01XX09	daptomycin	WHO ATC
0-L	J01XX10	bacitracin	WHO ATC
0-L	J02	ANTIMYCOTICS FOR SYSTEMIC USE	WHO ATC
0-L	J02A	ANTIMYCOTICS FOR SYSTEMIC USE	WHO ATC
0-L	J02AA	Antibiotics	WHO ATC
0-L	J02AA01	amphotericin B	WHO ATC
0-L	J02AA02	hachimycin	WHO ATC
0-L	J02AB	Imidazole derivatives	WHO ATC
0-L	J02AB01	miconazole	WHO ATC
0-L	J02AB02	ketoconazole	WHO ATC
0-L	J02AC	Triazole derivatives	WHO ATC
0-L	J02AC01	fluconazole	WHO ATC
0-L	J02AC02	itraconazole	WHO ATC
0-L	J02AC03	voriconazole	WHO ATC
0-L	J02AC04	posaconazole	WHO ATC
0-L	J02AX	Other antimycotics for systemic use	WHO ATC
0-L	J02AX01	flucytosine	WHO ATC
0-L	J02AX04	caspofungin	WHO ATC
0-L	J02AX05	micafungin	WHO ATC
0-L	J02AX06	anidulafungin	WHO ATC
0-L	J04	ANTIMYCOBACTERIALS	WHO ATC
0-L	J04A	DRUGS FOR TREATMENT OF TUBERCULOSIS	WHO ATC
0-L	J04AA	Aminosalicylic acid and derivatives	WHO ATC
0-L	J04AA01	aminosalicylic acid	WHO ATC
0-L	J04AA02	sodium aminosalicylate	WHO ATC
0-L	J04AA03	calcium aminosalicylate	WHO ATC
0-L	J04AB	Antibiotics	WHO ATC
0-L	J04AB01	cycloserine	WHO ATC
0-L	J04AB02	rifampicin	WHO ATC
0-L	J04AB03	rifamycin	WHO ATC
0-L	J04AB04	rifabutin	WHO ATC
0-L	J04AB05	rifapentine	WHO ATC
0-L	J04AB30	capreomycin	WHO ATC
0-L	J04AC	Hydrazides	WHO ATC
0-L	J04AC01	isoniazid	WHO ATC
0-L	J04AC51	isoniazid, combinations	WHO ATC
0-L	J04AD	Thiocarbamide derivatives	WHO ATC
0-L	J04AD01	protionamide	WHO ATC
0-L	J04AD02	tiocarlide	WHO ATC
0-L	J04AD03	ethionamide	WHO ATC
0-L	J04AK	Other drugs for treatment of tuberculosis	WHO ATC
0-L	J04AK01	pyrazinamide	WHO ATC
0-L	J04AK02	ethambutol	WHO ATC
0-L	J04AK03	terizidone	WHO ATC
0-L	J04AK04	morinamide	WHO ATC
0-L	J04AM	Combinations of drugs for treatment of tuberculosis	WHO ATC
0-L	J04AM01	streptomycin and isoniazid	WHO ATC
0-L	J04AM02	rifampicin and isoniazid	WHO ATC
0-L	J04AM03	ethambutol and isoniazid	WHO ATC
0-L	J04AM04	thioacetazone and isoniazid	WHO ATC
0-L	J04AM05	rifampicin, pyrazinamide and isoniazid	WHO ATC
0-L	J04AM06	rifampicin, pyrazinamide, ethambutol and isoniazid	WHO ATC
0-L	J04B	DRUGS FOR TREATMENT OF LEPRA	WHO ATC
0-L	J04BA	Drugs for treatment of lepra	WHO ATC
0-L	J04BA01	clofazimine	WHO ATC
0-L	J04BA02	dapsone	WHO ATC
0-L	J04BA03	aldesulfone sodium	WHO ATC
0-L	J05	ANTIVIRALS FOR SYSTEMIC USE	WHO ATC
0-L	J05A	DIRECT ACTING ANTIVIRALS	WHO ATC
0-L	J05AA	Thiosemicarbazones	WHO ATC
0-L	J05AA01	metisazone	WHO ATC
0-L	J05AB	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	WHO ATC
0-L	J05AB01	aciclovir	WHO ATC
0-L	J05AB02	idoxuridine	WHO ATC
0-L	J05AB03	vidarabine	WHO ATC
0-L	J05AB04	ribavirin	WHO ATC
0-L	J05AB06	ganciclovir	WHO ATC
0-L	J05AB09	famciclovir	WHO ATC
0-L	J05AB11	valaciclovir	WHO ATC
0-L	J05AB12	cidofovir	WHO ATC
0-L	J05AB13	penciclovir	WHO ATC
0-L	J05AB14	valganciclovir	WHO ATC
0-L	J05AB15	brivudine	WHO ATC
0-L	J05AC	Cyclic amines	WHO ATC
0-L	J05AC02	rimantadine	WHO ATC
0-L	J05AC03	tromantadine	WHO ATC
0-L	J05AD	Phosphonic acid derivatives	WHO ATC
0-L	J05AD01	foscarnet	WHO ATC
0-L	J05AD02	fosfonet	WHO ATC
0-L	J05AE	Protease inhibitors	WHO ATC
0-L	J05AE01	saquinavir	WHO ATC
0-L	J05AE02	indinavir	WHO ATC
0-L	J05AE03	ritonavir	WHO ATC
0-L	J05AE04	nelfinavir	WHO ATC
0-L	J05AE05	amprenavir	WHO ATC
0-L	J05AE06	lopinavir	WHO ATC
0-L	J05AE07	fosamprenavir	WHO ATC
0-L	J05AE08	atazanavir	WHO ATC
0-L	J05AE09	tipranavir	WHO ATC
0-L	J05AE10	darunavir	WHO ATC
0-L	J05AF	Nucleoside and nucleotide reverse transcriptase inhibitors	WHO ATC
0-L	J05AF01	zidovudine	WHO ATC
0-L	J05AF02	didanosine	WHO ATC
0-L	J05AF03	zalcitabine	WHO ATC
0-L	J05AF04	stavudine	WHO ATC
0-L	J05AF05	lamivudine	WHO ATC
0-L	J05AF06	abacavir	WHO ATC
0-L	J05AF07	tenofovir disoproxil	WHO ATC
0-L	J05AF08	adefovir dipivoxil	WHO ATC
0-L	J05AF09	emtricitabine	WHO ATC
0-L	J05AF10	entecavir	WHO ATC
0-L	J05AF11	telbivudine	WHO ATC
0-L	J05AF12	clevudine	WHO ATC
0-L	J05AG	Non-nucleoside reverse transcriptase inhibitors	WHO ATC
0-L	J05AG01	nevirapine	WHO ATC
0-L	J05AG02	delavirdine	WHO ATC
0-L	J05AG03	efavirenz	WHO ATC
0-L	J05AG04	etravirine	WHO ATC
0-L	J05AH	Neuraminidase inhibitors	WHO ATC
0-L	J05AH01	zanamivir	WHO ATC
0-L	J05AH02	oseltamivir	WHO ATC
0-L	J05AR	Antivirals for treatment of HIV infections, combinations	WHO ATC
0-L	J05AR01	zidovudine and lamivudine	WHO ATC
0-L	J05AR02	lamivudine and abacavir	WHO ATC
0-L	J05AR03	tenofovir disoproxil and emtricitabine	WHO ATC
0-L	J05AR04	zidovudine, lamivudine and abacavir	WHO ATC
0-L	J05AR05	zidovudine, lamivudine and nevirapine	WHO ATC
0-L	J05AR06	emtricitabine, tenofovir disoproxil and efavirenz	WHO ATC
0-L	J05AR07	stavudine, lamivudine and nevirapine	WHO ATC
0-L	J05AX	Other antivirals	WHO ATC
0-L	J05AX01	moroxydine	WHO ATC
0-L	J05AX02	lysozyme	WHO ATC
0-L	J05AX05	inosine pranobex	WHO ATC
0-L	J05AX06	pleconaril	WHO ATC
0-L	J05AX07	enfuvirtide	WHO ATC
0-L	J05AX08	raltegravir	WHO ATC
0-L	J05AX09	maraviroc	WHO ATC
0-L	J05AX10	maribavir	WHO ATC
0-L	J06	IMMUNE SERA AND IMMUNOGLOBULINS	WHO ATC
0-L	J06A	IMMUNE SERA	WHO ATC
0-L	J06AA	Immune sera	WHO ATC
0-L	J06AA01	diphtheria antitoxin	WHO ATC
0-L	J06AA02	tetanus antitoxin	WHO ATC
0-L	J06AA03	snake venom antiserum	WHO ATC
0-L	J06AA04	botulinum antitoxin	WHO ATC
0-L	J06AA05	gas-gangrene sera	WHO ATC
0-L	J06AA06	rabies serum	WHO ATC
0-L	J06B	IMMUNOGLOBULINS	WHO ATC
0-L	J06BA	Immunoglobulins, normal human	WHO ATC
0-L	J06BA01	immunoglobulins, normal human, for extravascular adm.	WHO ATC
0-L	J06BA02	immunoglobulins, normal human, for intravascular adm.	WHO ATC
0-L	J06BB	Specific immunoglobulins	WHO ATC
0-L	J06BB01	anti-D (rh) immunoglobulin	WHO ATC
0-L	J06BB02	tetanus immunoglobulin	WHO ATC
0-L	J06BB03	varicella/zoster immunoglobulin	WHO ATC
0-L	J06BB04	hepatitis B immunoglobulin	WHO ATC
0-L	J06BB05	rabies immunoglobulin	WHO ATC
0-L	J06BB06	rubella immunoglobulin	WHO ATC
0-L	J06BB07	vaccinia immunoglobulin	WHO ATC
0-L	J06BB08	staphylococcus immunoglobulin	WHO ATC
0-L	J06BB09	cytomegalovirus immunoglobulin	WHO ATC
0-L	J06BB10	diphtheria immunoglobulin	WHO ATC
0-L	J06BB11	hepatitis A immunoglobulin	WHO ATC
0-L	J06BB12	encephalitis, tick borne immunoglobulin	WHO ATC
0-L	J06BB13	pertussis immunoglobulin	WHO ATC
0-L	J06BB14	measles immunoglobulin	WHO ATC
0-L	J06BB15	mumps immunoglobulin	WHO ATC
0-L	J06BB16	palivizumab	WHO ATC
0-L	J06BB30	combinations	WHO ATC
0-L	J06BC	Other immunoglobulins	WHO ATC
0-L	J06BC01	nebacumab	WHO ATC
0-L	J07	VACCINES	WHO ATC
0-L	J07A	BACTERIAL VACCINES	WHO ATC
0-L	J07AC	Anthrax vaccines	WHO ATC
0-L	J07AC01	anthrax antigen	WHO ATC
0-L	J07AD	Brucellosis vaccines	WHO ATC
0-L	J07AD01	brucella antigen	WHO ATC
0-L	J07AE	Cholera vaccines	WHO ATC
0-L	J07AE01	cholera, inactivated, whole cell	WHO ATC
0-L	J07AE02	cholera, live attenuated	WHO ATC
0-L	J07AE51	cholera, combinations with typhoid vaccine, inactivated, whole cell	WHO ATC
0-L	J07AF	Diphtheria vaccines	WHO ATC
0-L	J07AF01	diphtheria toxoid	WHO ATC
0-L	J07AG	Hemophilus influenzae B vaccines	WHO ATC
0-L	J07AG01	hemophilus influenzae B, purified antigen conjugated	WHO ATC
0-L	J07AG51	hemophilus influenzae B, combinations with toxoids	WHO ATC
0-L	J07AG52	hemophilus influenzae B, combinations with pertussis and toxoids	WHO ATC
0-L	J07AG53	hemophilus influenzae B, combinations with meningococcus C, conjugated	WHO ATC
0-L	J07AH	Meningococcal vaccines	WHO ATC
0-L	J07AH01	meningococcus A, purified polysaccharides antigen	WHO ATC
0-L	J07AH02	other meningococcal monovalent purified polysaccharides antigen	WHO ATC
0-L	J07AH03	meningococcus, bivalent purified polysaccharides antigen	WHO ATC
0-L	J07AH04	meningococcus, tetravalent purified polysaccharides antigen	WHO ATC
0-L	J07AH05	other meningococcal polyvalent purified polysaccharides antigen	WHO ATC
0-L	J07AH06	meningococcus B, outer membrane vesicle vaccine	WHO ATC
0-L	J07AH07	meningococcus C, purified polysaccharides antigen conjugated	WHO ATC
0-L	J07AH08	meningococcus, tetravalent purified polysaccharides antigen conjugated	WHO ATC
0-L	J07AJ	Pertussis vaccines	WHO ATC
0-L	J07AJ01	pertussis, inactivated, whole cell	WHO ATC
0-L	J07AJ02	pertussis, purified antigen	WHO ATC
0-L	J07AJ51	pertussis, inactivated, whole cell, combinations with toxoids	WHO ATC
0-L	J07AJ52	pertussis, purified antigen, combinations with toxoids	WHO ATC
0-L	J07AK	Plague vaccines	WHO ATC
0-L	J07AK01	plague, inactivated, whole cell	WHO ATC
0-L	J07AL	Pneumococcal vaccines	WHO ATC
0-L	J07AL01	pneumococcus, purified polysaccharides antigen	WHO ATC
0-L	J07AL02	pneumococcus, purified polysaccharides antigen conjugated	WHO ATC
0-L	J07AL52	pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated	WHO ATC
0-L	J07AM	Tetanus vaccines	WHO ATC
0-L	J07AM01	tetanus toxoid	WHO ATC
0-L	J07AM51	tetanus toxoid, combinations with diphtheria toxoid	WHO ATC
0-L	J07AM52	tetanus toxoid, combinations with tetanus immunoglobulin	WHO ATC
0-L	J07AN	Tuberculosis vaccines	WHO ATC
0-L	J07AN01	tuberculosis, live attenuated	WHO ATC
0-L	J07AP	Typhoid vaccines	WHO ATC
0-L	J07AP01	typhoid, oral, live attenuated	WHO ATC
0-L	J07AP02	typhoid, inactivated, whole cell	WHO ATC
0-L	J07AP03	typhoid, purified polysaccharide antigen	WHO ATC
0-L	J07AP10	typhoid, combinations with paratyphi types	WHO ATC
0-L	J07AR	Typhus (exanthematicus) vaccines	WHO ATC
0-L	J07AR01	typhus exanthematicus, inactivated, whole cell	WHO ATC
0-L	J07AX	Other bacterial vaccines	WHO ATC
0-L	J07B	VIRAL VACCINES	WHO ATC
0-L	J07BA	Encephalitis vaccines	WHO ATC
0-L	J07BA01	encephalitis, tick borne, inactivated, whole virus	WHO ATC
0-L	J07BA02	encephalitis, Japanese, inactivated, whole virus	WHO ATC
0-L	J07BB	Influenza vaccines	WHO ATC
0-L	J07BB01	influenza, inactivated, whole virus	WHO ATC
0-L	J07BB02	influenza, inactivated, split virus or surface antigen	WHO ATC
0-L	J07BB03	influenza, live attenuated	WHO ATC
0-L	J07BC	Hepatitis vaccines	WHO ATC
0-L	J07BC01	hepatitis B, purified antigen	WHO ATC
0-L	J07BC02	hepatitis A, inactivated, whole virus	WHO ATC
0-L	J07BC20	combinations	WHO ATC
0-L	J07BD	Measles vaccines	WHO ATC
0-L	J07BD01	measles, live attenuated	WHO ATC
0-L	J07BD51	measles, combinations with mumps, live attenuated	WHO ATC
0-L	J07BD52	measles, combinations with mumps and rubella, live attenuated	WHO ATC
0-L	J07BD53	measles, combinations with rubella, live attenuated	WHO ATC
0-L	J07BD54	measles, combinations with mumps, rubella and varicella, live attenuated	WHO ATC
0-L	J07BE	Mumps vaccines	WHO ATC
0-L	J07BE01	mumps, live attenuated	WHO ATC
0-L	J07BF	Poliomyelitis vaccines	WHO ATC
0-L	J07BF01	poliomyelitis oral, monovalent live attenuated	WHO ATC
0-L	J07BF02	poliomyelitis oral, trivalent, live attenuated	WHO ATC
0-L	J07BF03	poliomyelitis, trivalent, inactivated, whole virus	WHO ATC
0-L	J07BG	Rabies vaccines	WHO ATC
0-L	J07BG01	rabies, inactivated, whole virus	WHO ATC
0-L	J07BH	Rota virus diarrhea vaccines	WHO ATC
0-L	J07BH01	rota virus, live attenuated	WHO ATC
0-L	J07BH02	rota virus, pentavalent, live, reassorted	WHO ATC
0-L	J07BJ	Rubella vaccines	WHO ATC
0-L	J07BJ01	rubella, live attenuated	WHO ATC
0-L	J07BJ51	rubella, combinations with mumps, live attenuated	WHO ATC
0-L	J07BK	Varicella zoster vaccines	WHO ATC
0-L	J07BK01	varicella, live attenuated	WHO ATC
0-L	J07BK02	zoster, live attenuated	WHO ATC
0-L	J07BL	Yellow fever vaccines	WHO ATC
0-L	J07BL01	yellow fever, live attenuated	WHO ATC
0-L	J07BM	Papillomavirus vaccines	WHO ATC
0-L	J07BM01	papillomavirus (human types 6, 11, 16, 18)	WHO ATC
0-L	J07BM02	papillomavirus (human types 16, 18)	WHO ATC
0-L	J07BX	Other viral vaccines	WHO ATC
0-L	J07C	BACTERIAL AND VIRAL VACCINES, COMBINED	WHO ATC
0-L	J07CA	Bacterial and viral vaccines, combined	WHO ATC
0-L	J07CA01	diphtheria-poliomyelitis-tetanus	WHO ATC
0-L	J07CA02	diphtheria-pertussis-poliomyelitis-tetanus	WHO ATC
0-L	J07CA03	diphtheria-rubella-tetanus	WHO ATC
0-L	J07CA04	hemophilus influenzae B and poliomyelitis	WHO ATC
0-L	J07CA05	diphtheria-hepatitis B-pertussis-tetanus	WHO ATC
0-L	J07CA06	diphtheria-Hemophilus influenzae B-pertussis-poliomyelitis-tetanus	WHO ATC
0-L	J07CA07	diphtheria-hepatitis B-tetanus	WHO ATC
0-L	J07CA08	hemophilus influenzae B and hepatitis B	WHO ATC
0-L	J07CA09	diphtheria-Hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B	WHO ATC
0-L	J07CA10	typhoid-hepatitis A	WHO ATC
0-L	J07CA11	diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B	WHO ATC
0-L	J07CA12	diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B	WHO ATC
0-L	J07CA13	diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C	WHO ATC
0-L	J07X	OTHER VACCINES	WHO ATC
0-L	L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS	WHO ATC
0-L	L01	ANTINEOPLASTIC AGENTS	WHO ATC
0-L	L01A	ALKYLATING AGENTS	WHO ATC
0-L	L01AA	Nitrogen mustard analogues	WHO ATC
0-L	L01AA01	cyclophosphamide	WHO ATC
0-L	L01AA02	chlorambucil	WHO ATC
0-L	L01AA03	melphalan	WHO ATC
0-L	L01AA05	chlormethine	WHO ATC
0-L	L01AA06	ifosfamide	WHO ATC
0-L	L01AA07	trofosfamide	WHO ATC
0-L	L01AA08	prednimustine	WHO ATC
0-L	L01AA09	bendamustine	WHO ATC
0-L	L01AB	Alkyl sulfonates	WHO ATC
0-L	L01AB01	busulfan	WHO ATC
0-L	L01AB02	treosulfan	WHO ATC
0-L	L01AB03	mannosulfan	WHO ATC
0-L	L01AC	Ethylene imines	WHO ATC
0-L	L01AC01	thiotepa	WHO ATC
0-L	L01AC02	triaziquone	WHO ATC
0-L	L01AC03	carboquone	WHO ATC
0-L	L01AD	Nitrosoureas	WHO ATC
0-L	L01AD01	carmustine	WHO ATC
0-L	L01AD02	lomustine	WHO ATC
0-L	L01AD03	semustine	WHO ATC
0-L	L01AD04	streptozocin	WHO ATC
0-L	L01AD05	fotemustine	WHO ATC
0-L	L01AD06	nimustine	WHO ATC
0-L	L01AD07	ranimustine	WHO ATC
0-L	L01AG	Epoxides	WHO ATC
0-L	L01AG01	etoglucid	WHO ATC
0-L	L01AX	Other alkylating agents	WHO ATC
0-L	L01AX01	mitobronitol	WHO ATC
0-L	L01AX02	pipobroman	WHO ATC
0-L	L01AX03	temozolomide	WHO ATC
0-L	L01AX04	dacarbazine	WHO ATC
0-L	L01B	ANTIMETABOLITES	WHO ATC
0-L	L01BA	Folic acid analogues	WHO ATC
0-L	L01BA01	methotrexate	WHO ATC
0-L	L01BA03	raltitrexed	WHO ATC
0-L	L01BA04	pemetrexed	WHO ATC
0-L	L01BA05	pralatrexate	WHO ATC
0-L	L01BB	Purine analogues	WHO ATC
0-L	L01BB02	mercaptopurine	WHO ATC
0-L	L01BB03	tioguanine	WHO ATC
0-L	L01BB04	cladribine	WHO ATC
0-L	L01BB05	fludarabine	WHO ATC
0-L	L01BB06	clofarabine	WHO ATC
0-L	L01BB07	nelarabine	WHO ATC
0-L	L01BC	Pyrimidine analogues	WHO ATC
0-L	L01BC01	cytarabine	WHO ATC
0-L	L01BC02	fluorouracil	WHO ATC
0-L	L01BC03	tegafur	WHO ATC
0-L	L01BC04	carmofur	WHO ATC
0-L	L01BC05	gemcitabine	WHO ATC
0-L	L01BC06	capecitabine	WHO ATC
0-L	L01BC07	azacitidine	WHO ATC
0-L	L01BC08	decitabine	WHO ATC
0-L	L01BC52	fluorouracil, combinations	WHO ATC
0-L	L01BC53	tegafur, combinations	WHO ATC
0-L	L01C	PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS	WHO ATC
0-L	L01CA	Vinca alkaloids and analogues	WHO ATC
0-L	L01CA01	vinblastine	WHO ATC
0-L	L01CA02	vincristine	WHO ATC
0-L	L01CA03	vindesine	WHO ATC
0-L	L01CA04	vinorelbine	WHO ATC
0-L	L01CA05	vinflunine	WHO ATC
0-L	L01CB	Podophyllotoxin derivatives	WHO ATC
0-L	L01CB01	etoposide	WHO ATC
0-L	L01CB02	teniposide	WHO ATC
0-L	L01CC	Colchicine derivatives	WHO ATC
0-L	L01CC01	demecolcine	WHO ATC
0-L	L01CD	Taxanes	WHO ATC
0-L	L01CD01	paclitaxel	WHO ATC
0-L	L01CD02	docetaxel	WHO ATC
0-L	L01CD03	paclitaxel poliglumex	WHO ATC
0-L	L01CX	Other plant alkaloids and natural products	WHO ATC
0-L	L01CX01	trabectedin	WHO ATC
0-L	L01D	CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES	WHO ATC
0-L	L01DA	Actinomycines	WHO ATC
0-L	L01DA01	dactinomycin	WHO ATC
0-L	L01DB	Anthracyclines and related substances	WHO ATC
0-L	L01DB01	doxorubicin	WHO ATC
0-L	L01DB02	daunorubicin	WHO ATC
0-L	L01DB03	epirubicin	WHO ATC
0-L	L01DB04	aclarubicin	WHO ATC
0-L	L01DB05	zorubicin	WHO ATC
0-L	L01DB06	idarubicin	WHO ATC
0-L	L01DB07	mitoxantrone	WHO ATC
0-L	L01DB08	pirarubicin	WHO ATC
0-L	L01DB09	valrubicin	WHO ATC
0-L	L01DC	Other cytotoxic antibiotics	WHO ATC
0-L	L01DC01	bleomycin	WHO ATC
0-L	L01DC02	plicamycin	WHO ATC
0-L	L01DC03	mitomycin	WHO ATC
0-L	L01DC04	ixabepilone	WHO ATC
0-L	L01X	OTHER ANTINEOPLASTIC AGENTS	WHO ATC
0-L	L01XA	Platinum compounds	WHO ATC
0-L	L01XA01	cisplatin	WHO ATC
0-L	L01XA02	carboplatin	WHO ATC
0-L	L01XA03	oxaliplatin	WHO ATC
0-L	L01XA04	satraplatin	WHO ATC
0-L	L01XB	Methylhydrazines	WHO ATC
0-L	L01XB01	procarbazine	WHO ATC
0-L	L01XC	Monoclonal antibodies	WHO ATC
0-L	L01XC01	edrecolomab	WHO ATC
0-L	L01XC02	rituximab	WHO ATC
0-L	L01XC03	trastuzumab	WHO ATC
0-L	L01XC04	alemtuzumab	WHO ATC
0-L	L01XC05	gemtuzumab	WHO ATC
0-L	L01XC06	cetuximab	WHO ATC
0-L	L01XC07	bevacizumab	WHO ATC
0-L	L01XC08	panitumumab	WHO ATC
0-L	L01XC09	catumaxomab	WHO ATC
0-L	L01XC10	ofatumumab	WHO ATC
0-L	L01XD	Sensitizers used in photodynamic/radiation therapy	WHO ATC
0-L	L01XD01	porfimer sodium	WHO ATC
0-L	L01XD03	methyl aminolevulinate	WHO ATC
0-L	L01XD04	aminolevulinic acid	WHO ATC
0-L	L01XD05	temoporfin	WHO ATC
0-L	L01XD06	efaproxiral	WHO ATC
0-L	L01XE	Protein kinase inhibitors	WHO ATC
0-L	L01XE01	imatinib	WHO ATC
0-L	L01XE02	gefitinib	WHO ATC
0-L	L01XE03	erlotinib	WHO ATC
0-L	L01XE04	sunitinib	WHO ATC
0-L	L01XE05	sorafenib	WHO ATC
0-L	L01XE06	dasatinib	WHO ATC
0-L	L01XE07	lapatinib	WHO ATC
0-L	L01XE08	nilotinib	WHO ATC
0-L	L01XE09	temsirolimus	WHO ATC
0-L	L01XE10	everolimus	WHO ATC
0-L	L01XE11	pazopanib	WHO ATC
0-L	L01XX	Other antineoplastic agents	WHO ATC
0-L	L01XX01	amsacrine	WHO ATC
0-L	L01XX02	asparaginase	WHO ATC
0-L	L01XX03	altretamine	WHO ATC
0-L	L01XX05	hydroxycarbamide	WHO ATC
0-L	L01XX07	lonidamine	WHO ATC
0-L	L01XX08	pentostatin	WHO ATC
0-L	L01XX09	miltefosine	WHO ATC
0-L	L01XX10	masoprocol	WHO ATC
0-L	L01XX11	estramustine	WHO ATC
0-L	L01XX14	tretinoin	WHO ATC
0-L	L01XX16	mitoguazone	WHO ATC
0-L	L01XX17	topotecan	WHO ATC
0-L	L01XX18	tiazofurine	WHO ATC
0-L	L01XX19	irinotecan	WHO ATC
0-L	L01XX22	alitretinoin	WHO ATC
0-L	L01XX23	mitotane	WHO ATC
0-L	L01XX24	pegaspargase	WHO ATC
0-L	L01XX25	bexarotene	WHO ATC
0-L	L01XX27	arsenic trioxide	WHO ATC
0-L	L01XX29	denileukin diftitox	WHO ATC
0-L	L01XX32	bortezomib	WHO ATC
0-L	L01XX33	celecoxib	WHO ATC
0-L	L01XX35	anagrelide	WHO ATC
0-L	L01XX36	oblimersen	WHO ATC
0-L	L01XX37	sitimagene ceradenovec	WHO ATC
0-L	L01XX38	vorinostat	WHO ATC
0-L	L01XX39	romidepsin	WHO ATC
0-L	L01XY	Combinations of antineoplastic agents	WHO ATC
0-L	L02	ENDOCRINE THERAPY	WHO ATC
0-L	L02A	HORMONES AND RELATED AGENTS	WHO ATC
0-L	L02AA	Estrogens	WHO ATC
0-L	L02AA01	diethylstilbestrol	WHO ATC
0-L	L02AA02	polyestradiol phosphate	WHO ATC
0-L	L02AA03	ethinylestradiol	WHO ATC
0-L	L02AA04	fosfestrol	WHO ATC
0-L	L02AB	Progestogens	WHO ATC
0-L	L02AB01	megestrol	WHO ATC
0-L	L02AB02	medroxyprogesterone	WHO ATC
0-L	L02AB03	gestonorone	WHO ATC
0-L	L02AE	Gonadotropin releasing hormone analogues	WHO ATC
0-L	L02AE01	buserelin	WHO ATC
0-L	L02AE02	leuprorelin	WHO ATC
0-L	L02AE03	goserelin	WHO ATC
0-L	L02AE04	triptorelin	WHO ATC
0-L	L02AX	Other hormones	WHO ATC
0-L	L02B	HORMONE ANTAGONISTS AND RELATED AGENTS	WHO ATC
0-L	L02BA	Anti-estrogens	WHO ATC
0-L	L02BA01	tamoxifen	WHO ATC
0-L	L02BA02	toremifene	WHO ATC
0-L	L02BA03	fulvestrant	WHO ATC
0-L	L02BB	Anti-androgens	WHO ATC
0-L	L02BB01	flutamide	WHO ATC
0-L	L02BB02	nilutamide	WHO ATC
0-L	L02BB03	bicalutamide	WHO ATC
0-L	L02BG	Enzyme inhibitors	WHO ATC
0-L	L02BG01	aminoglutethimide	WHO ATC
0-L	L02BG02	formestane	WHO ATC
0-L	L02BG03	anastrozole	WHO ATC
0-L	L02BG04	letrozole	WHO ATC
0-L	L02BG05	vorozole	WHO ATC
0-L	L02BG06	exemestane	WHO ATC
0-L	L02BX	Other hormone antagonists and related agents	WHO ATC
0-L	L02BX01	abarelix	WHO ATC
0-L	L02BX02	degarelix	WHO ATC
0-L	L03	IMMUNOSTIMULANTS	WHO ATC
0-L	L03A	IMMUNOSTIMULANTS	WHO ATC
0-L	L03AA	Colony stimulating factors	WHO ATC
0-L	L03AA02	filgrastim	WHO ATC
0-L	L03AA03	molgramostim	WHO ATC
0-L	L03AA09	sargramostim	WHO ATC
0-L	L03AA10	lenograstim	WHO ATC
0-L	L03AA12	ancestim	WHO ATC
0-L	L03AA13	pegfilgrastim	WHO ATC
0-L	L03AB	Interferons	WHO ATC
0-L	L03AB01	interferon alfa natural	WHO ATC
0-L	L03AB02	interferon beta natural	WHO ATC
0-L	L03AB03	interferon gamma	WHO ATC
0-L	L03AB04	interferon alfa-2a	WHO ATC
0-L	L03AB05	interferon alfa-2b	WHO ATC
0-L	L03AB06	interferon alfa-n1	WHO ATC
0-L	L03AB07	interferon beta-1a	WHO ATC
0-L	L03AB08	interferon beta-1b	WHO ATC
0-L	L03AB09	interferon alfacon-1	WHO ATC
0-L	L03AB10	peginterferon alfa-2b	WHO ATC
0-L	L03AB11	peginterferon alfa-2a	WHO ATC
0-L	L03AB60	peginterferon alfa-2b, combinations	WHO ATC
0-L	L03AB61	peginterferon alfa-2a, combinations	WHO ATC
0-L	L03AC	Interleukins	WHO ATC
0-L	L03AC01	aldesleukin	WHO ATC
0-L	L03AC02	oprelvekin	WHO ATC
0-L	L03AX	Other immunostimulants	WHO ATC
0-L	L03AX01	lentinan	WHO ATC
0-L	L03AX02	roquinimex	WHO ATC
0-L	L03AX03	BCG vaccine	WHO ATC
0-L	L03AX04	pegademase	WHO ATC
0-L	L03AX05	pidotimod	WHO ATC
0-L	L03AX07	poly I:C	WHO ATC
0-L	L03AX08	poly ICLC	WHO ATC
0-L	L03AX09	thymopentin	WHO ATC
0-L	L03AX10	immunocyanin	WHO ATC
0-L	L03AX11	tasonermin	WHO ATC
0-L	L03AX12	melanoma vaccine	WHO ATC
0-L	L03AX13	glatiramer acetate	WHO ATC
0-L	L03AX14	histamine dihydrochloride	WHO ATC
0-L	L03AX15	mifamurtide	WHO ATC
0-L	L03AX16	plerixafor	WHO ATC
0-L	L04	IMMUNOSUPPRESSANTS	WHO ATC
0-L	L04A	IMMUNOSUPPRESSANTS	WHO ATC
0-L	L04AA	Selective immunosuppressants	WHO ATC
0-L	L04AA02	muromonab-CD3	WHO ATC
0-L	L04AA03	antilymphocyte immunoglobulin (horse)	WHO ATC
0-L	L04AA04	antithymocyte immunoglobulin (rabbit)	WHO ATC
0-L	L04AA06	mycophenolic acid	WHO ATC
0-L	L04AA10	sirolimus	WHO ATC
0-L	L04AA13	leflunomide	WHO ATC
0-L	L04AA15	alefacept	WHO ATC
0-L	L04AA18	everolimus	WHO ATC
0-L	L04AA19	gusperimus	WHO ATC
0-L	L04AA21	efalizumab	WHO ATC
0-L	L04AA22	abetimus	WHO ATC
0-L	L04AA23	natalizumab	WHO ATC
0-L	L04AA24	abatacept	WHO ATC
0-L	L04AA25	eculizumab	WHO ATC
0-L	L04AB	Tumor necrosis factor alpha (TNF-α) inhibitors	WHO ATC
0-L	L04AB01	etanercept	WHO ATC
0-L	L04AB02	infliximab	WHO ATC
0-L	L04AB03	afelimomab	WHO ATC
0-L	L04AB04	adalimumab	WHO ATC
0-L	L04AB05	certolizumab pegol	WHO ATC
0-L	L04AB06	golimumab	WHO ATC
0-L	L04AC	Interleukin inhibitors	WHO ATC
0-L	L04AC01	daclizumab	WHO ATC
0-L	L04AC02	basiliximab	WHO ATC
0-L	L04AC03	anakinra	WHO ATC
0-L	L04AC04	rilonacept	WHO ATC
0-L	L04AC05	ustekinumab	WHO ATC
0-L	L04AC06	mepolizumab	WHO ATC
0-L	L04AC07	tocilizumab	WHO ATC
0-L	L04AC08	canakinumab	WHO ATC
0-L	L04AD	Calcineurin inhibitors	WHO ATC
0-L	L04AD01	ciclosporin	WHO ATC
0-L	L04AD02	tacrolimus	WHO ATC
0-L	L04AX	Other immunosuppressants	WHO ATC
0-L	L04AX01	azathioprine	WHO ATC
0-L	L04AX02	thalidomide	WHO ATC
0-L	L04AX03	methotrexate	WHO ATC
0-L	L04AX04	lenalidomide	WHO ATC
0-L	M	MUSCULO-SKELETAL SYSTEM	WHO ATC
0-L	M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS	WHO ATC
0-L	M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	WHO ATC
0-L	M01AA	Butylpyrazolidines	WHO ATC
0-L	M01AA01	phenylbutazone	WHO ATC
0-L	M01AA02	mofebutazone	WHO ATC
0-L	M01AA03	oxyphenbutazone	WHO ATC
0-L	M01AA05	clofezone	WHO ATC
0-L	M01AA06	kebuzone	WHO ATC
0-L	M01AB	Acetic acid derivatives and related substances	WHO ATC
0-L	M01AB01	indometacin	WHO ATC
0-L	M01AB02	sulindac	WHO ATC
0-L	M01AB03	tolmetin	WHO ATC
0-L	M01AB04	zomepirac	WHO ATC
0-L	M01AB05	diclofenac	WHO ATC
0-L	M01AB06	alclofenac	WHO ATC
0-L	M01AB07	bumadizone	WHO ATC
0-L	M01AB08	etodolac	WHO ATC
0-L	M01AB09	lonazolac	WHO ATC
0-L	M01AB10	fentiazac	WHO ATC
0-L	M01AB11	acemetacin	WHO ATC
0-L	M01AB12	difenpiramide	WHO ATC
0-L	M01AB13	oxametacin	WHO ATC
0-L	M01AB14	proglumetacin	WHO ATC
0-L	M01AB15	ketorolac	WHO ATC
0-L	M01AB16	aceclofenac	WHO ATC
0-L	M01AB17	bufexamac	WHO ATC
0-L	M01AB51	indometacin, combinations	WHO ATC
0-L	M01AB55	diclofenac, combinations	WHO ATC
0-L	M01AC	Oxicams	WHO ATC
0-L	M01AC01	piroxicam	WHO ATC
0-L	M01AC02	tenoxicam	WHO ATC
0-L	M01AC04	droxicam	WHO ATC
0-L	M01AC05	lornoxicam	WHO ATC
0-L	M01AC06	meloxicam	WHO ATC
0-L	M01AE	Propionic acid derivatives	WHO ATC
0-L	M01AE01	ibuprofen	WHO ATC
0-L	M01AE02	naproxen	WHO ATC
0-L	M01AE03	ketoprofen	WHO ATC
0-L	M01AE04	fenoprofen	WHO ATC
0-L	M01AE05	fenbufen	WHO ATC
0-L	M01AE06	benoxaprofen	WHO ATC
0-L	M01AE07	suprofen	WHO ATC
0-L	M01AE08	pirprofen	WHO ATC
0-L	M01AE09	flurbiprofen	WHO ATC
0-L	M01AE10	indoprofen	WHO ATC
0-L	M01AE11	tiaprofenic acid	WHO ATC
0-L	M01AE12	oxaprozin	WHO ATC
0-L	M01AE13	ibuproxam	WHO ATC
0-L	M01AE14	dexibuprofen	WHO ATC
0-L	M01AE15	flunoxaprofen	WHO ATC
0-L	M01AE16	alminoprofen	WHO ATC
0-L	M01AE17	dexketoprofen	WHO ATC
0-L	M01AE51	ibuprofen, combinations	WHO ATC
0-L	M01AE53	ketoprofen, combinations	WHO ATC
0-L	M01AG	Fenamates	WHO ATC
0-L	M01AG01	mefenamic acid	WHO ATC
0-L	M01AG02	tolfenamic acid	WHO ATC
0-L	M01AG03	flufenamic acid	WHO ATC
0-L	M01AG04	meclofenamic acid	WHO ATC
0-L	M01AH	Coxibs	WHO ATC
0-L	M01AH01	celecoxib	WHO ATC
0-L	M01AH02	rofecoxib	WHO ATC
0-L	M01AH03	valdecoxib	WHO ATC
0-L	M01AH04	parecoxib	WHO ATC
0-L	M01AH05	etoricoxib	WHO ATC
0-L	M01AH06	lumiracoxib	WHO ATC
0-L	M01AX	Other antiinflammatory and antirheumatic agents, non-steroids	WHO ATC
0-L	M01AX01	nabumetone	WHO ATC
0-L	M01AX02	niflumic acid	WHO ATC
0-L	M01AX04	azapropazone	WHO ATC
0-L	M01AX05	glucosamine	WHO ATC
0-L	M01AX07	benzydamine	WHO ATC
0-L	M01AX12	glucosaminoglycan polysulfate	WHO ATC
0-L	M01AX13	proquazone	WHO ATC
0-L	M01AX14	orgotein	WHO ATC
0-L	M01AX17	nimesulide	WHO ATC
0-L	M01AX18	feprazone	WHO ATC
0-L	M01AX21	diacerein	WHO ATC
0-L	M01AX22	morniflumate	WHO ATC
0-L	M01AX23	tenidap	WHO ATC
0-L	M01AX24	oxaceprol	WHO ATC
0-L	M01AX25	chondroitin sulfate	WHO ATC
0-L	M01AX68	feprazone, combinations	WHO ATC
0-L	M01B	ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION	WHO ATC
0-L	M01BA	Antiinflammatory/antirheumatic agents in combination with corticosteroids	WHO ATC
0-L	M01BA01	phenylbutazone and corticosteroids	WHO ATC
0-L	M01BA02	dipyrocetyl and corticosteroids	WHO ATC
0-L	M01BA03	acetylsalicylic acid and corticosteroids	WHO ATC
0-L	M01BX	Other antiinflammatory/antirheumatic agents in combination with other drugs	WHO ATC
0-L	M01C	SPECIFIC ANTIRHEUMATIC AGENTS	WHO ATC
0-L	M01CA	Quinolines	WHO ATC
0-L	M01CA03	oxycinchophen	WHO ATC
0-L	M01CB	Gold preparations	WHO ATC
0-L	M01CB01	sodium aurothiomalate	WHO ATC
0-L	M01CB02	sodium aurotiosulfate	WHO ATC
0-L	M01CB03	auranofin	WHO ATC
0-L	M01CB04	aurothioglucose	WHO ATC
0-L	M01CB05	aurotioprol	WHO ATC
0-L	M01CC	Penicillamine and similar agents	WHO ATC
0-L	M01CC01	penicillamine	WHO ATC
0-L	M01CC02	bucillamine	WHO ATC
0-L	M01CX	Other specific antirheumatic agents	WHO ATC
0-L	M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN	WHO ATC
0-L	M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN	WHO ATC
0-L	M02AA	Antiinflammatory preparations, non-steroids for topical use	WHO ATC
0-L	M02AA01	phenylbutazone	WHO ATC
0-L	M02AA02	mofebutazone	WHO ATC
0-L	M02AA03	clofezone	WHO ATC
0-L	M02AA04	oxyphenbutazone	WHO ATC
0-L	M02AA05	benzydamine	WHO ATC
0-L	M02AA06	etofenamate	WHO ATC
0-L	M02AA07	piroxicam	WHO ATC
0-L	M02AA08	felbinac	WHO ATC
0-L	M02AA09	bufexamac	WHO ATC
0-L	M02AA10	ketoprofen	WHO ATC
0-L	M02AA11	bendazac	WHO ATC
0-L	M02AA12	naproxen	WHO ATC
0-L	M02AA13	ibuprofen	WHO ATC
0-L	M02AA14	fentiazac	WHO ATC
0-L	M02AA15	diclofenac	WHO ATC
0-L	M02AA16	feprazone	WHO ATC
0-L	M02AA17	niflumic acid	WHO ATC
0-L	M02AA18	meclofenamic acid	WHO ATC
0-L	M02AA19	flurbiprofen	WHO ATC
0-L	M02AA21	tolmetin	WHO ATC
0-L	M02AA22	suxibuzone	WHO ATC
0-L	M02AA23	indometacin	WHO ATC
0-L	M02AA24	nifenazone	WHO ATC
0-L	M02AA25	aceclofenac	WHO ATC
0-L	M02AB	Capsaicin and similar agents	WHO ATC
0-L	M02AB01	capsaicin	WHO ATC
0-L	M02AB02	zucapsaicin	WHO ATC
0-L	M02AC	Preparations with salicylic acid derivatives	WHO ATC
0-L	M02AX	Other topical products for joint and muscular pain	WHO ATC
0-L	M02AX02	tolazoline	WHO ATC
0-L	M02AX03	dimethyl sulfoxide	WHO ATC
0-L	M02AX10	various	WHO ATC
0-L	M03	MUSCLE RELAXANTS	WHO ATC
0-L	M03A	MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS	WHO ATC
0-L	M03AA	Curare alkaloids	WHO ATC
0-L	M03AA01	alcuronium	WHO ATC
0-L	M03AA02	tubocurarine	WHO ATC
0-L	M03AA04	dimethyltubocurarine	WHO ATC
0-L	M03AB	Choline derivatives	WHO ATC
0-L	M03AB01	suxamethonium	WHO ATC
0-L	M03AC	Other quaternary ammonium compounds	WHO ATC
0-L	M03AC01	pancuronium	WHO ATC
0-L	M03AC02	gallamine	WHO ATC
0-L	M03AC03	vecuronium	WHO ATC
0-L	M03AC04	atracurium	WHO ATC
0-L	M03AC05	hexafluronium	WHO ATC
0-L	M03AC06	pipecuronium bromide	WHO ATC
0-L	M03AC07	doxacurium chloride	WHO ATC
0-L	M03AC08	fazadinium bromide	WHO ATC
0-L	M03AC09	rocuronium bromide	WHO ATC
0-L	M03AC10	mivacurium chloride	WHO ATC
0-L	M03AC11	cisatracurium	WHO ATC
0-L	M03AX	Other muscle relaxants, peripherally acting agents	WHO ATC
0-L	M03AX01	botulinum toxin	WHO ATC
0-L	M03B	MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS	WHO ATC
0-L	M03BA	Carbamic acid esters	WHO ATC
0-L	M03BA01	phenprobamate	WHO ATC
0-L	M03BA02	carisoprodol	WHO ATC
0-L	M03BA03	methocarbamol	WHO ATC
0-L	M03BA04	styramate	WHO ATC
0-L	M03BA05	febarbamate	WHO ATC
0-L	M03BA51	phenprobamate, combinations excl. psycholeptics	WHO ATC
0-L	M03BA52	carisoprodol, combinations excl. psycholeptics	WHO ATC
0-L	M03BA53	methocarbamol, combinations excl. psycholeptics	WHO ATC
0-L	M03BA71	phenprobamate, combinations with psycholeptics	WHO ATC
0-L	M03BA72	carisoprodol, combinations with psycholeptics	WHO ATC
0-L	M03BA73	methocarbamol, combinations with psycholeptics	WHO ATC
0-L	M03BB	Oxazol, thiazine, and triazine derivatives	WHO ATC
0-L	M03BB02	chlormezanone	WHO ATC
0-L	M03BB03	chlorzoxazone	WHO ATC
0-L	M03BB52	chlormezanone, combinations excl. psycholeptics	WHO ATC
0-L	M03BB53	chlorzoxazone, combinations excl. psycholeptics	WHO ATC
0-L	M03BB72	chlormezanone, combinations with psycholeptics	WHO ATC
0-L	M03BB73	chlorzoxazone, combinations with psycholeptics	WHO ATC
0-L	M03BC	Ethers, chemically close to antihistamines	WHO ATC
0-L	M03BC01	orphenadrine (citrate)	WHO ATC
0-L	M03BC51	orphenadrine, combinations	WHO ATC
0-L	M03BX	Other centrally acting agents	WHO ATC
0-L	M03BX01	baclofen	WHO ATC
0-L	M03BX02	tizanidine	WHO ATC
0-L	M03BX03	pridinol	WHO ATC
0-L	M03BX04	tolperisone	WHO ATC
0-L	M03BX05	thiocolchicoside	WHO ATC
0-L	M03BX06	mephenesin	WHO ATC
0-L	M03BX07	tetrazepam	WHO ATC
0-L	M03BX08	cyclobenzaprine	WHO ATC
0-L	M03BX09	eperisone	WHO ATC
0-L	M03BX30	fenyramidol	WHO ATC
0-L	M03C	MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS	WHO ATC
0-L	M03CA	Dantrolene and derivatives	WHO ATC
0-L	M03CA01	dantrolene	WHO ATC
0-L	M04	ANTIGOUT PREPARATIONS	WHO ATC
0-L	M04A	ANTIGOUT PREPARATIONS	WHO ATC
0-L	M04AA	Preparations inhibiting uric acid production	WHO ATC
0-L	M04AA01	allopurinol	WHO ATC
0-L	M04AA02	tisopurine	WHO ATC
0-L	M04AA03	febuxostat	WHO ATC
0-L	M04AA51	allopurinol, combinations	WHO ATC
0-L	M04AB	Preparations increasing uric acid excretion	WHO ATC
0-L	M04AB01	probenecid	WHO ATC
0-L	M04AB02	sulfinpyrazone	WHO ATC
0-L	M04AB03	benzbromarone	WHO ATC
0-L	M04AB04	isobromindione	WHO ATC
0-L	M04AC	Preparations with no effect on uric acid metabolism	WHO ATC
0-L	M04AC01	colchicine	WHO ATC
0-L	M04AC02	cinchophen	WHO ATC
0-L	M04AX	Other antigout preparations	WHO ATC
0-L	M04AX01	urate oxidase	WHO ATC
0-L	M04AX02	pegloticase	WHO ATC
0-L	M05	DRUGS FOR TREATMENT OF BONE DISEASES	WHO ATC
0-L	M05B	DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION	WHO ATC
0-L	M05BA	Bisphosphonates	WHO ATC
0-L	M05BA01	etidronic acid	WHO ATC
0-L	M05BA02	clodronic acid	WHO ATC
0-L	M05BA03	pamidronic acid	WHO ATC
0-L	M05BA04	alendronic acid	WHO ATC
0-L	M05BA05	tiludronic acid	WHO ATC
0-L	M05BA06	ibandronic acid	WHO ATC
0-L	M05BA07	risedronic acid	WHO ATC
0-L	M05BA08	zoledronic acid	WHO ATC
0-L	M05BB	Bisphosphonates, combinations	WHO ATC
0-L	M05BB01	etidronic acid and calcium, sequential	WHO ATC
0-L	M05BB02	risedronic acid and calcium, sequential	WHO ATC
0-L	M05BB03	alendronic acid and colecalciferol	WHO ATC
0-L	M05BB04	risedronic acid, calcium and colecalciferol, sequential	WHO ATC
0-L	M05BC	Bone morphogenetic proteins	WHO ATC
0-L	M05BC01	dibotermin alfa	WHO ATC
0-L	M05BC02	eptotermin alfa	WHO ATC
0-L	M05BX	Other drugs affecting bone structure and mineralization	WHO ATC
0-L	M05BX01	ipriflavone	WHO ATC
0-L	M05BX02	aluminium chlorohydrate	WHO ATC
0-L	M05BX03	strontium ranelate	WHO ATC
0-L	M05BX04	denosumab	WHO ATC
0-L	M09	OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM	WHO ATC
0-L	M09A	OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM	WHO ATC
0-L	M09AA	Quinine and derivatives	WHO ATC
0-L	M09AA01	hydroquinine	WHO ATC
0-L	M09AA72	quinine, combinations with psycholeptics	WHO ATC
0-L	M09AB	Enzymes	WHO ATC
0-L	M09AB01	chymopapain	WHO ATC
0-L	M09AB52	trypsin, combinations	WHO ATC
0-L	M09AX	Other drugs for disorders of the musculo-skeletal system	WHO ATC
0-L	M09AX01	hyaluronic acid	WHO ATC
0-L	N	NERVOUS SYSTEM	WHO ATC
0-L	N01	ANESTHETICS	WHO ATC
0-L	N01A	ANESTHETICS, GENERAL	WHO ATC
0-L	N01AA	Ethers	WHO ATC
0-L	N01AA01	diethyl ether	WHO ATC
0-L	N01AA02	vinyl ether	WHO ATC
0-L	N01AB	Halogenated hydrocarbons	WHO ATC
0-L	N01AB01	halothane	WHO ATC
0-L	N01AB02	chloroform	WHO ATC
0-L	N01AB04	enflurane	WHO ATC
0-L	N01AB05	trichloroethylene	WHO ATC
0-L	N01AB06	isoflurane	WHO ATC
0-L	N01AB07	desflurane	WHO ATC
0-L	N01AB08	sevoflurane	WHO ATC
0-L	N01AF	Barbiturates, plain	WHO ATC
0-L	N01AF01	methohexital	WHO ATC
0-L	N01AF02	hexobarbital	WHO ATC
0-L	N01AF03	thiopental	WHO ATC
0-L	N01AG	Barbiturates in combination with other drugs	WHO ATC
0-L	N01AG01	narcobarbital	WHO ATC
0-L	N01AH	Opioid anesthetics	WHO ATC
0-L	N01AH01	fentanyl	WHO ATC
0-L	N01AH02	alfentanil	WHO ATC
0-L	N01AH03	sufentanil	WHO ATC
0-L	N01AH04	phenoperidine	WHO ATC
0-L	N01AH05	anileridine	WHO ATC
0-L	N01AH06	remifentanil	WHO ATC
0-L	N01AH51	fentanyl, combinations	WHO ATC
0-L	N01AX	Other general anesthetics	WHO ATC
0-L	N01AX01	droperidol	WHO ATC
0-L	N01AX03	ketamine	WHO ATC
0-L	N01AX04	propanidid	WHO ATC
0-L	N01AX05	alfaxalone	WHO ATC
0-L	N01AX07	etomidate	WHO ATC
0-L	N01AX10	propofol	WHO ATC
0-L	N01AX11	sodium oxybate	WHO ATC
0-L	N01AX13	nitrous oxide	WHO ATC
0-L	N01AX14	esketamine	WHO ATC
0-L	N01AX15	xenon	WHO ATC
0-L	N01AX63	nitrous oxide, combinations	WHO ATC
0-L	N01B	ANESTHETICS, LOCAL	WHO ATC
0-L	N01BA	Esters of aminobenzoic acid	WHO ATC
0-L	N01BA01	metabutethamine	WHO ATC
0-L	N01BA02	procaine	WHO ATC
0-L	N01BA03	tetracaine	WHO ATC
0-L	N01BA04	chloroprocaine	WHO ATC
0-L	N01BA05	benzocaine	WHO ATC
0-L	N01BA52	procaine, combinations	WHO ATC
0-L	N01BB	Amides	WHO ATC
0-L	N01BB01	bupivacaine	WHO ATC
0-L	N01BB02	lidocaine	WHO ATC
0-L	N01BB03	mepivacaine	WHO ATC
0-L	N01BB04	prilocaine	WHO ATC
0-L	N01BB05	butanilicaine	WHO ATC
0-L	N01BB06	cinchocaine	WHO ATC
0-L	N01BB07	etidocaine	WHO ATC
0-L	N01BB08	articaine	WHO ATC
0-L	N01BB09	ropivacaine	WHO ATC
0-L	N01BB10	levobupivacaine	WHO ATC
0-L	N01BB20	combinations	WHO ATC
0-L	N01BB51	bupivacaine, combinations	WHO ATC
0-L	N01BB52	lidocaine, combinations	WHO ATC
0-L	N01BB53	mepivacaine, combinations	WHO ATC
0-L	N01BB54	prilocaine, combinations	WHO ATC
0-L	N01BB57	etidocaine, combinations	WHO ATC
0-L	N01BB58	articaine, combinations	WHO ATC
0-L	N01BC	Esters of benzoic acid	WHO ATC
0-L	N01BC01	cocaine	WHO ATC
0-L	N01BX	Other local anesthetics	WHO ATC
0-L	N01BX01	ethyl chloride	WHO ATC
0-L	N01BX02	dyclonine	WHO ATC
0-L	N01BX03	phenol	WHO ATC
0-L	N01BX04	capsaicin	WHO ATC
0-L	N02	ANALGESICS	WHO ATC
0-L	N02A	OPIOIDS	WHO ATC
0-L	N02AA	Natural opium alkaloids	WHO ATC
0-L	N02AA01	morphine	WHO ATC
0-L	N02AA02	opium	WHO ATC
0-L	N02AA03	hydromorphone	WHO ATC
0-L	N02AA04	nicomorphine	WHO ATC
0-L	N02AA05	oxycodone	WHO ATC
0-L	N02AA08	dihydrocodeine	WHO ATC
0-L	N02AA09	diamorphine	WHO ATC
0-L	N02AA10	papaveretum	WHO ATC
0-L	N02AA51	morphine, combinations	WHO ATC
0-L	N02AA55	oxycodone, combinations	WHO ATC
0-L	N02AA58	dihydrocodeine, combinations	WHO ATC
0-L	N02AA59	codeine, combinations excl. psycholeptics	WHO ATC
0-L	N02AA79	codeine, combinations with psycholeptics	WHO ATC
0-L	N02AB	Phenylpiperidine derivatives	WHO ATC
0-L	N02AB01	ketobemidone	WHO ATC
0-L	N02AB02	pethidine	WHO ATC
0-L	N02AB03	fentanyl	WHO ATC
0-L	N02AB52	pethidine, combinations excl. psycholeptics	WHO ATC
0-L	N02AB72	pethidine, combinations with psycholeptics	WHO ATC
0-L	N02AC	Diphenylpropylamine derivatives	WHO ATC
0-L	N02AC01	dextromoramide	WHO ATC
0-L	N02AC03	piritramide	WHO ATC
0-L	N02AC04	dextropropoxyphene	WHO ATC
0-L	N02AC05	bezitramide	WHO ATC
0-L	N02AC52	methadone, comb. excl. psycholeptics	WHO ATC
0-L	N02AC54	dextropropoxyphene, comb. excl. psycholeptics	WHO ATC
0-L	N02AC74	dextropropoxyphene, comb. with psycholeptics	WHO ATC
0-L	N02AD	Benzomorphan derivatives	WHO ATC
0-L	N02AD01	pentazocine	WHO ATC
0-L	N02AD02	phenazocine	WHO ATC
0-L	N02AE	Oripavine derivatives	WHO ATC
0-L	N02AE01	buprenorphine	WHO ATC
0-L	N02AF	Morphinan derivatives	WHO ATC
0-L	N02AF01	butorphanol	WHO ATC
0-L	N02AF02	nalbuphine	WHO ATC
0-L	N02AG	Opioids in combination with antispasmodics	WHO ATC
0-L	N02AG01	morphine and antispasmodics	WHO ATC
0-L	N02AG02	ketobemidone and antispasmodics	WHO ATC
0-L	N02AG03	pethidine and antispasmodics	WHO ATC
0-L	N02AG04	hydromorphone and antispasmodics	WHO ATC
0-L	N02AX	Other opioids	WHO ATC
0-L	N02AX01	tilidine	WHO ATC
0-L	N02AX02	tramadol	WHO ATC
0-L	N02AX03	dezocine	WHO ATC
0-L	N02AX05	meptazinol	WHO ATC
0-L	N02AX06	tapentadol	WHO ATC
0-L	N02AX52	tramadol, combinations	WHO ATC
0-L	N02B	OTHER ANALGESICS AND ANTIPYRETICS	WHO ATC
0-L	N02BA	Salicylic acid and derivatives	WHO ATC
0-L	N02BA01	acetylsalicylic acid	WHO ATC
0-L	N02BA02	aloxiprin	WHO ATC
0-L	N02BA03	choline salicylate	WHO ATC
0-L	N02BA04	sodium salicylate	WHO ATC
0-L	N02BA05	salicylamide	WHO ATC
0-L	N02BA06	salsalate	WHO ATC
0-L	N02BA07	ethenzamide	WHO ATC
0-L	N02BA08	morpholine salicylate	WHO ATC
0-L	N02BA09	dipyrocetyl	WHO ATC
0-L	N02BA10	benorilate	WHO ATC
0-L	N02BA11	diflunisal	WHO ATC
0-L	N02BA12	potassium salicylate	WHO ATC
0-L	N02BA14	guacetisal	WHO ATC
0-L	N02BA15	carbasalate calcium	WHO ATC
0-L	N02BA16	imidazole salicylate	WHO ATC
0-L	N02BA51	acetylsalicylic acid, combinations excl. psycholeptics	WHO ATC
0-L	N02BA55	salicylamide, combinations excl. psycholeptics	WHO ATC
0-L	N02BA57	ethenzamide, combinations excl. psycholeptics	WHO ATC
0-L	N02BA59	dipyrocetyl, combinations excl. psycholeptics	WHO ATC
0-L	N02BA65	carbasalate calcium combinations excl. psycholeptics	WHO ATC
0-L	N02BA71	acetylsalicylic acid, combinations with psycholeptics	WHO ATC
0-L	N02BA75	salicylamide, combinations with psycholeptics	WHO ATC
0-L	N02BA77	ethenzamide, combinations with psycholeptics	WHO ATC
0-L	N02BA79	dipyrocetyl, combinations with psycholeptics	WHO ATC
0-L	N02BB	Pyrazolones	WHO ATC
0-L	N02BB01	phenazone	WHO ATC
0-L	N02BB02	metamizole sodium	WHO ATC
0-L	N02BB03	aminophenazone	WHO ATC
0-L	N02BB04	propyphenazone	WHO ATC
0-L	N02BB05	nifenazone	WHO ATC
0-L	N02BB51	phenazone, combinations excl. psycholeptics	WHO ATC
0-L	N02BB52	metamizole sodium, combinations excl. psycholeptics	WHO ATC
0-L	N02BB53	aminophenazone, combinations excl. psycholeptics	WHO ATC
0-L	N02BB54	propyphenazone, combinations excl. psycholeptics	WHO ATC
0-L	N02BB71	phenazone, combinations with psycholeptics	WHO ATC
0-L	N02BB72	metamizole sodium, combinations with psycholeptics	WHO ATC
0-L	N02BB73	aminophenazone, combinations with psycholeptics	WHO ATC
0-L	N02BB74	propyphenazone, combinations with psycholeptics	WHO ATC
0-L	N02BE	Anilides	WHO ATC
0-L	N02BE01	paracetamol	WHO ATC
0-L	N02BE03	phenacetin	WHO ATC
0-L	N02BE04	bucetin	WHO ATC
0-L	N02BE05	propacetamol	WHO ATC
0-L	N02BE51	paracetamol, combinations excl. psycholeptics	WHO ATC
0-L	N02BE53	phenacetin, combinations excl. psycholeptics	WHO ATC
0-L	N02BE54	bucetin, combinations excl. psycholeptics	WHO ATC
0-L	N02BE71	paracetamol, combinations with psycholeptics	WHO ATC
0-L	N02BE73	phenacetin, combinations with psycholeptics	WHO ATC
0-L	N02BE74	bucetin, combinations with psycholeptics	WHO ATC
0-L	N02BG	Other analgesics and antipyretics	WHO ATC
0-L	N02BG02	rimazolium	WHO ATC
0-L	N02BG03	glafenine	WHO ATC
0-L	N02BG04	floctafenine	WHO ATC
0-L	N02BG05	viminol	WHO ATC
0-L	N02BG06	nefopam	WHO ATC
0-L	N02BG07	flupirtine	WHO ATC
0-L	N02BG08	ziconotide	WHO ATC
0-L	N02BG09	methoxyflurane	WHO ATC
0-L	N02BG10	nabiximols	WHO ATC
0-L	N02C	ANTIMIGRAINE PREPARATIONS	WHO ATC
0-L	N02CA	Ergot alkaloids	WHO ATC
0-L	N02CA01	dihydroergotamine	WHO ATC
0-L	N02CA02	ergotamine	WHO ATC
0-L	N02CA04	methysergide	WHO ATC
0-L	N02CA07	lisuride	WHO ATC
0-L	N02CA51	dihydroergotamine, combinations	WHO ATC
0-L	N02CA52	ergotamine, combinations excl. psycholeptics	WHO ATC
0-L	N02CA72	ergotamine, combinations with psycholeptics	WHO ATC
0-L	N02CB	Corticosteroid derivatives	WHO ATC
0-L	N02CB01	flumedroxone	WHO ATC
0-L	N02CC	Selective serotonin (5HT1) agonists	WHO ATC
0-L	N02CC01	sumatriptan	WHO ATC
0-L	N02CC02	naratriptan	WHO ATC
0-L	N02CC03	zolmitriptan	WHO ATC
0-L	N02CC04	rizatriptan	WHO ATC
0-L	N02CC05	almotriptan	WHO ATC
0-L	N02CC06	eletriptan	WHO ATC
0-L	N02CC07	frovatriptan	WHO ATC
0-L	N02CX	Other antimigraine preparations	WHO ATC
0-L	N02CX01	pizotifen	WHO ATC
0-L	N02CX02	clonidine	WHO ATC
0-L	N02CX03	iprazochrome	WHO ATC
0-L	N02CX05	dimetotiazine	WHO ATC
0-L	N02CX06	oxetorone	WHO ATC
0-L	N03	ANTIEPILEPTICS	WHO ATC
0-L	N03A	ANTIEPILEPTICS	WHO ATC
0-L	N03AA	Barbiturates and derivatives	WHO ATC
0-L	N03AA01	methylphenobarbital	WHO ATC
0-L	N03AA02	phenobarbital	WHO ATC
0-L	N03AA03	primidone	WHO ATC
0-L	N03AA04	barbexaclone	WHO ATC
0-L	N03AA30	metharbital	WHO ATC
0-L	N03AB	Hydantoin derivatives	WHO ATC
0-L	N03AB01	ethotoin	WHO ATC
0-L	N03AB02	phenytoin	WHO ATC
0-L	N03AB03	amino(diphenylhydantoin) valeric acid	WHO ATC
0-L	N03AB04	mephenytoin	WHO ATC
0-L	N03AB05	fosphenytoin	WHO ATC
0-L	N03AB52	phenytoin, combinations	WHO ATC
0-L	N03AB54	mephenytoin, combinations	WHO ATC
0-L	N03AC	Oxazolidine derivatives	WHO ATC
0-L	N03AC01	paramethadione	WHO ATC
0-L	N03AC02	trimethadione	WHO ATC
0-L	N03AC03	ethadione	WHO ATC
0-L	N03AD	Succinimide derivatives	WHO ATC
0-L	N03AD01	ethosuximide	WHO ATC
0-L	N03AD02	phensuximide	WHO ATC
0-L	N03AD03	mesuximide	WHO ATC
0-L	N03AD51	ethosuximide, combinations	WHO ATC
0-L	N03AE	Benzodiazepine derivatives	WHO ATC
0-L	N03AE01	clonazepam	WHO ATC
0-L	N03AF	Carboxamide derivatives	WHO ATC
0-L	N03AF01	carbamazepine	WHO ATC
0-L	N03AF02	oxcarbazepine	WHO ATC
0-L	N03AF03	rufinamide	WHO ATC
0-L	N03AF04	eslicarbazepine	WHO ATC
0-L	N03AG	Fatty acid derivatives	WHO ATC
0-L	N03AG01	valproic acid	WHO ATC
0-L	N03AG02	valpromide	WHO ATC
0-L	N03AG03	aminobutyric acid	WHO ATC
0-L	N03AG04	vigabatrin	WHO ATC
0-L	N03AG05	progabide	WHO ATC
0-L	N03AG06	tiagabine	WHO ATC
0-L	N03AX	Other antiepileptics	WHO ATC
0-L	N03AX03	sultiame	WHO ATC
0-L	N03AX07	phenacemide	WHO ATC
0-L	N03AX09	lamotrigine	WHO ATC
0-L	N03AX10	felbamate	WHO ATC
0-L	N03AX11	topiramate	WHO ATC
0-L	N03AX12	gabapentin	WHO ATC
0-L	N03AX13	pheneturide	WHO ATC
0-L	N03AX14	levetiracetam	WHO ATC
0-L	N03AX15	zonisamide	WHO ATC
0-L	N03AX16	pregabalin	WHO ATC
0-L	N03AX17	stiripentol	WHO ATC
0-L	N03AX18	lacosamide	WHO ATC
0-L	N03AX19	carisbamate	WHO ATC
0-L	N03AX30	beclamide	WHO ATC
0-L	N04	ANTI-PARKINSON DRUGS	WHO ATC
0-L	N04A	ANTICHOLINERGIC AGENTS	WHO ATC
0-L	N04AA	Tertiary amines	WHO ATC
0-L	N04AA01	trihexyphenidyl	WHO ATC
0-L	N04AA02	biperiden	WHO ATC
0-L	N04AA03	metixene	WHO ATC
0-L	N04AA04	procyclidine	WHO ATC
0-L	N04AA05	profenamine	WHO ATC
0-L	N04AA08	dexetimide	WHO ATC
0-L	N04AA09	phenglutarimide	WHO ATC
0-L	N04AA10	mazaticol	WHO ATC
0-L	N04AA11	bornaprine	WHO ATC
0-L	N04AA12	tropatepine	WHO ATC
0-L	N04AB	Ethers chemically close to antihistamines	WHO ATC
0-L	N04AB01	etanautine	WHO ATC
0-L	N04AB02	orphenadrine (chloride)	WHO ATC
0-L	N04AC	Ethers of tropine or tropine derivatives	WHO ATC
0-L	N04AC01	benzatropine	WHO ATC
0-L	N04AC30	etybenzatropine	WHO ATC
0-L	N04B	DOPAMINERGIC AGENTS	WHO ATC
0-L	N04BA	Dopa and dopa derivatives	WHO ATC
0-L	N04BA01	levodopa	WHO ATC
0-L	N04BA02	levodopa and decarboxylase inhibitor	WHO ATC
0-L	N04BA03	levodopa, decarboxylase inhibitor and COMT inhibitor	WHO ATC
0-L	N04BA04	melevodopa	WHO ATC
0-L	N04BA05	melevodopa and decarboxylase inhibitor	WHO ATC
0-L	N04BA06	etilevodopa and decarboxylase inhibitor	WHO ATC
0-L	N04BB	Adamantane derivatives	WHO ATC
0-L	N04BB01	amantadine	WHO ATC
0-L	N04BC	Dopamine agonists	WHO ATC
0-L	N04BC01	bromocriptine	WHO ATC
0-L	N04BC02	pergolide	WHO ATC
0-L	N04BC03	dihydroergocryptine mesylate	WHO ATC
0-L	N04BC04	ropinirole	WHO ATC
0-L	N04BC05	pramipexole	WHO ATC
0-L	N04BC06	cabergoline	WHO ATC
0-L	N04BC07	apomorphine	WHO ATC
0-L	N04BC08	piribedil	WHO ATC
0-L	N04BC09	rotigotine	WHO ATC
0-L	N04BD	Monoamine oxidase B inhibitors	WHO ATC
0-L	N04BD01	selegiline	WHO ATC
0-L	N04BD02	rasagiline	WHO ATC
0-L	N04BX	Other dopaminergic agents	WHO ATC
0-L	N04BX01	tolcapone	WHO ATC
0-L	N04BX02	entacapone	WHO ATC
0-L	N04BX03	budipine	WHO ATC
0-L	N05	PSYCHOLEPTICS	WHO ATC
0-L	N05A	ANTIPSYCHOTICS	WHO ATC
0-L	N05AA	Phenothiazines with aliphatic side-chain	WHO ATC
0-L	N05AA01	chlorpromazine	WHO ATC
0-L	N05AA02	levomepromazine	WHO ATC
0-L	N05AA03	promazine	WHO ATC
0-L	N05AA04	acepromazine	WHO ATC
0-L	N05AA05	triflupromazine	WHO ATC
0-L	N05AA06	cyamemazine	WHO ATC
0-L	N05AA07	chlorproethazine	WHO ATC
0-L	N05AB	Phenothiazines with piperazine structure	WHO ATC
0-L	N05AB01	dixyrazine	WHO ATC
0-L	N05AB02	fluphenazine	WHO ATC
0-L	N05AB03	perphenazine	WHO ATC
0-L	N05AB04	prochlorperazine	WHO ATC
0-L	N05AB05	thiopropazate	WHO ATC
0-L	N05AB06	trifluoperazine	WHO ATC
0-L	N05AB07	acetophenazine	WHO ATC
0-L	N05AB08	thioproperazine	WHO ATC
0-L	N05AB09	butaperazine	WHO ATC
0-L	N05AB10	perazine	WHO ATC
0-L	N05AC	Phenothiazines with piperidine structure	WHO ATC
0-L	N05AC01	periciazine	WHO ATC
0-L	N05AC02	thioridazine	WHO ATC
0-L	N05AC03	mesoridazine	WHO ATC
0-L	N05AC04	pipotiazine	WHO ATC
0-L	N05AD	Butyrophenone derivatives	WHO ATC
0-L	N05AD01	haloperidol	WHO ATC
0-L	N05AD02	trifluperidol	WHO ATC
0-L	N05AD03	melperone	WHO ATC
0-L	N05AD04	moperone	WHO ATC
0-L	N05AD05	pipamperone	WHO ATC
0-L	N05AD06	bromperidol	WHO ATC
0-L	N05AD07	benperidol	WHO ATC
0-L	N05AD08	droperidol	WHO ATC
0-L	N05AD09	fluanisone	WHO ATC
0-L	N05AE	Indole derivatives	WHO ATC
0-L	N05AE01	oxypertine	WHO ATC
0-L	N05AE02	molindone	WHO ATC
0-L	N05AE03	sertindole	WHO ATC
0-L	N05AE04	ziprasidone	WHO ATC
0-L	N05AF	Thioxanthene derivatives	WHO ATC
0-L	N05AF01	flupentixol	WHO ATC
0-L	N05AF02	clopenthixol	WHO ATC
0-L	N05AF03	chlorprothixene	WHO ATC
0-L	N05AF04	tiotixene	WHO ATC
0-L	N05AF05	zuclopenthixol	WHO ATC
0-L	N05AG	Diphenylbutylpiperidine derivatives	WHO ATC
0-L	N05AG01	fluspirilene	WHO ATC
0-L	N05AG02	pimozide	WHO ATC
0-L	N05AG03	penfluridol	WHO ATC
0-L	N05AH	Diazepines, oxazepines, thiazepines and oxepines	WHO ATC
0-L	N05AH01	loxapine	WHO ATC
0-L	N05AH02	clozapine	WHO ATC
0-L	N05AH03	olanzapine	WHO ATC
0-L	N05AH04	quetiapine	WHO ATC
0-L	N05AH05	asenapine	WHO ATC
0-L	N05AH06	clotiapine	WHO ATC
0-L	N05AL	Benzamides	WHO ATC
0-L	N05AL01	sulpiride	WHO ATC
0-L	N05AL02	sultopride	WHO ATC
0-L	N05AL03	tiapride	WHO ATC
0-L	N05AL04	remoxipride	WHO ATC
0-L	N05AL05	amisulpride	WHO ATC
0-L	N05AL06	veralipride	WHO ATC
0-L	N05AL07	levosulpiride	WHO ATC
0-L	N05AN	Lithium	WHO ATC
0-L	N05AN01	lithium	WHO ATC
0-L	N05AX	Other antipsychotics	WHO ATC
0-L	N05AX07	prothipendyl	WHO ATC
0-L	N05AX08	risperidone	WHO ATC
0-L	N05AX10	mosapramine	WHO ATC
0-L	N05AX11	zotepine	WHO ATC
0-L	N05AX12	aripiprazole	WHO ATC
0-L	N05AX13	paliperidone	WHO ATC
0-L	N05B	ANXIOLYTICS	WHO ATC
0-L	N05BA	Benzodiazepine derivatives	WHO ATC
0-L	N05BA01	diazepam	WHO ATC
0-L	N05BA02	chlordiazepoxide	WHO ATC
0-L	N05BA03	medazepam	WHO ATC
0-L	N05BA04	oxazepam	WHO ATC
0-L	N05BA05	potassium clorazepate	WHO ATC
0-L	N05BA06	lorazepam	WHO ATC
0-L	N05BA07	adinazolam	WHO ATC
0-L	N05BA08	bromazepam	WHO ATC
0-L	N05BA09	clobazam	WHO ATC
0-L	N05BA10	ketazolam	WHO ATC
0-L	N05BA11	prazepam	WHO ATC
0-L	N05BA12	alprazolam	WHO ATC
0-L	N05BA13	halazepam	WHO ATC
0-L	N05BA14	pinazepam	WHO ATC
0-L	N05BA15	camazepam	WHO ATC
0-L	N05BA16	nordazepam	WHO ATC
0-L	N05BA17	fludiazepam	WHO ATC
0-L	N05BA18	ethyl loflazepate	WHO ATC
0-L	N05BA19	etizolam	WHO ATC
0-L	N05BA21	clotiazepam	WHO ATC
0-L	N05BA22	cloxazolam	WHO ATC
0-L	N05BA23	tofisopam	WHO ATC
0-L	N05BA56	lorazepam, combinations	WHO ATC
0-L	N05BB	Diphenylmethane derivatives	WHO ATC
0-L	N05BB01	hydroxyzine	WHO ATC
0-L	N05BB02	captodiame	WHO ATC
0-L	N05BB51	hydroxyzine, combinations	WHO ATC
0-L	N05BC	Carbamates	WHO ATC
0-L	N05BC01	meprobamate	WHO ATC
0-L	N05BC03	emylcamate	WHO ATC
0-L	N05BC04	mebutamate	WHO ATC
0-L	N05BC51	meprobamate, combinations	WHO ATC
0-L	N05BD	Dibenzo-bicyclo-octadiene derivatives	WHO ATC
0-L	N05BD01	benzoctamine	WHO ATC
0-L	N05BE	Azaspirodecanedione derivatives	WHO ATC
0-L	N05BE01	buspirone	WHO ATC
0-L	N05BX	Other anxiolytics	WHO ATC
0-L	N05BX01	mephenoxalone	WHO ATC
0-L	N05BX02	gedocarnil	WHO ATC
0-L	N05BX03	etifoxine	WHO ATC
0-L	N05C	HYPNOTICS AND SEDATIVES	WHO ATC
0-L	N05CA	Barbiturates, plain	WHO ATC
0-L	N05CA01	pentobarbital	WHO ATC
0-L	N05CA02	amobarbital	WHO ATC
0-L	N05CA03	butobarbital	WHO ATC
0-L	N05CA04	barbital	WHO ATC
0-L	N05CA05	aprobarbital	WHO ATC
0-L	N05CA06	secobarbital	WHO ATC
0-L	N05CA07	talbutal	WHO ATC
0-L	N05CA08	vinylbital	WHO ATC
0-L	N05CA09	vinbarbital	WHO ATC
0-L	N05CA10	cyclobarbital	WHO ATC
0-L	N05CA11	heptabarbital	WHO ATC
0-L	N05CA12	reposal	WHO ATC
0-L	N05CA15	methohexital	WHO ATC
0-L	N05CA16	hexobarbital	WHO ATC
0-L	N05CA19	thiopental	WHO ATC
0-L	N05CA20	etallobarbital	WHO ATC
0-L	N05CA21	allobarbital	WHO ATC
0-L	N05CA22	proxibarbal	WHO ATC
0-L	N05CB	Barbiturates, combinations	WHO ATC
0-L	N05CB01	combinations of barbiturates	WHO ATC
0-L	N05CB02	barbiturates in combination with other drugs	WHO ATC
0-L	N05CC	Aldehydes and derivatives	WHO ATC
0-L	N05CC01	chloral hydrate	WHO ATC
0-L	N05CC02	chloralodol	WHO ATC
0-L	N05CC03	acetylglycinamide chloral hydrate	WHO ATC
0-L	N05CC04	dichloralphenazone	WHO ATC
0-L	N05CC05	paraldehyde	WHO ATC
0-L	N05CD	Benzodiazepine derivatives	WHO ATC
0-L	N05CD01	flurazepam	WHO ATC
0-L	N05CD02	nitrazepam	WHO ATC
0-L	N05CD03	flunitrazepam	WHO ATC
0-L	N05CD04	estazolam	WHO ATC
0-L	N05CD05	triazolam	WHO ATC
0-L	N05CD06	lormetazepam	WHO ATC
0-L	N05CD07	temazepam	WHO ATC
0-L	N05CD08	midazolam	WHO ATC
0-L	N05CD09	brotizolam	WHO ATC
0-L	N05CD10	quazepam	WHO ATC
0-L	N05CD11	loprazolam	WHO ATC
0-L	N05CD12	doxefazepam	WHO ATC
0-L	N05CD13	cinolazepam	WHO ATC
0-L	N05CE	Piperidinedione derivatives	WHO ATC
0-L	N05CE01	glutethimide	WHO ATC
0-L	N05CE02	methyprylon	WHO ATC
0-L	N05CE03	pyrithyldione	WHO ATC
0-L	N05CF	Benzodiazepine related drugs	WHO ATC
0-L	N05CF01	zopiclone	WHO ATC
0-L	N05CF02	zolpidem	WHO ATC
0-L	N05CF03	zaleplon	WHO ATC
0-L	N05CF04	eszopiclone	WHO ATC
0-L	N05CH	Melatonin receptor agonists	WHO ATC
0-L	N05CH01	melatonin	WHO ATC
0-L	N05CH02	ramelteon	WHO ATC
0-L	N05CM	Other hypnotics and sedatives	WHO ATC
0-L	N05CM01	methaqualone	WHO ATC
0-L	N05CM02	clomethiazole	WHO ATC
0-L	N05CM03	bromisoval	WHO ATC
0-L	N05CM04	carbromal	WHO ATC
0-L	N05CM05	scopolamine	WHO ATC
0-L	N05CM06	propiomazine	WHO ATC
0-L	N05CM07	triclofos	WHO ATC
0-L	N05CM08	ethchlorvynol	WHO ATC
0-L	N05CM09	valerian	WHO ATC
0-L	N05CM10	hexapropymate	WHO ATC
0-L	N05CM11	bromides	WHO ATC
0-L	N05CM12	apronal	WHO ATC
0-L	N05CM13	valnoctamide	WHO ATC
0-L	N05CM15	methylpentynol	WHO ATC
0-L	N05CM16	niaprazine	WHO ATC
0-L	N05CM18	dexmedetomidine	WHO ATC
0-L	N05CX	Hypnotics and sedatives in combination, excl. barbiturates	WHO ATC
0-L	N05CX01	meprobamate, combinations	WHO ATC
0-L	N05CX02	methaqualone, combinations	WHO ATC
0-L	N05CX03	methylpentynol, combinations	WHO ATC
0-L	N05CX04	clomethiazole, combinations	WHO ATC
0-L	N05CX05	emepronium, combinations	WHO ATC
0-L	N05CX06	dipiperonylaminoethanol, combinations	WHO ATC
0-L	N06	PSYCHOANALEPTICS	WHO ATC
0-L	N06A	ANTIDEPRESSANTS	WHO ATC
0-L	N06AA	Non-selective monoamine reuptake inhibitors	WHO ATC
0-L	N06AA01	desipramine	WHO ATC
0-L	N06AA02	imipramine	WHO ATC
0-L	N06AA03	imipramine oxide	WHO ATC
0-L	N06AA04	clomipramine	WHO ATC
0-L	N06AA05	opipramol	WHO ATC
0-L	N06AA06	trimipramine	WHO ATC
0-L	N06AA07	lofepramine	WHO ATC
0-L	N06AA08	dibenzepin	WHO ATC
0-L	N06AA09	amitriptyline	WHO ATC
0-L	N06AA10	nortriptyline	WHO ATC
0-L	N06AA11	protriptyline	WHO ATC
0-L	N06AA12	doxepin	WHO ATC
0-L	N06AA13	iprindole	WHO ATC
0-L	N06AA14	melitracen	WHO ATC
0-L	N06AA15	butriptyline	WHO ATC
0-L	N06AA16	dosulepin	WHO ATC
0-L	N06AA17	amoxapine	WHO ATC
0-L	N06AA18	dimetacrine	WHO ATC
0-L	N06AA19	amineptine	WHO ATC
0-L	N06AA21	maprotiline	WHO ATC
0-L	N06AA23	quinupramine	WHO ATC
0-L	N06AB	Selective serotonin reuptake inhibitors	WHO ATC
0-L	N06AB02	zimeldine	WHO ATC
0-L	N06AB03	fluoxetine	WHO ATC
0-L	N06AB04	citalopram	WHO ATC
0-L	N06AB05	paroxetine	WHO ATC
0-L	N06AB06	sertraline	WHO ATC
0-L	N06AB07	alaproclate	WHO ATC
0-L	N06AB08	fluvoxamine	WHO ATC
0-L	N06AB09	etoperidone	WHO ATC
0-L	N06AB10	escitalopram	WHO ATC
0-L	N06AF	Monoamine oxidase inhibitors, non-selective	WHO ATC
0-L	N06AF01	isocarboxazid	WHO ATC
0-L	N06AF02	nialamide	WHO ATC
0-L	N06AF03	phenelzine	WHO ATC
0-L	N06AF04	tranylcypromine	WHO ATC
0-L	N06AF05	iproniazide	WHO ATC
0-L	N06AF06	iproclozide	WHO ATC
0-L	N06AG	Monoamine oxidase A inhibitors	WHO ATC
0-L	N06AG02	moclobemide	WHO ATC
0-L	N06AG03	toloxatone	WHO ATC
0-L	N06AX	Other antidepressants	WHO ATC
0-L	N06AX01	oxitriptan	WHO ATC
0-L	N06AX02	tryptophan	WHO ATC
0-L	N06AX03	mianserin	WHO ATC
0-L	N06AX04	nomifensine	WHO ATC
0-L	N06AX05	trazodone	WHO ATC
0-L	N06AX06	nefazodone	WHO ATC
0-L	N06AX07	minaprine	WHO ATC
0-L	N06AX08	bifemelane	WHO ATC
0-L	N06AX09	viloxazine	WHO ATC
0-L	N06AX10	oxaflozane	WHO ATC
0-L	N06AX11	mirtazapine	WHO ATC
0-L	N06AX12	bupropion	WHO ATC
0-L	N06AX13	medifoxamine	WHO ATC
0-L	N06AX14	tianeptine	WHO ATC
0-L	N06AX15	pivagabine	WHO ATC
0-L	N06AX16	venlafaxine	WHO ATC
0-L	N06AX17	milnacipran	WHO ATC
0-L	N06AX18	reboxetine	WHO ATC
0-L	N06AX19	gepirone	WHO ATC
0-L	N06AX21	duloxetine	WHO ATC
0-L	N06AX22	agomelatine	WHO ATC
0-L	N06AX23	desvenlafaxine	WHO ATC
0-L	N06B	PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS	WHO ATC
0-L	N06BA	Centrally acting sympathomimetics	WHO ATC
0-L	N06BA01	amfetamine	WHO ATC
0-L	N06BA02	dexamfetamine	WHO ATC
0-L	N06BA03	metamfetamine	WHO ATC
0-L	N06BA04	methylphenidate	WHO ATC
0-L	N06BA05	pemoline	WHO ATC
0-L	N06BA06	fencamfamin	WHO ATC
0-L	N06BA07	modafinil	WHO ATC
0-L	N06BA08	fenozolone	WHO ATC
0-L	N06BA09	atomoxetine	WHO ATC
0-L	N06BA10	fenetylline	WHO ATC
0-L	N06BA11	dexmethylphenidate	WHO ATC
0-L	N06BC	Xanthine derivatives	WHO ATC
0-L	N06BC01	caffeine	WHO ATC
0-L	N06BC02	propentofylline	WHO ATC
0-L	N06BX	Other psychostimulants and nootropics	WHO ATC
0-L	N06BX01	meclofenoxate	WHO ATC
0-L	N06BX02	pyritinol	WHO ATC
0-L	N06BX03	piracetam	WHO ATC
0-L	N06BX04	deanol	WHO ATC
0-L	N06BX05	fipexide	WHO ATC
0-L	N06BX06	citicoline	WHO ATC
0-L	N06BX07	oxiracetam	WHO ATC
0-L	N06BX08	pirisudanol	WHO ATC
0-L	N06BX09	linopirdine	WHO ATC
0-L	N06BX10	nizofenone	WHO ATC
0-L	N06BX11	aniracetam	WHO ATC
0-L	N06BX12	acetylcarnitine	WHO ATC
0-L	N06BX13	idebenone	WHO ATC
0-L	N06BX14	prolintane	WHO ATC
0-L	N06BX15	pipradrol	WHO ATC
0-L	N06BX16	pramiracetam	WHO ATC
0-L	N06BX17	adrafinil	WHO ATC
0-L	N06BX18	vinpocetine	WHO ATC
0-L	N06C	PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION	WHO ATC
0-L	N06CA	Antidepressants in combination with psycholeptics	WHO ATC
0-L	N06CA01	amitriptyline and psycholeptics	WHO ATC
0-L	N06CA02	melitracen and psycholeptics	WHO ATC
0-L	N06CB	Psychostimulants in combination with psycholeptics	WHO ATC
0-L	N06D	ANTI-DEMENTIA DRUGS	WHO ATC
0-L	N06DA	Anticholinesterases	WHO ATC
0-L	N06DA01	tacrine	WHO ATC
0-L	N06DA02	donepezil	WHO ATC
0-L	N06DA03	rivastigmine	WHO ATC
0-L	N06DA04	galantamine	WHO ATC
0-L	N06DX	Other anti-dementia drugs	WHO ATC
0-L	N06DX01	memantine	WHO ATC
0-L	N06DX02	ginkgo biloba	WHO ATC
0-L	N07	OTHER NERVOUS SYSTEM DRUGS	WHO ATC
0-L	N07A	PARASYMPATHOMIMETICS	WHO ATC
0-L	N07AA	Anticholinesterases	WHO ATC
0-L	N07AA01	neostigmine	WHO ATC
0-L	N07AA02	pyridostigmine	WHO ATC
0-L	N07AA03	distigmine	WHO ATC
0-L	N07AA30	ambenonium	WHO ATC
0-L	N07AA51	neostigmine, combinations	WHO ATC
0-L	N07AB	Choline esters	WHO ATC
0-L	N07AB01	carbachol	WHO ATC
0-L	N07AB02	bethanechol	WHO ATC
0-L	N07AX	Other parasympathomimetics	WHO ATC
0-L	N07AX01	pilocarpine	WHO ATC
0-L	N07AX02	choline alfoscerate	WHO ATC
0-L	N07AX03	cevimeline	WHO ATC
0-L	N07B	DRUGS USED IN ADDICTIVE DISORDERS	WHO ATC
0-L	N07BA	Drugs used in nicotine dependence	WHO ATC
0-L	N07BA01	nicotine	WHO ATC
0-L	N07BA03	varenicline	WHO ATC
0-L	N07BB	Drugs used in alcohol dependence	WHO ATC
0-L	N07BB01	disulfiram	WHO ATC
0-L	N07BB02	calcium carbimide	WHO ATC
0-L	N07BB03	acamprosate	WHO ATC
0-L	N07BB04	naltrexone	WHO ATC
0-L	N07BC	Drugs used in opioid dependence	WHO ATC
0-L	N07BC01	buprenorphine	WHO ATC
0-L	N07BC02	methadone	WHO ATC
0-L	N07BC03	levacetylmethadol	WHO ATC
0-L	N07BC04	lofexidine	WHO ATC
0-L	N07BC51	buprenorphine, combinations	WHO ATC
0-L	N07C	ANTIVERTIGO PREPARATIONS	WHO ATC
0-L	N07CA	Antivertigo preparations	WHO ATC
0-L	N07CA01	betahistine	WHO ATC
0-L	N07CA02	cinnarizine	WHO ATC
0-L	N07CA03	flunarizine	WHO ATC
0-L	N07CA04	acetylleucine	WHO ATC
0-L	N07CA52	cinnarizine, combinations	WHO ATC
0-L	N07X	OTHER NERVOUS SYSTEM DRUGS	WHO ATC
0-L	N07XA	Gangliosides and ganglioside derivatives	WHO ATC
0-L	N07XX	Other nervous system drugs	WHO ATC
0-L	N07XX01	tirilazad	WHO ATC
0-L	N07XX02	riluzole	WHO ATC
0-L	N07XX03	xaliproden	WHO ATC
0-L	N07XX04	sodium oxybate	WHO ATC
0-L	N07XX05	amifampridine	WHO ATC
0-L	N07XX06	tetrabenazine	WHO ATC
0-L	P	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS	WHO ATC
0-L	P01	ANTIPROTOZOALS	WHO ATC
0-L	P01A	AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES	WHO ATC
0-L	P01AA	Hydroxyquinoline derivatives	WHO ATC
0-L	P01AA01	broxyquinoline	WHO ATC
0-L	P01AA02	clioquinol	WHO ATC
0-L	P01AA04	chlorquinaldol	WHO ATC
0-L	P01AA05	tilbroquinol	WHO ATC
0-L	P01AA52	clioquinol, combinations	WHO ATC
0-L	P01AB	Nitroimidazole derivatives	WHO ATC
0-L	P01AB01	metronidazole	WHO ATC
0-L	P01AB02	tinidazole	WHO ATC
0-L	P01AB03	ornidazole	WHO ATC
0-L	P01AB04	azanidazole	WHO ATC
0-L	P01AB05	propenidazole	WHO ATC
0-L	P01AB06	nimorazole	WHO ATC
0-L	P01AB07	secnidazole	WHO ATC
0-L	P01AC	Dichloroacetamide derivatives	WHO ATC
0-L	P01AC01	diloxanide	WHO ATC
0-L	P01AC02	clefamide	WHO ATC
0-L	P01AC03	etofamide	WHO ATC
0-L	P01AC04	teclozan	WHO ATC
0-L	P01AR	Arsenic compounds	WHO ATC
0-L	P01AR01	arsthinol	WHO ATC
0-L	P01AR02	difetarsone	WHO ATC
0-L	P01AR03	glycobiarsol	WHO ATC
0-L	P01AR53	glycobiarsol, combinations	WHO ATC
0-L	P01AX	Other agents against amoebiasis and other protozoal diseases	WHO ATC
0-L	P01AX01	chiniofon	WHO ATC
0-L	P01AX02	emetine	WHO ATC
0-L	P01AX04	phanquinone	WHO ATC
0-L	P01AX05	mepacrine	WHO ATC
0-L	P01AX06	atovaquone	WHO ATC
0-L	P01AX07	trimetrexate	WHO ATC
0-L	P01AX08	tenonitrozole	WHO ATC
0-L	P01AX09	dihydroemetine	WHO ATC
0-L	P01AX10	fumagillin	WHO ATC
0-L	P01AX11	nitazoxanide	WHO ATC
0-L	P01AX52	emetine, combinations	WHO ATC
0-L	P01B	ANTIMALARIALS	WHO ATC
0-L	P01BA	Aminoquinolines	WHO ATC
0-L	P01BA01	chloroquine	WHO ATC
0-L	P01BA02	hydroxychloroquine	WHO ATC
0-L	P01BA03	primaquine	WHO ATC
0-L	P01BA06	amodiaquine	WHO ATC
0-L	P01BB	Biguanides	WHO ATC
0-L	P01BB01	proguanil	WHO ATC
0-L	P01BB02	cycloguanil embonate	WHO ATC
0-L	P01BB51	proguanil, combinations	WHO ATC
0-L	P01BC	Methanolquinolines	WHO ATC
0-L	P01BC01	quinine	WHO ATC
0-L	P01BC02	mefloquine	WHO ATC
0-L	P01BD	Diaminopyrimidines	WHO ATC
0-L	P01BD01	pyrimethamine	WHO ATC
0-L	P01BD51	pyrimethamine, combinations	WHO ATC
0-L	P01BE	Artemisinin and derivatives	WHO ATC
0-L	P01BE01	artemisinin	WHO ATC
0-L	P01BE02	artemether	WHO ATC
0-L	P01BE03	artesunate	WHO ATC
0-L	P01BE04	artemotil	WHO ATC
0-L	P01BE05	artenimol	WHO ATC
0-L	P01BE52	artemether, combinations	WHO ATC
0-L	P01BX	Other antimalarials	WHO ATC
0-L	P01BX01	halofantrine	WHO ATC
0-L	P01C	AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS	WHO ATC
0-L	P01CA	Nitroimidazole derivatives	WHO ATC
0-L	P01CA02	benznidazole	WHO ATC
0-L	P01CB	Antimony compounds	WHO ATC
0-L	P01CB01	meglumine antimonate	WHO ATC
0-L	P01CB02	sodium stibogluconate	WHO ATC
0-L	P01CC	Nitrofuran derivatives	WHO ATC
0-L	P01CC01	nifurtimox	WHO ATC
0-L	P01CC02	nitrofural	WHO ATC
0-L	P01CD	Arsenic compounds	WHO ATC
0-L	P01CD01	melarsoprol	WHO ATC
0-L	P01CD02	acetarsol	WHO ATC
0-L	P01CX	Other agents against leishmaniasis and trypanosomiasis	WHO ATC
0-L	P01CX01	pentamidine isethionate	WHO ATC
0-L	P01CX02	suramin sodium	WHO ATC
0-L	P01CX03	eflornithine	WHO ATC
0-L	P02	ANTHELMINTICS	WHO ATC
0-L	P02B	ANTITREMATODALS	WHO ATC
0-L	P02BA	Quinoline derivatives and related substances	WHO ATC
0-L	P02BA01	praziquantel	WHO ATC
0-L	P02BA02	oxamniquine	WHO ATC
0-L	P02BB	Organophosphorous compounds	WHO ATC
0-L	P02BB01	metrifonate	WHO ATC
0-L	P02BX	Other antitrematodal agents	WHO ATC
0-L	P02BX01	bithionol	WHO ATC
0-L	P02BX02	niridazole	WHO ATC
0-L	P02BX03	stibophen	WHO ATC
0-L	P02BX04	triclabendazole	WHO ATC
0-L	P02C	ANTINEMATODAL AGENTS	WHO ATC
0-L	P02CA	Benzimidazole derivatives	WHO ATC
0-L	P02CA01	mebendazole	WHO ATC
0-L	P02CA02	tiabendazole	WHO ATC
0-L	P02CA03	albendazole	WHO ATC
0-L	P02CA04	ciclobendazole	WHO ATC
0-L	P02CA05	flubendazole	WHO ATC
0-L	P02CA06	fenbendazole	WHO ATC
0-L	P02CA51	mebendazole, combinations	WHO ATC
0-L	P02CB	Piperazine and derivatives	WHO ATC
0-L	P02CB01	piperazine	WHO ATC
0-L	P02CB02	diethylcarbamazine	WHO ATC
0-L	P02CC	Tetrahydropyrimidine derivatives	WHO ATC
0-L	P02CC01	pyrantel	WHO ATC
0-L	P02CC02	oxantel	WHO ATC
0-L	P02CE	Imidazothiazole derivatives	WHO ATC
0-L	P02CE01	levamisole	WHO ATC
0-L	P02CF	Avermectines	WHO ATC
0-L	P02CF01	ivermectin	WHO ATC
0-L	P02CX	Other antinematodals	WHO ATC
0-L	P02CX01	pyrvinium	WHO ATC
0-L	P02CX02	bephenium	WHO ATC
0-L	P02D	ANTICESTODALS	WHO ATC
0-L	P02DA	Salicylic acid derivatives	WHO ATC
0-L	P02DA01	niclosamide	WHO ATC
0-L	P02DX	Other anticestodals	WHO ATC
0-L	P02DX01	desaspidin	WHO ATC
0-L	P02DX02	dichlorophen	WHO ATC
0-L	P03	ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS	WHO ATC
0-L	P03A	ECTOPARASITICIDES, INCL. SCABICIDES	WHO ATC
0-L	P03AA	Sulfur containing products	WHO ATC
0-L	P03AA01	dixanthogen	WHO ATC
0-L	P03AA02	potassium polysulfide	WHO ATC
0-L	P03AA03	mesulfen	WHO ATC
0-L	P03AA04	disulfiram	WHO ATC
0-L	P03AA05	thiram	WHO ATC
0-L	P03AA54	disulfiram, combinations	WHO ATC
0-L	P03AB	Chlorine containing products	WHO ATC
0-L	P03AB01	clofenotane	WHO ATC
0-L	P03AB02	lindane	WHO ATC
0-L	P03AB51	clofenotane, combinations	WHO ATC
0-L	P03AC	Pyrethrines, incl. synthetic compounds	WHO ATC
0-L	P03AC01	pyrethrum	WHO ATC
0-L	P03AC02	bioallethrin	WHO ATC
0-L	P03AC03	phenothrin	WHO ATC
0-L	P03AC04	permethrin	WHO ATC
0-L	P03AC51	pyrethrum, combinations	WHO ATC
0-L	P03AC52	bioallethrin, combinations	WHO ATC
0-L	P03AC53	phenothrin, combinations	WHO ATC
0-L	P03AC54	permethrin, combinations	WHO ATC
0-L	P03AX	Other ectoparasiticides, incl. scabicides	WHO ATC
0-L	P03AX01	benzyl benzoate	WHO ATC
0-L	P03AX02	copper oleinate	WHO ATC
0-L	P03AX03	malathion	WHO ATC
0-L	P03AX04	quassia	WHO ATC
0-L	P03B	INSECTICIDES AND REPELLENTS	WHO ATC
0-L	P03BA	Pyrethrines	WHO ATC
0-L	P03BA01	cyfluthrin	WHO ATC
0-L	P03BA02	cypermethrin	WHO ATC
0-L	P03BA03	decamethrin	WHO ATC
0-L	P03BA04	tetramethrin	WHO ATC
0-L	P03BX	Other insecticides and repellents	WHO ATC
0-L	P03BX01	diethyltoluamide	WHO ATC
0-L	P03BX02	dimethylphthalate	WHO ATC
0-L	P03BX03	dibutylphthalate	WHO ATC
0-L	P03BX04	dibutylsuccinate	WHO ATC
0-L	P03BX05	dimethylcarbate	WHO ATC
0-L	P03BX06	etohexadiol	WHO ATC
0-L	R	RESPIRATORY SYSTEM	WHO ATC
0-L	R01	NASAL PREPARATIONS	WHO ATC
0-L	R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE	WHO ATC
0-L	R01AA	Sympathomimetics, plain	WHO ATC
0-L	R01AA02	cyclopentamine	WHO ATC
0-L	R01AA03	ephedrine	WHO ATC
0-L	R01AA04	phenylephrine	WHO ATC
0-L	R01AA05	oxymetazoline	WHO ATC
0-L	R01AA06	tetryzoline	WHO ATC
0-L	R01AA07	xylometazoline	WHO ATC
0-L	R01AA08	naphazoline	WHO ATC
0-L	R01AA09	tramazoline	WHO ATC
0-L	R01AA10	metizoline	WHO ATC
0-L	R01AA11	tuaminoheptane	WHO ATC
0-L	R01AA12	fenoxazoline	WHO ATC
0-L	R01AA13	tymazoline	WHO ATC
0-L	R01AA14	epinephrine	WHO ATC
0-L	R01AB	Sympathomimetics, combinations excl. corticosteroids	WHO ATC
0-L	R01AB01	phenylephrine	WHO ATC
0-L	R01AB02	naphazoline	WHO ATC
0-L	R01AB03	tetryzoline	WHO ATC
0-L	R01AB05	ephedrine	WHO ATC
0-L	R01AB06	xylometazoline	WHO ATC
0-L	R01AB07	oxymetazoline	WHO ATC
0-L	R01AB08	tuaminoheptane	WHO ATC
0-L	R01AC	Antiallergic agents, excl. corticosteroids	WHO ATC
0-L	R01AC01	cromoglicic acid	WHO ATC
0-L	R01AC02	levocabastine	WHO ATC
0-L	R01AC03	azelastine	WHO ATC
0-L	R01AC04	antazoline	WHO ATC
0-L	R01AC05	spaglumic acid	WHO ATC
0-L	R01AC06	thonzylamine	WHO ATC
0-L	R01AC07	nedocromil	WHO ATC
0-L	R01AC08	olopatadine	WHO ATC
0-L	R01AC51	cromoglicic acid, combinations	WHO ATC
0-L	R01AD	Corticosteroids	WHO ATC
0-L	R01AD01	beclometasone	WHO ATC
0-L	R01AD02	prednisolone	WHO ATC
0-L	R01AD03	dexamethasone	WHO ATC
0-L	R01AD04	flunisolide	WHO ATC
0-L	R01AD05	budesonide	WHO ATC
0-L	R01AD06	betamethasone	WHO ATC
0-L	R01AD07	tixocortol	WHO ATC
0-L	R01AD08	fluticasone	WHO ATC
0-L	R01AD09	mometasone	WHO ATC
0-L	R01AD11	triamcinolone	WHO ATC
0-L	R01AD12	fluticasone furoate	WHO ATC
0-L	R01AD52	prednisolone, combinations	WHO ATC
0-L	R01AD53	dexamethasone, combinations	WHO ATC
0-L	R01AD57	tixocortol, combinations	WHO ATC
0-L	R01AD60	hydrocortisone, combinations	WHO ATC
0-L	R01AX	Other nasal preparations	WHO ATC
0-L	R01AX01	calcium hexamine thiocyanate	WHO ATC
0-L	R01AX02	retinol	WHO ATC
0-L	R01AX03	ipratropium bromide	WHO ATC
0-L	R01AX05	ritiometan	WHO ATC
0-L	R01AX06	mupirocin	WHO ATC
0-L	R01AX07	hexamidine	WHO ATC
0-L	R01AX08	framycetin	WHO ATC
0-L	R01AX09	hyaluronic acid	WHO ATC
0-L	R01AX10	various	WHO ATC
0-L	R01AX30	combinations	WHO ATC
0-L	R01B	NASAL DECONGESTANTS FOR SYSTEMIC USE	WHO ATC
0-L	R01BA	Sympathomimetics	WHO ATC
0-L	R01BA01	phenylpropanolamine	WHO ATC
0-L	R01BA02	pseudoephedrine	WHO ATC
0-L	R01BA03	phenylephrine	WHO ATC
0-L	R01BA51	phenylpropanolamine, combinations	WHO ATC
0-L	R01BA52	pseudoephedrine, combinations	WHO ATC
0-L	R01BA53	phenylephrine, combinations	WHO ATC
0-L	R02	THROAT PREPARATIONS	WHO ATC
0-L	R02A	THROAT PREPARATIONS	WHO ATC
0-L	R02AA	Antiseptics	WHO ATC
0-L	R02AA01	ambazone	WHO ATC
0-L	R02AA02	dequalinium	WHO ATC
0-L	R02AA03	dichlorobenzyl alcohol	WHO ATC
0-L	R02AA05	chlorhexidine	WHO ATC
0-L	R02AA06	cetylpyridinium	WHO ATC
0-L	R02AA09	benzethonium	WHO ATC
0-L	R02AA10	myristyl-benzalkonium	WHO ATC
0-L	R02AA11	chlorquinaldol	WHO ATC
0-L	R02AA12	hexylresorcinol	WHO ATC
0-L	R02AA13	acriflavinium chloride	WHO ATC
0-L	R02AA14	oxyquinoline	WHO ATC
0-L	R02AA15	povidone-iodine	WHO ATC
0-L	R02AA16	benzalkonium	WHO ATC
0-L	R02AA17	cetrimonium	WHO ATC
0-L	R02AA18	hexamidine	WHO ATC
0-L	R02AA19	phenol	WHO ATC
0-L	R02AA20	various	WHO ATC
0-L	R02AB	Antibiotics	WHO ATC
0-L	R02AB01	neomycin	WHO ATC
0-L	R02AB02	tyrothricin	WHO ATC
0-L	R02AB03	fusafungine	WHO ATC
0-L	R02AB04	bacitracin	WHO ATC
0-L	R02AB30	gramicidin	WHO ATC
0-L	R02AD	Anesthetics, local	WHO ATC
0-L	R02AD01	benzocaine	WHO ATC
0-L	R02AD02	lidocaine	WHO ATC
0-L	R02AD03	cocaine	WHO ATC
0-L	R02AD04	dyclonine	WHO ATC
0-L	R02AX	Other throat preparations	WHO ATC
0-L	R02AX01	flurbiprofen	WHO ATC
0-L	R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES	WHO ATC
0-L	R03A	ADRENERGICS, INHALANTS	WHO ATC
0-L	R03AA	Alpha- and beta-adrenoreceptor agonists	WHO ATC
0-L	R03AA01	epinephrine	WHO ATC
0-L	R03AB	Non-selective beta-adrenoreceptor agonists	WHO ATC
0-L	R03AB02	isoprenaline	WHO ATC
0-L	R03AB03	orciprenaline	WHO ATC
0-L	R03AC	Selective beta-2-adrenoreceptor agonists	WHO ATC
0-L	R03AC02	salbutamol	WHO ATC
0-L	R03AC03	terbutaline	WHO ATC
0-L	R03AC04	fenoterol	WHO ATC
0-L	R03AC05	rimiterol	WHO ATC
0-L	R03AC06	hexoprenaline	WHO ATC
0-L	R03AC07	isoetarine	WHO ATC
0-L	R03AC08	pirbuterol	WHO ATC
0-L	R03AC09	tretoquinol	WHO ATC
0-L	R03AC10	carbuterol	WHO ATC
0-L	R03AC11	tulobuterol	WHO ATC
0-L	R03AC12	salmeterol	WHO ATC
0-L	R03AC13	formoterol	WHO ATC
0-L	R03AC14	clenbuterol	WHO ATC
0-L	R03AC15	reproterol	WHO ATC
0-L	R03AC16	procaterol	WHO ATC
0-L	R03AC17	bitolterol	WHO ATC
0-L	R03AC18	indacaterol	WHO ATC
0-L	R03AH	Combinations of adrenergics	WHO ATC
0-L	R03AK	Adrenergics and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK01	epinephrine and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK02	isoprenaline and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK03	fenoterol and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK04	salbutamol and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK05	reproterol and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK06	salmeterol and other drugs for obstructive airway diseases	WHO ATC
0-L	R03AK07	formoterol and other drugs for obstructive airway diseases	WHO ATC
0-L	R03B	OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS	WHO ATC
0-L	R03BA	Glucocorticoids	WHO ATC
0-L	R03BA01	beclometasone	WHO ATC
0-L	R03BA02	budesonide	WHO ATC
0-L	R03BA03	flunisolide	WHO ATC
0-L	R03BA04	betamethasone	WHO ATC
0-L	R03BA05	fluticasone	WHO ATC
0-L	R03BA06	triamcinolone	WHO ATC
0-L	R03BA07	mometasone	WHO ATC
0-L	R03BA08	ciclesonide	WHO ATC
0-L	R03BB	Anticholinergics	WHO ATC
0-L	R03BB01	ipratropium bromide	WHO ATC
0-L	R03BB02	oxitropium bromide	WHO ATC
0-L	R03BB03	stramoni preparations	WHO ATC
0-L	R03BB04	tiotropium bromide	WHO ATC
0-L	R03BC	Antiallergic agents, excl. corticosteroids	WHO ATC
0-L	R03BC01	cromoglicic acid	WHO ATC
0-L	R03BC03	nedocromil	WHO ATC
0-L	R03BX	Other drugs for obstructive airway diseases, inhalants	WHO ATC
0-L	R03BX01	fenspiride	WHO ATC
0-L	R03C	ADRENERGICS FOR SYSTEMIC USE	WHO ATC
0-L	R03CA	Alpha- and beta-adrenoreceptor agonists	WHO ATC
0-L	R03CA02	ephedrine	WHO ATC
0-L	R03CB	Non-selective beta-adrenoreceptor agonists	WHO ATC
0-L	R03CB01	isoprenaline	WHO ATC
0-L	R03CB02	methoxyphenamine	WHO ATC
0-L	R03CB03	orciprenaline	WHO ATC
0-L	R03CB51	isoprenaline, combinations	WHO ATC
0-L	R03CB53	orciprenaline, combinations	WHO ATC
0-L	R03CC	Selective beta-2-adrenoreceptor agonists	WHO ATC
0-L	R03CC02	salbutamol	WHO ATC
0-L	R03CC03	terbutaline	WHO ATC
0-L	R03CC04	fenoterol	WHO ATC
0-L	R03CC05	hexoprenaline	WHO ATC
0-L	R03CC06	isoetarine	WHO ATC
0-L	R03CC07	pirbuterol	WHO ATC
0-L	R03CC08	procaterol	WHO ATC
0-L	R03CC09	tretoquinol	WHO ATC
0-L	R03CC10	carbuterol	WHO ATC
0-L	R03CC11	tulobuterol	WHO ATC
0-L	R03CC12	bambuterol	WHO ATC
0-L	R03CC13	clenbuterol	WHO ATC
0-L	R03CC14	reproterol	WHO ATC
0-L	R03CC53	terbutaline, combinations	WHO ATC
0-L	R03CK	Adrenergics and other drugs for obstructive airway diseases	WHO ATC
0-L	R03D	OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES	WHO ATC
0-L	R03DA	Xanthines	WHO ATC
0-L	R03DA01	diprophylline	WHO ATC
0-L	R03DA02	choline theophyllinate	WHO ATC
0-L	R03DA03	proxyphylline	WHO ATC
0-L	R03DA04	theophylline	WHO ATC
0-L	R03DA05	aminophylline	WHO ATC
0-L	R03DA06	etamiphylline	WHO ATC
0-L	R03DA07	theobromine	WHO ATC
0-L	R03DA08	bamifylline	WHO ATC
0-L	R03DA09	acefylline piperazine	WHO ATC
0-L	R03DA10	bufylline	WHO ATC
0-L	R03DA11	doxofylline	WHO ATC
0-L	R03DA20	combinations of xanthines	WHO ATC
0-L	R03DA51	diprophylline, combinations	WHO ATC
0-L	R03DA54	theophylline, combinations excl. psycholeptics	WHO ATC
0-L	R03DA55	aminophylline, combinations	WHO ATC
0-L	R03DA57	theobromine, combinations	WHO ATC
0-L	R03DA74	theophylline, combinations with psycholeptics	WHO ATC
0-L	R03DB	Xanthines and adrenergics	WHO ATC
0-L	R03DB01	diprophylline and adrenergics	WHO ATC
0-L	R03DB02	choline theophyllinate and adrenergics	WHO ATC
0-L	R03DB03	proxyphylline and adrenergics	WHO ATC
0-L	R03DB04	theophylline and adrenergics	WHO ATC
0-L	R03DB05	aminophylline and adrenergics	WHO ATC
0-L	R03DB06	etamiphylline and adrenergics	WHO ATC
0-L	R03DC	Leukotriene receptor antagonists	WHO ATC
0-L	R03DC01	zafirlukast	WHO ATC
0-L	R03DC02	pranlukast	WHO ATC
0-L	R03DC03	montelukast	WHO ATC
0-L	R03DC04	ibudilast	WHO ATC
0-L	R03DX	Other systemic drugs for obstructive airway diseases	WHO ATC
0-L	R03DX01	amlexanox	WHO ATC
0-L	R03DX02	eprozinol	WHO ATC
0-L	R03DX03	fenspiride	WHO ATC
0-L	R03DX05	omalizumab	WHO ATC
0-L	R03DX06	seratrodast	WHO ATC
0-L	R03DX07	roflumilast	WHO ATC
0-L	R05	COUGH AND COLD PREPARATIONS	WHO ATC
0-L	R05C	EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS	WHO ATC
0-L	R05CA	Expectorants	WHO ATC
0-L	R05CA01	tyloxapol	WHO ATC
0-L	R05CA02	potassium iodide	WHO ATC
0-L	R05CA03	guaifenesin	WHO ATC
0-L	R05CA04	ipecacuanha	WHO ATC
0-L	R05CA05	althea root	WHO ATC
0-L	R05CA06	senega	WHO ATC
0-L	R05CA07	antimony pentasulfide	WHO ATC
0-L	R05CA08	creosote	WHO ATC
0-L	R05CA09	guaiacolsulfonate	WHO ATC
0-L	R05CA10	combinations	WHO ATC
0-L	R05CA11	levoverbenone	WHO ATC
0-L	R05CB	Mucolytics	WHO ATC
0-L	R05CB01	acetylcysteine	WHO ATC
0-L	R05CB02	bromhexine	WHO ATC
0-L	R05CB03	carbocisteine	WHO ATC
0-L	R05CB04	eprazinone	WHO ATC
0-L	R05CB05	mesna	WHO ATC
0-L	R05CB06	ambroxol	WHO ATC
0-L	R05CB07	sobrerol	WHO ATC
0-L	R05CB08	domiodol	WHO ATC
0-L	R05CB09	letosteine	WHO ATC
0-L	R05CB10	combinations	WHO ATC
0-L	R05CB11	stepronin	WHO ATC
0-L	R05CB12	tiopronin	WHO ATC
0-L	R05CB13	dornase alfa (desoxyribonuclease)	WHO ATC
0-L	R05CB14	neltenexine	WHO ATC
0-L	R05CB15	erdosteine	WHO ATC
0-L	R05D	COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS	WHO ATC
0-L	R05DA	Opium alkaloids and derivatives	WHO ATC
0-L	R05DA01	ethylmorphine	WHO ATC
0-L	R05DA03	hydrocodone	WHO ATC
0-L	R05DA04	codeine	WHO ATC
0-L	R05DA05	opium alkaloids with morphine	WHO ATC
0-L	R05DA06	normethadone	WHO ATC
0-L	R05DA07	noscapine	WHO ATC
0-L	R05DA08	pholcodine	WHO ATC
0-L	R05DA09	dextromethorphan	WHO ATC
0-L	R05DA10	thebacon	WHO ATC
0-L	R05DA11	dimemorfan	WHO ATC
0-L	R05DA12	acetyldihydrocodeine	WHO ATC
0-L	R05DA20	combinations	WHO ATC
0-L	R05DB	Other cough suppressants	WHO ATC
0-L	R05DB01	benzonatate	WHO ATC
0-L	R05DB02	benproperine	WHO ATC
0-L	R05DB03	clobutinol	WHO ATC
0-L	R05DB04	isoaminile	WHO ATC
0-L	R05DB05	pentoxyverine	WHO ATC
0-L	R05DB07	oxolamine	WHO ATC
0-L	R05DB09	oxeladin	WHO ATC
0-L	R05DB10	clofedanol	WHO ATC
0-L	R05DB11	pipazetate	WHO ATC
0-L	R05DB12	bibenzonium bromide	WHO ATC
0-L	R05DB13	butamirate	WHO ATC
0-L	R05DB14	fedrilate	WHO ATC
0-L	R05DB15	zipeprol	WHO ATC
0-L	R05DB16	dibunate	WHO ATC
0-L	R05DB17	droxypropine	WHO ATC
0-L	R05DB18	prenoxdiazine	WHO ATC
0-L	R05DB19	dropropizine	WHO ATC
0-L	R05DB20	combinations	WHO ATC
0-L	R05DB21	cloperastine	WHO ATC
0-L	R05DB22	meprotixol	WHO ATC
0-L	R05DB23	piperidione	WHO ATC
0-L	R05DB24	tipepidine	WHO ATC
0-L	R05DB25	morclofone	WHO ATC
0-L	R05DB26	nepinalone	WHO ATC
0-L	R05DB27	levodropropizine	WHO ATC
0-L	R05DB28	dimethoxanate	WHO ATC
0-L	R05F	COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS	WHO ATC
0-L	R05FA	Opium derivatives and expectorants	WHO ATC
0-L	R05FA01	opium derivatives and mucolytics	WHO ATC
0-L	R05FA02	opium derivatives and expectorants	WHO ATC
0-L	R05FB	Other cough suppressants and expectorants	WHO ATC
0-L	R05FB01	cough suppressants and mucolytics	WHO ATC
0-L	R05FB02	cough suppressants and expectorants	WHO ATC
0-L	R05X	OTHER COLD COMBINATION PREPARATIONS	WHO ATC
0-L	R06	ANTIHISTAMINES FOR SYSTEMIC USE	WHO ATC
0-L	R06A	ANTIHISTAMINES FOR SYSTEMIC USE	WHO ATC
0-L	R06AA	Aminoalkyl ethers	WHO ATC
0-L	R06AA01	bromazine	WHO ATC
0-L	R06AA02	diphenhydramine	WHO ATC
0-L	R06AA04	clemastine	WHO ATC
0-L	R06AA06	chlorphenoxamine	WHO ATC
0-L	R06AA07	diphenylpyraline	WHO ATC
0-L	R06AA08	carbinoxamine	WHO ATC
0-L	R06AA09	doxylamine	WHO ATC
0-L	R06AA52	diphenhydramine, combinations	WHO ATC
0-L	R06AA54	clemastine, combinations	WHO ATC
0-L	R06AA56	chlorphenoxamine, combinations	WHO ATC
0-L	R06AA57	diphenylpyraline, combinations	WHO ATC
0-L	R06AB	Substituted alkylamines	WHO ATC
0-L	R06AB01	brompheniramine	WHO ATC
0-L	R06AB02	dexchlorpheniramine	WHO ATC
0-L	R06AB03	dimetindene	WHO ATC
0-L	R06AB04	chlorphenamine	WHO ATC
0-L	R06AB05	pheniramine	WHO ATC
0-L	R06AB06	dexbrompheniramine	WHO ATC
0-L	R06AB07	talastine	WHO ATC
0-L	R06AB51	brompheniramine, combinations	WHO ATC
0-L	R06AB52	dexchlorpheniramine, combinations	WHO ATC
0-L	R06AB54	chlorphenamine, combinations	WHO ATC
0-L	R06AB56	dexbrompheniramine, combinations	WHO ATC
0-L	R06AC	Substituted ethylene diamines	WHO ATC
0-L	R06AC01	mepyramine	WHO ATC
0-L	R06AC02	histapyrrodine	WHO ATC
0-L	R06AC03	chloropyramine	WHO ATC
0-L	R06AC04	tripelennamine	WHO ATC
0-L	R06AC05	methapyrilene	WHO ATC
0-L	R06AC06	thonzylamine	WHO ATC
0-L	R06AC52	histapyrrodine, combinations	WHO ATC
0-L	R06AC53	chloropyramine, combinations	WHO ATC
0-L	R06AD	Phenothiazine derivatives	WHO ATC
0-L	R06AD01	alimemazine	WHO ATC
0-L	R06AD02	promethazine	WHO ATC
0-L	R06AD03	thiethylperazine	WHO ATC
0-L	R06AD04	methdilazine	WHO ATC
0-L	R06AD05	hydroxyethylpromethazine	WHO ATC
0-L	R06AD06	thiazinam	WHO ATC
0-L	R06AD07	mequitazine	WHO ATC
0-L	R06AD08	oxomemazine	WHO ATC
0-L	R06AD09	isothipendyl	WHO ATC
0-L	R06AD52	promethazine, combinations	WHO ATC
0-L	R06AD55	hydroxyethylpromethazine, combinations	WHO ATC
0-L	R06AE	Piperazine derivatives	WHO ATC
0-L	R06AE01	buclizine	WHO ATC
0-L	R06AE03	cyclizine	WHO ATC
0-L	R06AE04	chlorcyclizine	WHO ATC
0-L	R06AE05	meclozine	WHO ATC
0-L	R06AE06	oxatomide	WHO ATC
0-L	R06AE07	cetirizine	WHO ATC
0-L	R06AE09	levocetirizine	WHO ATC
0-L	R06AE51	buclizine, combinations	WHO ATC
0-L	R06AE53	cyclizine, combinations	WHO ATC
0-L	R06AE55	meclozine, combinations	WHO ATC
0-L	R06AK	Combinations of antihistamines	WHO ATC
0-L	R06AX	Other antihistamines for systemic use	WHO ATC
0-L	R06AX01	bamipine	WHO ATC
0-L	R06AX02	cyproheptadine	WHO ATC
0-L	R06AX03	thenalidine	WHO ATC
0-L	R06AX04	phenindamine	WHO ATC
0-L	R06AX05	antazoline	WHO ATC
0-L	R06AX07	triprolidine	WHO ATC
0-L	R06AX08	pyrrobutamine	WHO ATC
0-L	R06AX09	azatadine	WHO ATC
0-L	R06AX11	astemizole	WHO ATC
0-L	R06AX12	terfenadine	WHO ATC
0-L	R06AX13	loratadine	WHO ATC
0-L	R06AX15	mebhydrolin	WHO ATC
0-L	R06AX16	deptropine	WHO ATC
0-L	R06AX17	ketotifen	WHO ATC
0-L	R06AX18	acrivastine	WHO ATC
0-L	R06AX19	azelastine	WHO ATC
0-L	R06AX21	tritoqualine	WHO ATC
0-L	R06AX22	ebastine	WHO ATC
0-L	R06AX23	pimethixene	WHO ATC
0-L	R06AX24	epinastine	WHO ATC
0-L	R06AX25	mizolastine	WHO ATC
0-L	R06AX26	fexofenadine	WHO ATC
0-L	R06AX27	desloratadine	WHO ATC
0-L	R06AX28	rupatadine	WHO ATC
0-L	R06AX53	thenalidine, combinations	WHO ATC
0-L	R06AX58	pyrrobutamine, combinations	WHO ATC
0-L	R07	OTHER RESPIRATORY SYSTEM PRODUCTS	WHO ATC
0-L	R07A	OTHER RESPIRATORY SYSTEM PRODUCTS	WHO ATC
0-L	R07AA	Lung surfactants	WHO ATC
0-L	R07AA01	colfosceril palmitate	WHO ATC
0-L	R07AA02	natural phospholipids	WHO ATC
0-L	R07AA30	combinations	WHO ATC
0-L	R07AB	Respiratory stimulants	WHO ATC
0-L	R07AB01	doxapram	WHO ATC
0-L	R07AB02	nikethamide	WHO ATC
0-L	R07AB03	pentetrazol	WHO ATC
0-L	R07AB04	etamivan	WHO ATC
0-L	R07AB05	bemegride	WHO ATC
0-L	R07AB06	prethcamide	WHO ATC
0-L	R07AB07	almitrine	WHO ATC
0-L	R07AB08	dimefline	WHO ATC
0-L	R07AB09	mepixanox	WHO ATC
0-L	R07AB52	nikethamide, combinations	WHO ATC
0-L	R07AB53	pentetrazol, combinations	WHO ATC
0-L	R07AX	Other respiratory system products	WHO ATC
0-L	R07AX01	nitric oxide	WHO ATC
0-L	S	SENSORY ORGANS	WHO ATC
0-L	S01	OPHTHALMOLOGICALS	WHO ATC
0-L	S01A	ANTIINFECTIVES	WHO ATC
0-L	S01AA	Antibiotics	WHO ATC
0-L	S01AA01	chloramphenicol	WHO ATC
0-L	S01AA02	chlortetracycline	WHO ATC
0-L	S01AA03	neomycin	WHO ATC
0-L	S01AA04	oxytetracycline	WHO ATC
0-L	S01AA05	tyrothricin	WHO ATC
0-L	S01AA07	framycetin	WHO ATC
0-L	S01AA09	tetracycline	WHO ATC
0-L	S01AA10	natamycin	WHO ATC
0-L	S01AA11	gentamicin	WHO ATC
0-L	S01AA12	tobramycin	WHO ATC
0-L	S01AA13	fusidic acid	WHO ATC
0-L	S01AA14	benzylpenicillin	WHO ATC
0-L	S01AA15	dihydrostreptomycin	WHO ATC
0-L	S01AA16	rifamycin	WHO ATC
0-L	S01AA17	erythromycin	WHO ATC
0-L	S01AA18	polymyxin B	WHO ATC
0-L	S01AA19	ampicillin	WHO ATC
0-L	S01AA20	antibiotics in combination with other drugs	WHO ATC
0-L	S01AA21	amikacin	WHO ATC
0-L	S01AA22	micronomicin	WHO ATC
0-L	S01AA23	netilmicin	WHO ATC
0-L	S01AA24	kanamycin	WHO ATC
0-L	S01AA25	azidamfenicol	WHO ATC
0-L	S01AA26	azithromycin	WHO ATC
0-L	S01AA30	combinations of different antibiotics	WHO ATC
0-L	S01AB	Sulfonamides	WHO ATC
0-L	S01AB01	sulfamethizole	WHO ATC
0-L	S01AB02	sulfafurazole	WHO ATC
0-L	S01AB03	sulfadicramide	WHO ATC
0-L	S01AB04	sulfacetamide	WHO ATC
0-L	S01AB05	sulfafenazol	WHO ATC
0-L	S01AD	Antivirals	WHO ATC
0-L	S01AD01	idoxuridine	WHO ATC
0-L	S01AD02	trifluridine	WHO ATC
0-L	S01AD03	aciclovir	WHO ATC
0-L	S01AD05	interferon	WHO ATC
0-L	S01AD06	vidarabine	WHO ATC
0-L	S01AD07	famciclovir	WHO ATC
0-L	S01AD08	fomivirsen	WHO ATC
0-L	S01AD09	ganciclovir	WHO ATC
0-L	S01AX	Other antiinfectives	WHO ATC
0-L	S01AX01	mercury compounds	WHO ATC
0-L	S01AX02	silver compounds	WHO ATC
0-L	S01AX03	zinc compounds	WHO ATC
0-L	S01AX04	nitrofural	WHO ATC
0-L	S01AX05	bibrocathol	WHO ATC
0-L	S01AX06	resorcinol	WHO ATC
0-L	S01AX07	sodium borate	WHO ATC
0-L	S01AX08	hexamidine	WHO ATC
0-L	S01AX09	chlorhexidine	WHO ATC
0-L	S01AX10	sodium propionate	WHO ATC
0-L	S01AX11	ofloxacin	WHO ATC
0-L	S01AX12	norfloxacin	WHO ATC
0-L	S01AX13	ciprofloxacin	WHO ATC
0-L	S01AX14	dibrompropamidine	WHO ATC
0-L	S01AX15	propamidine	WHO ATC
0-L	S01AX16	picloxydine	WHO ATC
0-L	S01AX17	lomefloxacin	WHO ATC
0-L	S01AX18	povidone-iodine	WHO ATC
0-L	S01AX19	levofloxacin	WHO ATC
0-L	S01AX21	gatifloxacin	WHO ATC
0-L	S01AX22	moxifloxacin	WHO ATC
0-L	S01B	ANTIINFLAMMATORY AGENTS	WHO ATC
0-L	S01BA	Corticosteroids, plain	WHO ATC
0-L	S01BA01	dexamethasone	WHO ATC
0-L	S01BA02	hydrocortisone	WHO ATC
0-L	S01BA03	cortisone	WHO ATC
0-L	S01BA04	prednisolone	WHO ATC
0-L	S01BA05	triamcinolone	WHO ATC
0-L	S01BA06	betamethasone	WHO ATC
0-L	S01BA07	fluorometholone	WHO ATC
0-L	S01BA08	medrysone	WHO ATC
0-L	S01BA09	clobetasone	WHO ATC
0-L	S01BA10	alclometasone	WHO ATC
0-L	S01BA11	desonide	WHO ATC
0-L	S01BA12	formocortal	WHO ATC
0-L	S01BA13	rimexolone	WHO ATC
0-L	S01BA14	loteprednol	WHO ATC
0-L	S01BA15	fluocinolone acetonide	WHO ATC
0-L	S01BB	Corticosteroids and mydriatics in combination	WHO ATC
0-L	S01BB01	hydrocortisone and mydriatics	WHO ATC
0-L	S01BB02	prednisolone and mydriatics	WHO ATC
0-L	S01BB03	fluorometholone and mydriatics	WHO ATC
0-L	S01BB04	betamethasone and mydriatics	WHO ATC
0-L	S01BC	Antiinflammatory agents, non-steroids	WHO ATC
0-L	S01BC01	indometacin	WHO ATC
0-L	S01BC02	oxyphenbutazone	WHO ATC
0-L	S01BC03	diclofenac	WHO ATC
0-L	S01BC04	flurbiprofen	WHO ATC
0-L	S01BC05	ketorolac	WHO ATC
0-L	S01BC06	piroxicam	WHO ATC
0-L	S01BC07	bendazac	WHO ATC
0-L	S01BC08	salicylic acid	WHO ATC
0-L	S01BC09	pranoprofen	WHO ATC
0-L	S01BC10	nepafenac	WHO ATC
0-L	S01BC11	bromfenac	WHO ATC
0-L	S01C	ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION	WHO ATC
0-L	S01CA	Corticosteroids and antiinfectives in combination	WHO ATC
0-L	S01CA01	dexamethasone and antiinfectives	WHO ATC
0-L	S01CA02	prednisolone and antiinfectives	WHO ATC
0-L	S01CA03	hydrocortisone and antiinfectives	WHO ATC
0-L	S01CA04	fluocortolone and antiinfectives	WHO ATC
0-L	S01CA05	betamethasone and antiinfectives	WHO ATC
0-L	S01CA06	fludrocortisone and antiinfectives	WHO ATC
0-L	S01CA07	fluorometholone and antiinfectives	WHO ATC
0-L	S01CA08	methylprednisolone and antiinfectives	WHO ATC
0-L	S01CA09	chloroprednisone and antiinfectives	WHO ATC
0-L	S01CA10	fluocinolone acetonide and antiinfectives	WHO ATC
0-L	S01CA11	clobetasone and antiinfectives	WHO ATC
0-L	S01CB	Corticosteroids/antiinfectives/mydriatics in combination	WHO ATC
0-L	S01CB01	dexamethasone	WHO ATC
0-L	S01CB02	prednisolone	WHO ATC
0-L	S01CB03	hydrocortisone	WHO ATC
0-L	S01CB04	betamethasone	WHO ATC
0-L	S01CB05	fluorometholone	WHO ATC
0-L	S01CC	Antiinflammatory agents, non-steroids and antiinfectives in combination	WHO ATC
0-L	S01CC01	diclofenac and antiinfectives	WHO ATC
0-L	S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS	WHO ATC
0-L	S01EA	Sympathomimetics in glaucoma therapy	WHO ATC
0-L	S01EA01	epinephrine	WHO ATC
0-L	S01EA02	dipivefrine	WHO ATC
0-L	S01EA03	apraclonidine	WHO ATC
0-L	S01EA04	clonidine	WHO ATC
0-L	S01EA05	brimonidine	WHO ATC
0-L	S01EA51	epinephrine, combinations	WHO ATC
0-L	S01EB	Parasympathomimetics	WHO ATC
0-L	S01EB01	pilocarpine	WHO ATC
0-L	S01EB02	carbachol	WHO ATC
0-L	S01EB03	ecothiopate	WHO ATC
0-L	S01EB04	demecarium	WHO ATC
0-L	S01EB05	physostigmine	WHO ATC
0-L	S01EB06	neostigmine	WHO ATC
0-L	S01EB07	fluostigmine	WHO ATC
0-L	S01EB08	aceclidine	WHO ATC
0-L	S01EB09	acetylcholine	WHO ATC
0-L	S01EB10	paraoxon	WHO ATC
0-L	S01EB51	pilocarpine, combinations	WHO ATC
0-L	S01EB58	aceclidine, combinations	WHO ATC
0-L	S01EC	Carbonic anhydrase inhibitors	WHO ATC
0-L	S01EC01	acetazolamide	WHO ATC
0-L	S01EC02	diclofenamide	WHO ATC
0-L	S01EC03	dorzolamide	WHO ATC
0-L	S01EC04	brinzolamide	WHO ATC
0-L	S01EC05	methazolamide	WHO ATC
0-L	S01ED	Beta blocking agents1)	WHO ATC
0-L	S01ED01	timolol	WHO ATC
0-L	S01ED02	betaxolol	WHO ATC
0-L	S01ED03	levobunolol	WHO ATC
0-L	S01ED04	metipranolol	WHO ATC
0-L	S01ED05	carteolol	WHO ATC
0-L	S01ED06	befunolol	WHO ATC
0-L	S01ED51	timolol, combinations	WHO ATC
0-L	S01ED52	betaxolol, combinations	WHO ATC
0-L	S01ED54	metipranolol, combinations	WHO ATC
0-L	S01ED55	carteolol, combinations	WHO ATC
0-L	S01EE	Prostaglandin analogues1)	WHO ATC
0-L	S01EE01	latanoprost	WHO ATC
0-L	S01EE02	unoprostone	WHO ATC
0-L	S01EE03	bimatoprost	WHO ATC
0-L	S01EE04	travoprost	WHO ATC
0-L	S01EE05	tafluprost	WHO ATC
0-L	S01EX	Other antiglaucoma preparations	WHO ATC
0-L	S01EX01	guanethidine	WHO ATC
0-L	S01EX02	dapiprazole	WHO ATC
0-L	S01F	MYDRIATICS AND CYCLOPLEGICS	WHO ATC
0-L	S01FA	Anticholinergics	WHO ATC
0-L	S01FA01	atropine	WHO ATC
0-L	S01FA02	scopolamine	WHO ATC
0-L	S01FA03	methylscopolamine	WHO ATC
0-L	S01FA04	cyclopentolate	WHO ATC
0-L	S01FA05	homatropine	WHO ATC
0-L	S01FA06	tropicamide	WHO ATC
0-L	S01FA56	tropicamide, combinations	WHO ATC
0-L	S01FB	Sympathomimetics excl. antiglaucoma preparations	WHO ATC
0-L	S01FB01	phenylephrine	WHO ATC
0-L	S01FB02	ephedrine	WHO ATC
0-L	S01FB03	ibopamine	WHO ATC
0-L	S01G	DECONGESTANTS AND ANTIALLERGICS	WHO ATC
0-L	S01GA	Sympathomimetics used as decongestants	WHO ATC
0-L	S01GA01	naphazoline	WHO ATC
0-L	S01GA02	tetryzoline	WHO ATC
0-L	S01GA03	xylometazoline	WHO ATC
0-L	S01GA04	oxymetazoline	WHO ATC
0-L	S01GA05	phenylephrine	WHO ATC
0-L	S01GA06	oxedrine	WHO ATC
0-L	S01GA51	naphazoline, combinations	WHO ATC
0-L	S01GA52	tetryzoline, combinations	WHO ATC
0-L	S01GA53	xylometazoline, combinations	WHO ATC
0-L	S01GA55	phenylephrine, combinations	WHO ATC
0-L	S01GA56	oxedrine, combinations	WHO ATC
0-L	S01GX	Other antiallergics	WHO ATC
0-L	S01GX01	cromoglicic acid	WHO ATC
0-L	S01GX02	levocabastine	WHO ATC
0-L	S01GX03	spaglumic acid	WHO ATC
0-L	S01GX04	nedocromil	WHO ATC
0-L	S01GX05	lodoxamide	WHO ATC
0-L	S01GX06	emedastine	WHO ATC
0-L	S01GX07	azelastine	WHO ATC
0-L	S01GX08	ketotifen	WHO ATC
0-L	S01GX09	olopatadine	WHO ATC
0-L	S01GX10	epinastine	WHO ATC
0-L	S01GX51	cromoglicic acid, combinations	WHO ATC
0-L	S01H	LOCAL ANESTHETICS	WHO ATC
0-L	S01HA	Local anesthetics	WHO ATC
0-L	S01HA01	cocaine	WHO ATC
0-L	S01HA02	oxybuprocaine	WHO ATC
0-L	S01HA03	tetracaine	WHO ATC
0-L	S01HA04	proxymetacaine	WHO ATC
0-L	S01HA05	procaine	WHO ATC
0-L	S01HA06	cinchocaine	WHO ATC
0-L	S01HA07	lidocaine	WHO ATC
0-L	S01HA30	combinations	WHO ATC
0-L	S01J	DIAGNOSTIC AGENTS	WHO ATC
0-L	S01JA	Colouring agents	WHO ATC
0-L	S01JA01	fluorescein	WHO ATC
0-L	S01JA02	rose bengal sodium	WHO ATC
0-L	S01JA51	fluorescein, combinations	WHO ATC
0-L	S01JX	Other ophthalmological diagnostic agents	WHO ATC
0-L	S01K	SURGICAL AIDS	WHO ATC
0-L	S01KA	Viscoelastic substances	WHO ATC
0-L	S01KA01	hyaluronic acid	WHO ATC
0-L	S01KA02	hypromellose	WHO ATC
0-L	S01KA51	hyaluronic acid, combinations	WHO ATC
0-L	S01KX	Other surgical aids	WHO ATC
0-L	S01KX01	chymotrypsin	WHO ATC
0-L	S01L	OCULAR VASCULAR DISORDER AGENTS	WHO ATC
0-L	S01LA	Antineovascularisation agents	WHO ATC
0-L	S01LA01	verteporfin	WHO ATC
0-L	S01LA02	anecortave	WHO ATC
0-L	S01LA03	pegaptanib	WHO ATC
0-L	S01LA04	ranibizumab	WHO ATC
0-L	S01X	OTHER OPHTHALMOLOGICALS	WHO ATC
0-L	S01XA	Other ophthalmologicals	WHO ATC
0-L	S01XA01	guaiazulen	WHO ATC
0-L	S01XA02	retinol	WHO ATC
0-L	S01XA03	sodium chloride, hypertonic	WHO ATC
0-L	S01XA04	potassium iodide	WHO ATC
0-L	S01XA05	sodium edetate	WHO ATC
0-L	S01XA06	ethylmorphine	WHO ATC
0-L	S01XA07	alum	WHO ATC
0-L	S01XA08	acetylcysteine	WHO ATC
0-L	S01XA09	iodoheparinate	WHO ATC
0-L	S01XA10	inosine	WHO ATC
0-L	S01XA11	nandrolone	WHO ATC
0-L	S01XA12	dexpanthenol	WHO ATC
0-L	S01XA13	alteplase	WHO ATC
0-L	S01XA14	heparin	WHO ATC
0-L	S01XA15	ascorbic acid	WHO ATC
0-L	S01XA18	ciclosporin	WHO ATC
0-L	S01XA20	artificial tears and other indifferent preparations	WHO ATC
0-L	S02	OTOLOGICALS	WHO ATC
0-L	S02A	ANTIINFECTIVES	WHO ATC
0-L	S02AA	Antiinfectives	WHO ATC
0-L	S02AA01	chloramphenicol	WHO ATC
0-L	S02AA02	nitrofural	WHO ATC
0-L	S02AA03	boric acid	WHO ATC
0-L	S02AA04	aluminium acetotartrate	WHO ATC
0-L	S02AA05	clioquinol	WHO ATC
0-L	S02AA06	hydrogen peroxide	WHO ATC
0-L	S02AA07	neomycin	WHO ATC
0-L	S02AA08	tetracycline	WHO ATC
0-L	S02AA09	chlorhexidine	WHO ATC
0-L	S02AA10	acetic acid	WHO ATC
0-L	S02AA11	polymyxin B	WHO ATC
0-L	S02AA12	rifamycin	WHO ATC
0-L	S02AA13	miconazole	WHO ATC
0-L	S02AA14	gentamicin	WHO ATC
0-L	S02AA15	ciprofloxacin	WHO ATC
0-L	S02AA16	ofloxacin	WHO ATC
0-L	S02AA30	antiinfectives, combinations	WHO ATC
0-L	S02B	CORTICOSTEROIDS	WHO ATC
0-L	S02BA	Corticosteroids	WHO ATC
0-L	S02BA01	hydrocortisone	WHO ATC
0-L	S02BA03	prednisolone	WHO ATC
0-L	S02BA06	dexamethasone	WHO ATC
0-L	S02BA07	betamethasone	WHO ATC
0-L	S02BA08	fluocinolone acetonide	WHO ATC
0-L	S02C	CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION	WHO ATC
0-L	S02CA	Corticosteroids and antiinfectives in combination	WHO ATC
0-L	S02CA01	prednisolone and antiinfectives	WHO ATC
0-L	S02CA02	flumetasone and antiinfectives	WHO ATC
0-L	S02CA03	hydrocortisone and antiinfectives	WHO ATC
0-L	S02CA04	triamcinolone and antiinfectives	WHO ATC
0-L	S02CA05	fluocinolone acetonide and antiinfectives	WHO ATC
0-L	S02CA06	dexamethasone and antiinfectives	WHO ATC
0-L	S02CA07	fludrocortisone and antiinfectives	WHO ATC
0-L	S02D	OTHER OTOLOGICALS	WHO ATC
0-L	S02DA	Analgesics and anesthetics	WHO ATC
0-L	S02DA01	lidocaine	WHO ATC
0-L	S02DA02	cocaine	WHO ATC
0-L	S02DA03	phenazone	WHO ATC
0-L	S02DA30	combinations	WHO ATC
0-L	S02DC	Indifferent preparations	WHO ATC
0-L	S03	OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS	WHO ATC
0-L	S03A	ANTIINFECTIVES	WHO ATC
0-L	S03AA	Antiinfectives	WHO ATC
0-L	S03AA01	neomycin	WHO ATC
0-L	S03AA02	tetracycline	WHO ATC
0-L	S03AA03	polymyxin B	WHO ATC
0-L	S03AA04	chlorhexidine	WHO ATC
0-L	S03AA05	hexamidine	WHO ATC
0-L	S03AA06	gentamicin	WHO ATC
0-L	S03AA07	ciprofloxacin	WHO ATC
0-L	S03AA08	chloramphenicol	WHO ATC
0-L	S03AA30	antiinfectives, combinations	WHO ATC
0-L	S03B	CORTICOSTEROIDS	WHO ATC
0-L	S03BA	Corticosteroids	WHO ATC
0-L	S03BA01	dexamethasone	WHO ATC
0-L	S03BA02	prednisolone	WHO ATC
0-L	S03BA03	betamethasone	WHO ATC
0-L	S03C	CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION	WHO ATC
0-L	S03CA	Corticosteroids and antiinfectives in combination	WHO ATC
0-L	S03CA01	dexamethasone and antiinfectives	WHO ATC
0-L	S03CA02	prednisolone and antiinfectives	WHO ATC
0-L	S03CA04	hydrocortisone and antiinfectives	WHO ATC
0-L	S03CA05	fludrocortisone and antiinfectives	WHO ATC
0-L	S03CA06	betamethasone and antiinfectives	WHO ATC
0-L	S03D	OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS	WHO ATC
0-L	V	VARIOUS	WHO ATC
0-L	V01	ALLERGENS	WHO ATC
0-L	V01A	ALLERGENS	WHO ATC
0-L	V01AA	Allergen extracts	WHO ATC
0-L	V01AA01	feather	WHO ATC
0-L	V01AA02	grass pollen	WHO ATC
0-L	V01AA03	house dust mites	WHO ATC
0-L	V01AA04	mould fungus and yeast fungus	WHO ATC
0-L	V01AA05	tree pollen	WHO ATC
0-L	V01AA07	insects	WHO ATC
0-L	V01AA08	food	WHO ATC
0-L	V01AA09	textiles	WHO ATC
0-L	V01AA10	flowers	WHO ATC
0-L	V01AA11	animals	WHO ATC
0-L	V01AA20	various	WHO ATC
0-L	V03	ALL OTHER THERAPEUTIC PRODUCTS	WHO ATC
0-L	V03A	ALL OTHER THERAPEUTIC PRODUCTS	WHO ATC
0-L	V03AB	Antidotes	WHO ATC
0-L	V03AB01	ipecacuanha	WHO ATC
0-L	V03AB02	nalorphine	WHO ATC
0-L	V03AB03	edetates	WHO ATC
0-L	V03AB04	pralidoxime	WHO ATC
0-L	V03AB05	prednisolone and promethazine	WHO ATC
0-L	V03AB06	thiosulfate	WHO ATC
0-L	V03AB08	sodium nitrite	WHO ATC
0-L	V03AB09	dimercaprol	WHO ATC
0-L	V03AB13	obidoxime	WHO ATC
0-L	V03AB14	protamine	WHO ATC
0-L	V03AB15	naloxone	WHO ATC
0-L	V03AB16	ethanol	WHO ATC
0-L	V03AB17	methylthioninium chloride	WHO ATC
0-L	V03AB18	potassium permanganate	WHO ATC
0-L	V03AB19	physostigmine	WHO ATC
0-L	V03AB20	copper sulfate	WHO ATC
0-L	V03AB21	potassium iodide	WHO ATC
0-L	V03AB22	amyl nitrite	WHO ATC
0-L	V03AB23	acetylcysteine	WHO ATC
0-L	V03AB24	digitalis antitoxin	WHO ATC
0-L	V03AB25	flumazenil	WHO ATC
0-L	V03AB26	methionine	WHO ATC
0-L	V03AB27	4-dimethylaminophenol	WHO ATC
0-L	V03AB29	cholinesterase	WHO ATC
0-L	V03AB31	prussian blue	WHO ATC
0-L	V03AB32	glutathione	WHO ATC
0-L	V03AB33	hydroxocobalamin	WHO ATC
0-L	V03AB34	fomepizole	WHO ATC
0-L	V03AB35	sugammadex	WHO ATC
0-L	V03AC	Iron chelating agents	WHO ATC
0-L	V03AC01	deferoxamine	WHO ATC
0-L	V03AC02	deferiprone	WHO ATC
0-L	V03AC03	deferasirox	WHO ATC
0-L	V03AE	Drugs for treatment of hyperkalemia and hyperphosphatemia	WHO ATC
0-L	V03AE01	polystyrene sulfonate	WHO ATC
0-L	V03AE02	sevelamer	WHO ATC
0-L	V03AE03	lanthanum carbonate	WHO ATC
0-L	V03AE04	calcium acetate and magnesium carbonate	WHO ATC
0-L	V03AF	Detoxifying agents for antineoplastic treatment	WHO ATC
0-L	V03AF01	mesna	WHO ATC
0-L	V03AF02	dexrazoxane	WHO ATC
0-L	V03AF03	calcium folinate	WHO ATC
0-L	V03AF04	calcium levofolinate	WHO ATC
0-L	V03AF05	amifostine	WHO ATC
0-L	V03AF06	sodium folinate	WHO ATC
0-L	V03AF07	rasburicase	WHO ATC
0-L	V03AF08	palifermin	WHO ATC
0-L	V03AF09	glucarpidase	WHO ATC
0-L	V03AF10	sodium levofolinate	WHO ATC
0-L	V03AG	Drugs for treatment of hypercalcemia	WHO ATC
0-L	V03AG01	sodium cellulose phosphate	WHO ATC
0-L	V03AH	Drugs for treatment of hypoglycemia	WHO ATC
0-L	V03AH01	diazoxide	WHO ATC
0-L	V03AK	Tissue adhesives	WHO ATC
0-L	V03AM	Drugs for embolisation	WHO ATC
0-L	V03AN	Medical gases	WHO ATC
0-L	V03AN01	oxygen	WHO ATC
0-L	V03AN02	carbon dioxide	WHO ATC
0-L	V03AN03	helium	WHO ATC
0-L	V03AN04	nitrogen	WHO ATC
0-L	V03AN05	medical air	WHO ATC
0-L	V03AX	Other therapeutic products	WHO ATC
0-L	V03AX02	nalfurafine	WHO ATC
0-L	V03AZ	Nerve depressants	WHO ATC
0-L	V03AZ01	ethanol	WHO ATC
0-L	V04	DIAGNOSTIC AGENTS	WHO ATC
0-L	V04B	URINE TESTS	WHO ATC
0-L	V04C	OTHER DIAGNOSTIC AGENTS	WHO ATC
0-L	V04CA	Tests for diabetes	WHO ATC
0-L	V04CA01	tolbutamide	WHO ATC
0-L	V04CA02	glucose	WHO ATC
0-L	V04CB	Tests for fat absorption	WHO ATC
0-L	V04CB01	vitamin A concentrates	WHO ATC
0-L	V04CC	Tests for bile duct patency	WHO ATC
0-L	V04CC01	sorbitol	WHO ATC
0-L	V04CC02	magnesium sulfate	WHO ATC
0-L	V04CC03	sincalide	WHO ATC
0-L	V04CC04	ceruletide	WHO ATC
0-L	V04CD	Tests for pituitary function	WHO ATC
0-L	V04CD01	metyrapone	WHO ATC
0-L	V04CD03	sermorelin	WHO ATC
0-L	V04CD04	corticorelin	WHO ATC
0-L	V04CD05	somatorelin	WHO ATC
0-L	V04CE	Tests for liver functional capacity	WHO ATC
0-L	V04CE01	galactose	WHO ATC
0-L	V04CE02	sulfobromophthalein	WHO ATC
0-L	V04CF	Tuberculosis diagnostics	WHO ATC
0-L	V04CF01	tuberculin	WHO ATC
0-L	V04CG	Tests for gastric secretion	WHO ATC
0-L	V04CG01	cation exchange resins	WHO ATC
0-L	V04CG02	betazole	WHO ATC
0-L	V04CG03	histamine phosphate	WHO ATC
0-L	V04CG04	pentagastrin	WHO ATC
0-L	V04CG05	methylthioninium chloride	WHO ATC
0-L	V04CG30	caffeine and sodium benzoate	WHO ATC
0-L	V04CH	Tests for renal function	WHO ATC
0-L	V04CH01	inulin and other polyfructosans	WHO ATC
0-L	V04CH02	indigo carmine	WHO ATC
0-L	V04CH03	phenolsulfonphthalein	WHO ATC
0-L	V04CH04	alsactide	WHO ATC
0-L	V04CH30	aminohippuric acid	WHO ATC
0-L	V04CJ	Tests for thyreoidea function	WHO ATC
0-L	V04CJ01	thyrotropin	WHO ATC
0-L	V04CJ02	protirelin	WHO ATC
0-L	V04CK	Tests for pancreatic function	WHO ATC
0-L	V04CK01	secretin	WHO ATC
0-L	V04CK02	pancreozymin (cholecystokinin)	WHO ATC
0-L	V04CK03	bentiromide	WHO ATC
0-L	V04CL	Tests for allergic diseases	WHO ATC
0-L	V04CM	Tests for fertility disturbances	WHO ATC
0-L	V04CM01	gonadorelin	WHO ATC
0-L	V04CX	Other diagnostic agents	WHO ATC
0-L	V06	GENERAL NUTRIENTS	WHO ATC
0-L	V06A	DIET FORMULATIONS FOR TREATMENT OF OBESITY	WHO ATC
0-L	V06AA	Low-energy diets	WHO ATC
0-L	V06B	PROTEIN SUPPLEMENTS	WHO ATC
0-L	V06C	INFANT FORMULAS	WHO ATC
0-L	V06CA	Nutrients without phenylalanine	WHO ATC
0-L	V06D	OTHER NUTRIENTS	WHO ATC
0-L	V06DA	Carbohydrates/proteins/minerals/vitamins, combinations	WHO ATC
0-L	V06DB	Fat/carbohydrates/proteins/minerals/vitamins, combinations	WHO ATC
0-L	V06DC	Carbohydrates	WHO ATC
0-L	V06DC01	glucose	WHO ATC
0-L	V06DC02	fructose	WHO ATC
0-L	V06DD	Amino acids, incl. combinations with polypeptides	WHO ATC
0-L	V06DE	Amino acids/carbohydrates/minerals/vitamins, combinations	WHO ATC
0-L	V06DF	Milk substitutes	WHO ATC
0-L	V06DX	Other combinations of nutrients	WHO ATC
0-L	V07	ALL OTHER NON-THERAPEUTIC PRODUCTS	WHO ATC
0-L	V07A	ALL OTHER NON-THERAPEUTIC PRODUCTS	WHO ATC
0-L	V07AA	Plasters	WHO ATC
0-L	V07AB	Solvents and diluting agents, incl. irrigating solutions	WHO ATC
0-L	V07AC	Blood transfusion, auxiliary products	WHO ATC
0-L	V07AD	Blood tests, auxiliary products	WHO ATC
0-L	V07AN	Incontinence equipment	WHO ATC
0-L	V07AR	Sensitivity tests, discs and tablets	WHO ATC
0-L	V07AS	Stomi equipment	WHO ATC
0-L	V07AT	Cosmetics	WHO ATC
0-L	V07AV	Technical disinfectants	WHO ATC
0-L	V07AX	Washing agents etc.	WHO ATC
0-L	V07AY	Other non-therapeutic auxiliary products	WHO ATC
0-L	V07AZ	Chemicals and reagents for analysis	WHO ATC
0-L	V08	CONTRAST MEDIA	WHO ATC
0-L	V08A	X-RAY CONTRAST MEDIA, IODINATED	WHO ATC
0-L	V08AA	Watersoluble, nephrotropic, high osmolar X-ray contrast media	WHO ATC
0-L	V08AA01	diatrizoic acid	WHO ATC
0-L	V08AA02	metrizoic acid	WHO ATC
0-L	V08AA03	iodamide	WHO ATC
0-L	V08AA04	iotalamic acid	WHO ATC
0-L	V08AA05	ioxitalamic acid	WHO ATC
0-L	V08AA06	ioglicic acid	WHO ATC
0-L	V08AA07	acetrizoic acid	WHO ATC
0-L	V08AA08	iocarmic acid	WHO ATC
0-L	V08AA09	methiodal	WHO ATC
0-L	V08AA10	diodone	WHO ATC
0-L	V08AB	Watersoluble, nephrotropic, low osmolar X-ray contrast media	WHO ATC
0-L	V08AB01	metrizamide	WHO ATC
0-L	V08AB02	iohexol	WHO ATC
0-L	V08AB03	ioxaglic acid	WHO ATC
0-L	V08AB04	iopamidol	WHO ATC
0-L	V08AB05	iopromide	WHO ATC
0-L	V08AB06	iotrolan	WHO ATC
0-L	V08AB07	ioversol	WHO ATC
0-L	V08AB08	iopentol	WHO ATC
0-L	V08AB09	iodixanol	WHO ATC
0-L	V08AB10	iomeprol	WHO ATC
0-L	V08AB11	iobitridol	WHO ATC
0-L	V08AB12	ioxilan	WHO ATC
0-L	V08AC	Watersoluble, hepatotropic X-ray contrast media	WHO ATC
0-L	V08AC01	iodoxamic acid	WHO ATC
0-L	V08AC02	iotroxic acid	WHO ATC
0-L	V08AC03	ioglycamic acid	WHO ATC
0-L	V08AC04	adipiodone	WHO ATC
0-L	V08AC05	iobenzamic acid	WHO ATC
0-L	V08AC06	iopanoic acid	WHO ATC
0-L	V08AC07	iocetamic acid	WHO ATC
0-L	V08AC08	sodium iopodate	WHO ATC
0-L	V08AC09	tyropanoic acid	WHO ATC
0-L	V08AC10	calcium iopodate	WHO ATC
0-L	V08AD	Non-watersoluble X-ray contrast media	WHO ATC
0-L	V08AD01	ethyl esters of iodised fatty acids	WHO ATC
0-L	V08AD02	iopydol	WHO ATC
0-L	V08AD03	propyliodone	WHO ATC
0-L	V08AD04	iofendylate	WHO ATC
0-L	V08B	X-RAY CONTRAST MEDIA, NON-IODINATED	WHO ATC
0-L	V08BA	Barium sulfate containing X-ray contrast media	WHO ATC
0-L	V08BA01	barium sulfate with suspending agents	WHO ATC
0-L	V08BA02	barium sulfate without suspending agents	WHO ATC
0-L	V08C	MAGNETIC RESONANCE IMAGING CONTRAST MEDIA	WHO ATC
0-L	V08CA	Paramagnetic contrast media	WHO ATC
0-L	V08CA01	gadopentetic acid	WHO ATC
0-L	V08CA02	gadoteric acid	WHO ATC
0-L	V08CA03	gadodiamide	WHO ATC
0-L	V08CA04	gadoteridol	WHO ATC
0-L	V08CA05	mangafodipir	WHO ATC
0-L	V08CA06	gadoversetamide	WHO ATC
0-L	V08CA07	ferric ammonium citrate	WHO ATC
0-L	V08CA08	gadobenic acid	WHO ATC
0-L	V08CA09	gadobutrol	WHO ATC
0-L	V08CA10	gadoxetic acid	WHO ATC
0-L	V08CA11	gadofosveset	WHO ATC
0-L	V08CB	Superparamagnetic contrast media	WHO ATC
0-L	V08CB01	ferumoxsil	WHO ATC
0-L	V08CB02	ferristene	WHO ATC
0-L	V08CB03	iron oxide, nanoparticles	WHO ATC
0-L	V08CX	Other magnetic resonance imaging contrast media	WHO ATC
0-L	V08CX01	perflubron	WHO ATC
0-L	V08D	ULTRASOUND CONTRAST MEDIA	WHO ATC
0-L	V08DA	Ultrasound contrast media	WHO ATC
0-L	V08DA01	microspheres of human albumin	WHO ATC
0-L	V08DA02	microparticles of galactose	WHO ATC
0-L	V08DA03	perflenapent	WHO ATC
0-L	V08DA04	microspheres of phospholipids	WHO ATC
0-L	V08DA05	sulfur hexafluoride	WHO ATC
0-L	V09	DIAGNOSTIC RADIOPHARMACEUTICALS	WHO ATC
0-L	V09A	CENTRAL NERVOUS SYSTEM	WHO ATC
0-L	V09AA	Technetium (99mTc) compounds	WHO ATC
0-L	V09AA01	technetium (99mTc) exametazime	WHO ATC
0-L	V09AA02	technetium (99mTc) bicisate	WHO ATC
0-L	V09AB	Iodine (123I) compounds	WHO ATC
0-L	V09AB01	iodine iofetamine (123I)	WHO ATC
0-L	V09AB02	iodine iolopride (123I)	WHO ATC
0-L	V09AB03	iodine ioflupane (123I)	WHO ATC
0-L	V09AX	Other central nervous system diagnostic radiopharmaceuticals	WHO ATC
0-L	V09AX01	indium (111In) pentetic acid	WHO ATC
0-L	V09AX03	iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane	WHO ATC
0-L	V09B	SKELETON	WHO ATC
0-L	V09BA	Technetium (99mTc) compounds	WHO ATC
0-L	V09BA01	technetium (99mTc) oxidronic acid	WHO ATC
0-L	V09BA02	technetium (99mTc) medronic acid	WHO ATC
0-L	V09BA03	technetium (99mTc) pyrophosphate	WHO ATC
0-L	V09BA04	technetium (99mTc) butedronic acid	WHO ATC
0-L	V09C	RENAL SYSTEM	WHO ATC
0-L	V09CA	Technetium (99mTc) compounds	WHO ATC
0-L	V09CA01	technetium (99mTc) pentetic acid	WHO ATC
0-L	V09CA02	technetium (99mTc) succimer	WHO ATC
0-L	V09CA03	technetium (99mTc) mertiatide	WHO ATC
0-L	V09CA04	technetium (99mTc) gluceptate	WHO ATC
0-L	V09CA05	technetium (99mTc) gluconate	WHO ATC
0-L	V09CX	Other renal system diagnostic radiopharmaceuticals	WHO ATC
0-L	V09CX01	sodium iodohippurate (123I)	WHO ATC
0-L	V09CX02	sodium iodohippurate (131I)	WHO ATC
0-L	V09CX03	sodium iothalamate (125I)	WHO ATC
0-L	V09CX04	chromium (51Cr) edetate	WHO ATC
0-L	V09D	HEPATIC AND RETICULO ENDOTHELIAL SYSTEM	WHO ATC
0-L	V09DA	Technetium (99mTc) compounds	WHO ATC
0-L	V09DA01	technetium (99mTc) disofenin	WHO ATC
0-L	V09DA02	technetium (99mTc) etifenin	WHO ATC
0-L	V09DA03	technetium (99mTc) lidofenin	WHO ATC
0-L	V09DA04	technetium (99mTc) mebrofenin	WHO ATC
0-L	V09DA05	technetium (99mTc) galtifenin	WHO ATC
0-L	V09DB	Technetium (99mTc), particles and colloids	WHO ATC
0-L	V09DB01	technetium (99mTc) nanocolloid	WHO ATC
0-L	V09DB02	technetium (99mTc) microcolloid	WHO ATC
0-L	V09DB03	technetium (99mTc) millimicrospheres	WHO ATC
0-L	V09DB04	technetium (99mTc) tin colloid	WHO ATC
0-L	V09DB05	technetium (99mTc) sulfur colloid	WHO ATC
0-L	V09DB06	technetium (99mTc) rheniumsulfide colloid	WHO ATC
0-L	V09DB07	technetium (99mTc) phytate	WHO ATC
0-L	V09DX	Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals	WHO ATC
0-L	V09DX01	selenium (75Se) tauroselcholic acid	WHO ATC
0-L	V09E	RESPIRATORY SYSTEM	WHO ATC
0-L	V09EA	Technetium (99mTc), inhalants	WHO ATC
0-L	V09EA01	technetium (99mTc) pentetic acid	WHO ATC
0-L	V09EA02	technetium (99mTc) technegas	WHO ATC
0-L	V09EA03	technetium (99mTc) nanocolloid	WHO ATC
0-L	V09EB	Technetium (99mTc), particles for injection	WHO ATC
0-L	V09EB01	technetium (99mTc) macrosalb	WHO ATC
0-L	V09EB02	technetium (99mTc) microspheres	WHO ATC
0-L	V09EX	Other respiratory system diagnostic radiopharmaceuticals	WHO ATC
0-L	V09EX01	krypton (81mKr) gas	WHO ATC
0-L	V09EX02	xenon (127Xe) gas	WHO ATC
0-L	V09EX03	xenon (133Xe) gas	WHO ATC
0-L	V09F	THYROID	WHO ATC
0-L	V09FX	Various thyroid diagnostic radiopharmaceuticals	WHO ATC
0-L	V09FX01	technetium (99mTc) pertechnetate	WHO ATC
0-L	V09FX02	sodium iodide (123I)	WHO ATC
0-L	V09FX03	sodium iodide (131I)	WHO ATC
0-L	V09FX04	sodium iodide (124I)	WHO ATC
0-L	V09G	CARDIOVASCULAR SYSTEM	WHO ATC
0-L	V09GA	Technetium (99mTc) compounds	WHO ATC
0-L	V09GA01	technetium (99mTc) sestamibi	WHO ATC
0-L	V09GA02	technetium (99mTc) tetrofosmin	WHO ATC
0-L	V09GA03	technetium (99mTc) teboroxime	WHO ATC
0-L	V09GA04	technetium (99mTc) human albumin	WHO ATC
0-L	V09GA05	technetium (99mTc) furifosmin	WHO ATC
0-L	V09GA06	technetium (99mTc) stannous agent labelled cells	WHO ATC
0-L	V09GA07	technetium (99mTc) apcitide	WHO ATC
0-L	V09GB	Iodine (125I) compounds	WHO ATC
0-L	V09GB01	fibrinogen (125I)	WHO ATC
0-L	V09GB02	iodine (125I) human albumin	WHO ATC
0-L	V09GX	Other cardiovascular system diagnostic radiopharmaceuticals	WHO ATC
0-L	V09GX01	thallium (201Tl) chloride	WHO ATC
0-L	V09GX02	indium (111In) imciromab	WHO ATC
0-L	V09GX03	chromium (51Cr) chromate labelled cells	WHO ATC
0-L	V09H	INFLAMMATION AND INFECTION DETECTION	WHO ATC
0-L	V09HA	Technetium (99mTc) compounds	WHO ATC
0-L	V09HA01	technetium (99mTc) human immunoglobulin	WHO ATC
0-L	V09HA02	technetium (99mTc) exametazime labelled cells	WHO ATC
0-L	V09HA03	technetium (99mTc) antigranulocyte antibody	WHO ATC
0-L	V09HA04	technetium (99mTc) sulesomab	WHO ATC
0-L	V09HB	Indium (111In) compounds	WHO ATC
0-L	V09HB01	indium (111In) oxinate labelled cells	WHO ATC
0-L	V09HB02	indium (111In) tropolonate labelled cells	WHO ATC
0-L	V09HX	Other diagnostic radiopharmaceuticals for inflammation and infection detection	WHO ATC
0-L	V09HX01	gallium (67Ga) citrate	WHO ATC
0-L	V09I	TUMOUR DETECTION	WHO ATC
0-L	V09IA	Technetium (99mTc) compounds	WHO ATC
0-L	V09IA01	technetium (99mTc) antiCarcinoEmbryonicAntigen antibody	WHO ATC
0-L	V09IA02	technetium (99mTc) antimelanoma antibody	WHO ATC
0-L	V09IA03	technetium (99mTc) pentavalent succimer	WHO ATC
0-L	V09IA04	technetium (99mTc) votumumab	WHO ATC
0-L	V09IA05	technetium (99mTc) depreotide	WHO ATC
0-L	V09IA06	technetium (99mTc) arcitumomab	WHO ATC
0-L	V09IB	Indium (111In) compounds	WHO ATC
0-L	V09IB01	indium (111In) pentetreotide	WHO ATC
0-L	V09IB02	indium (111In) satumomab pendetide	WHO ATC
0-L	V09IB03	indium (111In) antiovariumcarcinoma antibody	WHO ATC
0-L	V09IB04	indium (111In) capromab pendetide	WHO ATC
0-L	V09IX	Other diagnostic radiopharmaceuticals for tumour detection	WHO ATC
0-L	V09IX01	iobenguane (123I)	WHO ATC
0-L	V09IX02	iobenguane (131I)	WHO ATC
0-L	V09IX03	iodine (125I) CC49-monoclonal antibody	WHO ATC
0-L	V09IX04	fludeoxyglucose (18F)	WHO ATC
0-L	V09IX05	fluorodopa (18F)	WHO ATC
0-L	V09IX06	sodium fluoride (18F)	WHO ATC
0-L	V09IX07	fluoromethylcholine (18F)	WHO ATC
0-L	V09X	OTHER DIAGNOSTIC RADIOPHARMACEUTICALS	WHO ATC
0-L	V09XA	Iodine (131I) compounds	WHO ATC
0-L	V09XA01	iodine (131I) norcholesterol	WHO ATC
0-L	V09XA02	iodocholesterol (131I)	WHO ATC
0-L	V09XA03	iodine (131I) human albumin	WHO ATC
0-L	V09XX	Various diagnostic radiopharmaceuticals	WHO ATC
0-L	V09XX01	cobalt (57Co) cyanocobalamine	WHO ATC
0-L	V09XX02	cobalt (58Co) cyanocobalamine	WHO ATC
0-L	V09XX03	selenium (75Se) norcholesterol	WHO ATC
0-L	V09XX04	ferric (59Fe) citrate	WHO ATC
0-L	V10	THERAPEUTIC RADIOPHARMACEUTICALS	WHO ATC
0-L	V10A	ANTIINFLAMMATORY AGENTS	WHO ATC
0-L	V10AA	Yttrium (90Y) compounds	WHO ATC
0-L	V10AA01	yttrium (90Y) citrate colloid	WHO ATC
0-L	V10AA02	yttrium (90Y) ferrihydroxide colloid	WHO ATC
0-L	V10AA03	yttrium (90Y) silicate colloid	WHO ATC
0-L	V10AX	Other antiinflammatory therapeutic radiopharmaceuticals	WHO ATC
0-L	V10AX01	phosphorous (32P) chromicphosphate colloid	WHO ATC
0-L	V10AX02	samarium (153Sm) hydroxyapatite colloid	WHO ATC
0-L	V10AX03	dysprosium (165Dy) colloid	WHO ATC
0-L	V10AX04	erbium (169Er) citrate colloid	WHO ATC
0-L	V10AX05	rhenium (186Re) sulfide colloid	WHO ATC
0-L	V10AX06	gold (198Au) colloidal	WHO ATC
0-L	V10B	PAIN PALLIATION (BONE SEEKING AGENTS)	WHO ATC
0-L	V10BX	Various pain palliation radiopharmaceuticals	WHO ATC
0-L	V10BX01	strontium (89Sr) chloride	WHO ATC
0-L	V10BX02	samarium (153Sm) lexidronam	WHO ATC
0-L	V10BX03	rhenium (186Re) etidronic acid	WHO ATC
0-L	V10X	OTHER THERAPEUTIC RADIOPHARMACEUTICALS	WHO ATC
0-L	V10XA	Iodine (131I) compounds	WHO ATC
0-L	V10XA01	sodium iodide (131I)	WHO ATC
0-L	V10XA02	iobenguane (131I)	WHO ATC
0-L	V10XA53	tositumomab/iodine (131I) tositumomab	WHO ATC
0-L	V10XX	Various therapeutic radiopharmaceuticals	WHO ATC
0-L	V10XX01	sodium phosphate (32P)	WHO ATC
0-L	V10XX02	ibritumomab tiuxetan (90Y)	WHO ATC
0-L	V20	SURGICAL DRESSINGS	WHO ATC

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.

CSV XML

Value Set epSOSActiveIngredient 2013‑06‑03 The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies an...

Value Set epSOSActiveIngredient 2013‑06‑03

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies an...